10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☑	Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
	For the Quarterly Period Ended	March 31, 2020
	or

☐	Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
	For the transition period
	from____________________	to_________________________

Commission File Number: 0-261

ALICO, INC.

(Exact name of registrant as specified in its charter)

Florida			59-0906081
(State or other jurisdiction of incorporation or organization)			(I.R.S. Employer Identification No.)
10070 Daniels Interstate Court
Suite 100	Fort Myers	FL	33913
(Address of principal executive offices)			(Zip Code)

(239)	226-2000
(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock	ALCO	Nasdaq Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☑Yes ☐ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☑Yes ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer” and “smaller reporting company” and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check one):

Large Accelerated Filer	☐	Accelerated Filer	☑
Non-accelerated filer	☐	Smaller Reporting Company	☐
Emerging Growth Company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes ☐ No ☑

There were 7,486,108 shares of common stock outstanding at May 8, 2020.

ALICO, INC.

FORM 10-Q

For the three and six months ended March 31, 2020 and 2019

Table of Contents

Part I - FINANCIAL INFORMATION
Item 1. Condensed Consolidated Financial Statements	1
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations	24
Item 3. Quantitative and Qualitative Disclosures About Market Risk	36
Item 4. Controls and Procedures	36
Part II - OTHER INFORMATION
Item 1. Legal Proceedings	37
Item 1A. Risk Factors	37
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	38
Item 3. Defaults Upon Senior Securities	38
Item 4. Mine Safety Disclosures	38
Item 5. Other Information	39
Item 6. Exhibits	39
Signatures	40

PART I

Item 1. Condensed Consolidated Financial Statements

Index to Condensed Consolidated Financial Statements

	Page
Condensed Consolidated Balance Sheets as of March 31, 2020 (Unaudited) and September 30, 2019	1
Condensed Consolidated Statements of Operations for the three and six months ended March 31, 2020 and 2019 (Unaudited)	2
Condensed Consolidated Statements of Changes in Equity for the three and six months ended March 31, 2020 and 2019 (Unaudited)	3
Condensed Consolidated Statements of Cash Flows for the six months ended March 31, 2020 and 2019 (Unaudited)	5
Notes to Condensed Consolidated Financial Statements (Unaudited)	6

ALICO, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands, except share amounts)
	March 31,			September 30,
	2020			2019
	(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents	$	80,407		$	18,630
Accounts receivable, net	4,385			713
Inventories	28,503			40,143
Assets held for sale	1,366			1,442
Prepaid expenses and other current assets	1,521			1,049
Total current assets	116,182			61,977
Restricted cash	3,671			5,208
Property and equipment, net	347,816			345,648
Goodwill	2,246			2,246
Other non-current assets	2,369			2,309
Total assets	$	472,284		$	417,388
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable	$	5,154		$	4,163
Accrued liabilities	4,943			7,769
Long-term debt, current portion	5,130			5,338
Deferred retirement obligations	5,226			5,226
Income taxes payable	2,660			5,536
Other current liabilities	554			919
Total current liabilities	23,667			28,951
Long-term debt:
Principal amount, net of current portion	148,499			158,111
Less: deferred financing costs, net	(1,240		)	(1,369		)
Long-term debt less current portion and deferred financing costs, net	147,259			156,742
Lines of credit	66,714			—
Deferred income tax liabilities, net	31,298			32,125
Other liabilities	278			172
Total liabilities	269,216			217,990
Commitments and Contingencies (Note 12)
Stockholders' equity:
Preferred stock, no par value, 1,000,000 shares authorized; none issued	—			—
Common stock, $1.00 par value, 15,000,000 shares authorized; 8,416,145 shares issued and 7,479,671 and 7,476,513 shares outstanding at March 31, 2020 and September 30, 2019, respectively	8,416			8,416
Additional paid in capital	20,174			19,781
Treasury stock, at cost, 936,474 and 939,632 shares held at March 31, 2020 and September 30, 2019, respectively	(31,784		)	(31,943		)
Retained earnings	201,065			198,049
Total Alico stockholders' equity	197,871			194,303
Noncontrolling interest	5,197			5,095
Total stockholders' equity	203,068			199,398
Total liabilities and stockholders' equity	$	472,284		$	417,388

See accompanying notes to the condensed consolidated financial statements.

1

ALICO, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (in thousands, except per share amounts)
	Three Months Ended March 31,						Six Months Ended March 31,
	2020			2019			2020			2019
Operating revenues:
Alico Citrus	$	49,801		$	47,823		$	59,976		$	61,720
Water Resources and Other Operations	714			698			1,544			1,580
Total operating revenues	50,515			48,521			61,520			63,300
Operating expenses:
Alico Citrus	43,518			31,582			48,358			42,456
Water Resources and Other Operations	380			625			931			1,348
Total operating expenses	43,898			32,207			49,289			43,804
Gross profit	6,617			16,314			12,231			19,496
General and administrative expenses	2,953			4,654			5,713			8,104
Income from operations	3,664			11,660			6,518			11,392
Other income (expense), net:
Interest expense	(1,452		)	(1,963		)	(2,996		)	(3,880		)
Gain on sale of real estate, property and equipment and assets held for sale	2,838			1			2,863			23
Change in fair value of derivatives	—			(33		)	—			(989		)
Other income (expense)	12			23			(64		)	10
Total other income (expense), net	1,398			(1,972		)	(197		)	(4,836		)
Income before income taxes	5,062			9,688			6,321			6,556
Income tax provision	1,496			2,228			1,857			1,599
Net income	3,566			7,460			4,464			4,957
Net loss (income) attributable to noncontrolling interests	5			87			(102		)	123
Net income attributable to Alico, Inc. common stockholders	$	3,571		$	7,547		$	4,362		$	5,080
Per share information attributable to Alico, Inc. common stockholders:
Earnings per common share:
Basic	$	0.48		$	1.01		$	0.58		$	0.68
Diluted	$	0.48		$	1.01		$	0.58		$	0.68
Weighted-average number of common shares outstanding:
Basic	7,480			7,463			7,478			7,471
Diluted	7,496			7,469			7,494			7,506
Cash dividends declared per common share	$	0.09		$	0.06		$	0.18		$	0.12

See accompanying notes to the condensed consolidated financial statements.

2

ALICO, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED)
(in thousands)
For the Three Months Ended March 31, 2020
				Additional									Total			Non-
	Common stock			Paid In			Treasury			Retained			Alico, Inc.			controlling			Total
	Shares	Amount		Capital			Stock			Earnings			Equity			Interest			Equity
Balance at December 31, 2019	8,416	$	8,416	$	19,857		$	(31,956	)	$	198,169		$	194,486		$	5,202		$	199,688
Net income (loss)	—	—		—			—			3,571			3,571			(5		)	3,566
Dividends ($0.09/share)	—	—		—			—			(675		)	(675		)	—			(675		)
Stock-based compensation:
Directors	—	—		(10		)	172			—			162			—			162
Executives	—	—		327			—			—			327			—			327
Balance at March 31, 2020	8,416	$	8,416	$	20,174		$	(31,784	)	$	201,065		$	197,871		$	5,197		$	203,068
For the Six Months Ended March 31, 2020
				Additional									Total			Non-
	Common stock			Paid In			Treasury			Retained			Alico, Inc.			controlling			Total
	Shares	Amount		Capital			Stock			Earnings			Equity			Interest			Equity
Balance at September 30, 2019	8,416	$	8,416	$	19,781		$	(31,943	)	$	198,049		$	194,303		$	5,095		$	199,398
Net income	—	—		—			—			4,362			4,362			102			4,464
Dividends ($0.18/share)	—	—		—			—			(1,346		)	(1,346		)	—			(1,346		)
Treasury stock purchases	—	—		—			(238		)	—			(238		)	—			(238		)
Stock-based compensation:
Directors	—	—		(42		)	397			—			355			—			355
Executives	—	—		435			—			—			435			—			435
Balance at March 31, 2020	8,416	$	8,416	$	20,174		$	(31,784	)	$	201,065		$	197,871		$	5,197		$	203,068

3

ALICO, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED)
(in thousands)
For the Three Months Ended March 31, 2019
				Additional									Total			Non-
	Common stock			Paid In			Treasury			Retained			Alico, Inc.			controlling			Total
	Shares	Amount		Capital			Stock			Earnings			Equity			Interest			Equity
Balance at December 31, 2018	8,416	$	8,416	$	20,384		$	(32,817	)	$	159,094		$	155,077		$	5,442		$	160,519
Net income (loss)	—	—		—			—			7,547			7,547			(87		)	7,460
Dividends ($0.06/share)	—	—		—			—			(448		)	(448		)	—			(448		)
Stock-based compensation:																			—
Directors	—	—		(83		)	321			—			238			—			238
Executives	—	—		255			—			—			255			—			255
Executive forfeiture	—	—		(823		)	—			—			(823		)	—			(823		)
Balance at March 31, 2019	8,416	$	8,416	$	19,733		$	(32,496	)	$	166,193		$	161,846		$	5,355		$	167,201
For the Six Months Ended March 31, 2019
				Additional									Total			Non-
	Common stock			Paid In			Treasury			Retained			Alico, Inc.			controlling			Total
	Shares	Amount		Capital			Stock			Earnings			Equity			Interest			Equity
Balance at September 30, 2018	8,416	$	8,416	$	20,126		$	(7,536	)	$	151,111		$	172,117		$	5,478		$	177,595
Net income (loss)	—	—		—			—			5,080			5,080			(123		)	4,957
Dividends ($0.12/share)	—	—		—			—			(895		)	(895		)	—			(895		)
Treasury stock purchases	—	—		—			(25,576		)	—			(25,576		)	—			(25,576		)
ASC 610-20 adoption	—	—		—			—			10,897			10,897			—			10,897
Stock-based compensation:
Directors	—	—		(140		)	616			—			476			—			476
Executives	—	—		570			—			—			570			—			570
Executive forfeiture	—	—		(823		)	—			—			(823		)	—			(823		)
Balance at March 31, 2019	8,416	$	8,416	$	19,733		$	(32,496	)	$	166,193		$	161,846		$	5,355		$	167,201

See accompanying notes to the condensed consolidated financial statements.

4

ALICO, INC. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (in thousands)
	Six Months Ended March 31,
	2020			2019
Net cash provided by operating activities:
Net income	$	4,464		$	4,957
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, depletion and amortization	7,199			6,951
Deferred income tax (benefit) expense	(827		)	73
Gain on sale of real estate, property and equipment and assets held for sale	(2,863		)	(23		)
Change in fair value of derivatives	—			989
Impairment of long-lived assets	723			—
Impairment of right-of-use asset	87			—
Stock-based compensation expense	790			223
Other	(36		)	(51		)
Changes in operating assets and liabilities:
Accounts receivable	(3,672		)	(11,453		)
Inventories	11,640			4,922
Prepaid expenses	(234		)	92
Other assets	(387		)	—
Accounts payable and accrued liabilities	(2,061		)	370
Income tax payable	(2,876		)	(852		)
Other liabilities	(259		)	(130		)
Net cash provided by operating activities	11,688			6,068
Cash flows from investing activities:
Purchases of property and equipment	(9,960		)	(9,524		)
Net proceeds from sale of property and equipment and assets held for sale	2,994			202
Change in deposits on purchase of citrus trees	(57		)	(515		)
Deposit on purchase of citrus grove	(25		)	—
Advances on notes receivables, net	87			50
Net cash used in investing activities	(6,961		)	(9,787		)
Cash flows from financing activities:
Repayments on revolving lines of credit	(18,805		)	(41,360		)
Borrowings on revolving lines of credit	85,519			63,637
Principal payments on term loans	(9,820		)	(5,437		)
Treasury stock purchases	(238		)	(25,576		)
Payment on termination of sugarcane agreement	—			(11,300		)
Dividends paid	(1,120		)	(895		)
Deferred financing costs	(23		)	—
Net cash provided by (used in) financing activities	55,513			(20,931		)
Net increase (decrease) in cash and cash equivalents and restricted cash	60,240			(24,650		)
Cash and cash equivalents and restricted cash at beginning of the period	23,838			32,260
Cash and cash equivalents and restricted cash at end of the period	$	84,078		$	7,610

See accompanying notes to the condensed consolidated financial statements.

5

ALICO, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

Note 1. Description of Business and Basis of Presentation

Description of Business

Alico, Inc., together with its subsidiaries (collectively, “Alico”, the “Company", "we", "us" or "our”), is a Florida agribusiness and land management company owning approximately 110,000 acres of land throughout Florida, including approximately 90,000 acres of mineral rights. The Company manages its land based upon its primary usage, and reviews its performance based upon two primary classifications: (i) Alico Citrus and (ii) Water Resources and Other Operations. Financial results are presented based upon these two business segments. 

Basis of Presentation

The Company has prepared the accompanying financial statements on a condensed consolidated basis. These accompanying unaudited condensed consolidated interim financial statements, which are referred to herein as the “Financial Statements", have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to Article 10-01 of Regulation S-X of the U.S. Securities and Exchange Commission ("SEC") for interim financial information. These Financial Statements do not include all of the disclosures required for complete annual financial statements and, accordingly, certain information, footnotes and disclosures normally included in annual financial statements, prepared in accordance with U.S. GAAP, have been condensed or omitted in accordance with SEC rules and regulations. Accordingly, the Financial Statements should be read in conjunction with the Company's audited Consolidated Financial Statements and Notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended September 30, 2019, as filed with the SEC on December 5, 2019.

The Financial Statements presented in this Quarterly Report on Form 10-Q are unaudited. However, in the opinion of management, such Financial Statements include all adjustments, consisting solely of normal recurring adjustments, necessary to present fairly the financial position, results of operations and cash flows for the periods presented in conformity with U.S. GAAP applicable to interim periods.

Operating results for the interim periods presented are not necessarily indicative of the results that may be expected for the current fiscal year ending September 30, 2020. All intercompany transactions and account balances between the consolidated businesses have been eliminated.

Segments

Operating segments are defined in the criteria established under the Financial Accounting Standards Board - Accounting Standards Codification (“FASB ASC”) Topic 280 as components of public entities that engage in business activities from which they may earn revenues and incur expenses for which separate financial information is available and which is evaluated regularly by the Company’s chief operating decision maker (“CODM”) in deciding how to assess performance and allocate resources. The Company’s CODM assesses performance and allocates resources based on two operating segments: (i) Alico Citrus and (ii) Water Resources and Other Operations.

Principles of Consolidation

The Financial Statements include the accounts of Alico and the accounts of all the subsidiaries in which a controlling interest is held by the Company. Under U.S. GAAP, consolidation is generally required for investments of more than 50% of the outstanding voting stock of an investee, except when control is not held by the majority owner. The Company’s subsidiaries include: Alico Land Development, Inc., Alico-Agri, Ltd., Alico Plant World, LLC, Alico Fruit Company, LLC, Alico Citrus Nursery, LLC, Alico Chemical Sales, LLC, 734 Citrus Holdings, LLC and subsidiaries, Alico Skink Mitigation, LLC and Citree Holdings 1, LLC (“Citree”). The Company considers the criteria established under FASB ASC Topic 810, “Consolidations” in its consolidation process. All significant intercompany balances and transactions have been eliminated in consolidation.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities as of the date of the accompanying Financial Statements, the disclosure of contingent assets and liabilities in the Financial Statements and the accompanying Notes, and the reported amounts

6

of revenues and expenses and cash flows during the periods presented. Actual results could differ from those estimates. The Company evaluates estimates on an ongoing basis. The estimates are based on current and expected economic conditions, historical experience, the experience and judgment of the Company’s management and various other specific assumptions that the Company believes to be reasonable.

Restricted Cash

Restricted cash is comprised of cash received from the sale of certain assets in which the use of funds is restricted and certain cash receipts from the sale of property which was being held specifically for the purpose of deferring a tax impact on the gain on sale of the property.

For certain sales transactions, the Company sells property which serves as collateral for specific debt obligations. As a result, the sale proceeds are only permitted to be used to purchase like-kind citrus groves acceptable to the debt holder or to pay down existing debt obligations and thus are included in restricted cash. During the fiscal year ended September 30, 2019, the Company utilized restricted cash of $1,800,000 towards the purchase of citrus groves. Such purchases are included as part of the collateral under certain debt obligations. Additionally, in November 2019, the Company utilized restricted cash to pay down existing debt, including outstanding interest on such debt, $4,489,000. If the remaining restricted cash is not otherwise used as of September 30, 2020, it will need to be used to pay down principal on Company debt.

In March 2020, the Company sold certain sections of the East     Ranch, from which the Company received net cash proceeds (through its qualified intermediary) of approximately $2,952,000. The Company used substantially all of the net cash proceeds to purchase a like-kind asset in May 2020 (See Note 14.” Subsequent Events”), which will allow the Company to defer substantially all of the tax impact of the gain on sale of the ranch land.

Revenue Recognition

Revenues are derived from the sale of processed fruit, fresh fruit, other citrus revenue, leasing revenue and other water and resource revenues. The majority of the revenue is generated from the sale of citrus fruit to processing facilities and fresh fruit sales. The Company recognizes revenue at the amount it expects to be entitled to be paid, determined when control of the products or services is transferred to its customers, which occurs upon delivery of and acceptance of the fruit by the customer and when the Company has a right to payment.

The Company has identified one performance obligation as the delivery of fruit to the processing facility of the customer (or harvesting of the citrus in the case of fresh fruit) for each separate variety of fruit identified in the contract. The Company initially recognizes revenue in an amount which is estimated based on contractual and market prices, including if such market price falls within the range (known as “floor” and “ceiling” prices) identified in the specific contracts. Additionally, the Company also has a contractual agreement whereby revenue is determined based on applying a cost-plus structure methodology. As such, since these contracts contain elements of variable consideration, the Company recognizes this variable consideration by using the expected value method. On a quarterly basis, management reviews the reasonableness of the revenues accrued based on buyers’ and processors’ advances to growers, cash and futures markets and experience in the industry. Adjustments are made throughout the year to these estimates as more current relevant industry information becomes available. Differences between the estimates and the final realization of revenues at the close of the harvesting season can result in either an increase or decrease to reported revenues. During the periods presented, no material adjustments were made to the reported citrus revenues.

Receivables under contracts, whereby pricing is based on contractual and market prices, are primarily paid at the floor amount and are collected within seven days after the harvest week. Any adjustments to pricing as a result of changes in market prices are collected or paid thirty to sixty days after final market pricing is published. Receivables under contracts, whereby pricing is based off a cost-plus structure methodology, are paid at the final prior year rate. Any adjustments to pricing as a result of the cost-plus calculation are collected or paid upon finalization of the calculation and agreement by both parties. As of March 31, 2020, and September 30, 2019, the Company had total receivables relating to sales of citrus of approximately $4,183,000 and $160,000, respectively, recorded in Accounts Receivable, net, in the Condensed Consolidated Balance Sheets.

7

Disaggregated Revenue

Revenues disaggregated by significant products and services for the three and six months ended March 31, 2020 and 2019 are as follows:

(in thousands)
	Three Months Ended March 31,				Six Months Ended March 31,
	2020		2019		2020		2019
Alico Citrus
Early and Mid-Season	$	22,237	$	27,929	$	31,303	$	39,574
Valencias	25,810		18,746		25,810		18,746
Fresh Fruit	802		671		1,537		2,577
Other	952		477		1,326		823
Total	$	49,801	$	47,823	$	59,976	$	61,720
Water Resources and Other Operations
Land and other leasing	$	679	$	658	$	1,342	$	1,392
Other	35		40		202		188
Total	$	714	$	698	$	1,544	$	1,580
Total Revenues	$	50,515	$	48,521	$	61,520	$	63,300

Noncontrolling Interest in Consolidated Subsidiary

The Financial Statements include all assets and liabilities of the less-than-100%-owned subsidiary the Company controls, Citree. Accordingly, the Company has recorded a noncontrolling interest in the equity of such entity. Citree had a net loss of approximately $11,000 and $177,000 for the three months ended March 31, 2020 and 2019, respectively, and had a net income of approximately $208,000 and a net loss of $251,000 for the six months ended March 31, 2020 and 2019, respectively, of which 51% is attributable to the Company. The shift to net income for the six months ended March 31, 2020 was the result of reimbursements received under the federal relief program relating to Hurricane Irma aggregating approximately $493,000.

Recent Accounting Pronouncements

In January 2017, the FASB issued Accounting Standards Update (“ASU”) 2017-04, “Intangibles-Goodwill and Other” (Topic 350), which simplifies the accounting for goodwill impairment. The updated guidance eliminates Step 2 of the impairment test, which requires entities to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, entities will record an impairment charge based on the excess of a reporting unit’s carrying amount over its fair value, determined in Step 1. This guidance will become effective for us in the fiscal years beginning after December 15, 2019, including interim periods within those reporting periods. We will adopt this guidance using a prospective approach. The Company does not expect the adoption of ASU 2017-04 will have a material impact on its consolidated financial statements and will adopt the standard effective October 1, 2020.

In August 2018, the FASB issued ASU 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurements” (“ASU 2018-13”), which aims to improve the overall usefulness of disclosures to financial statement users and reduce unnecessary costs to companies when preparing fair value measurement disclosures. ASU 2018-13 is effective for annual and interim periods in the fiscal years beginning after December 15, 2019. Retrospective adoption is required, except for certain disclosures, which will be required to be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. The Company does not expect the adoption of ASU 2018-13 will have a material impact on its consolidated financial statements and will adopt the standard effective October 1, 2020.

In November 2018, the FASB issued ASU 2018-19, “Codification Improvements to Topic 326, Financial Instruments-Credit Losses.” ASU 2018-19 clarifies that receivables arising from operating leases are not within the scope of Subtopic 326-20. Instead,

8

impairment of receivables arising from operating leases should be accounted for in accordance with Leases (Topic 842). The standard is effective for us on October 1, 2020, with early adoption permitted. The Company does not expect the adoption of ASU 2018-19 to have a material impact on its consolidated financial statements of the Company.

The Company has reviewed other recently issued accounting standards which have not yet been adopted in order to determine their potential effect, if any, on the results of operations or financial condition. Based on the review of these other recently issued standards, the Company does not currently believe that any of those accounting pronouncements will have a significant effect on its current or future financial position, results of operations, cash flows or disclosures.

Recently Adopted Accounting Pronouncements

In February 2016, the FASB issued ASU 2016-02, “Leases (Topic 842).” This guidance requires entities that sign leases as a lessee to recognize right-of-use assets and lease liabilities for those leases classified as operating leases under previous U.S. GAAP. The accounting applied by a lessor is largely unchanged from that applied under previous U.S. GAAP. The Company adopted ASU 2016-02 on October 1, 2019.

The Company determines whether an arrangement is a lease at inception. The Company’s leases consist of operating lease arrangements for certain office space and IT facilities. When these lease arrangements include lease and non-lease components, the Company accounts for lease components and non-lease components (e.g. common area maintenance) separately based on their relative standalone prices.

Any lease arrangements with an initial term of 12 months or less are not recorded on the Company’s Condensed Consolidated Balance Sheet, and it recognizes lease cost for these lease arrangements on a straight-line basis over the lease term. Many lease arrangements provide the options to exercise one or more renewal terms or to terminate the lease arrangement. The Company includes these options when it will be reasonably certain to exercise them in the lease term used to establish the right of use assets and lease liabilities. Generally, lease agreements do not include an option to purchase the leased asset, residual value guarantees or material restrictive covenants.

As most of our lease arrangements do not provide an implicit interest rate, the Company applies an incremental borrowing rate based on the information available at the commencement date of the lease arrangement to determine the present value of lease payments.

No lease costs associated with finance leases and sale-leaseback transactions occurred and our lease income associated with lessor and sublease arrangements are not material to our Condensed Consolidated Financial Statements.

Our operating leases are reported in our Condensed Consolidated Balance Sheet as follows:

(in thousands)
Operating lease components	Classification	March 31, 2020
Right-of-use assets	Other non-current assets	$	329
Current lease liabilities	Other current liabilities	$	167
Non-current lease liabilities	Other liabilities	$	252

Our operating leases cost components are reported in our Condensed Consolidated Statement of Operations as follows:

(in thousands)
		Three Months Ended		Six Months Ended
Operating lease components	Classification	March 31, 2020		March 31, 2020
Operating lease costs	General and administrative expenses	$	52	$	104
Operating lease right-of-use asset impairment	Other expense	$	—	$	87

9

Future maturities of our operating lease obligations as of March 31, 2020 by fiscal year are as follows:

(in thousands)
2020	$	82
2021	169
2022	175
2023	15
Total noncancelable future lease obligations	$	441
Less: Interest	(22		)
Present value of lease obligations	$	419

The weighted-average remaining lease term and weighted-average discount rate for our operating leases are as follows:

	March 31, 2020
Weighted-average remaining lease term	2.58	years
Weighted-average discount rate	3.89	%

Cash flow information related to leases consists of the following:
(in thousands)	Six Months Ended
	March 31, 2020
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	101
Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$	511

The COVID-19 Pandemic

On March 11, 2020, the World Health Organization declared the current novel coronavirus outbreak (“COVID-19”) to be a global pandemic. In response to this declaration and the rapid spread of COVID-19 within the United States, federal, state and local governments throughout the country have imposed varying degrees of restrictions on social and commercial activity to promote social distancing in an effort to slow the spread of the illness. These measures have begun to have a significant adverse impact upon many sectors of the economy, including certain agriculture businesses. To date, the Company has experienced no adverse impact from this pandemic.

Seasonality

The Company is primarily engaged in the production of fruit for sale to citrus markets, which is of a seasonal nature, and subject to the influence of natural phenomena and wide price fluctuations. Historically, the second and third quarters of Alico's fiscal year produce the majority of the Company's annual revenue. Working capital requirements are typically greater in the first and fourth quarters of the fiscal year, coinciding with harvesting cycles. Because of the seasonality of the business, results for any quarter are not necessarily indicative of the results that may be achieved for the full fiscal year.

10

Note 2. Inventories

Inventories consist of the following at March 31, 2020 and September 30, 2019:

(in thousands)	March 31,		September 30,
	2020		2019
Unharvested fruit crop on the trees	$	27,054	$	39,276
Other	1,449		867
Total inventories	$	28,503	$	40,143

The Company records its inventory at the lower of cost or net realizable value. For the three and six months ended March 31, 2020, the Company did not record any adjustments to reduce inventory to net realizable value.

During the fiscal year ended September 30, 2018, the Company received insurance proceeds relating to Hurricane Irma of approximately $477,000 for property and casualty damage claims and approximately $8,952,000 for crop claims. During the fiscal year ended September 30, 2019, the Company received additional insurance proceeds relating to Hurricane Irma of approximately $486,000 in property and casualty claims reimbursement. There are no further property and casualty or crop insurance claims pending relating to Hurricane Irma. These insurance proceeds are included as a reduction to operating expenses in the Condensed Consolidated Statements of Operations.

The Company is eligible for Hurricane Irma federal relief programs for block grants that are being administered through the State of Florida. During the fiscal year ended September 30, 2019, the Company received approximately $15,597,000 under the Florida Citrus Recovery Block Grant (“CRBG”) program. This represented Part 1 and a portion of Part 2 reimbursement under the three-part program. During the six months ended March 31, 2020, the Company received additional proceeds of approximately $4,629,000 under the Florida CRBG program. This represented the remaining portion of Part 2 reimbursement under the three-part program. The timing and amount to be received under Part 3 of the program, if any, has not been finalized. These federal relief proceeds are included as a reduction to operating expenses in the Condensed Consolidated Statements of Operations.

Note 3. Assets Held for Sale

In accordance with its strategy to dispose of non-core and under-performing assets, the following assets have been classified as assets held for sale at March 31, 2020 and September 30, 2019:

(in thousands)	Carrying Value
	March 31,		September 30,
	2020		2019
East Ranch	$	1,366	$	1,442
Total Assets Held for Sale	$	1,366	$	1,442

On March 27, 2020, the Company sold certain sections at the East Ranch for approximately $2,952,000 and realized a gain of approximately $2,838,000.

During the fiscal year ended September 30, 2019, the Company sold certain trailers for approximately $47,000, and reclassified the remaining Assets Held for Sale to property and equipment, as management has determined not to offer for sale the remaining trailers.

On October 30, 2018, the Company sold certain parcels at Frostproof for approximately $206,000 and realized a gain of approximately $12,000.

11

Note 4. Property and Equipment, Net

Property and equipment, net consists of the following at March 31, 2020 and September 30, 2019:

(in thousands)	March 31,			September 30,
	2020			2019
Citrus trees	$	287,238		$	281,149
Equipment and other facilities	56,216			54,622
Buildings and improvements	8,189			8,224
Total depreciable properties	351,643			343,995
Less: accumulated depreciation and depletion	(109,662		)	(104,169		)
Net depreciable properties	241,981			239,826
Land and land improvements	105,835			105,822
Property and equipment, net	$	347,816		$	345,648

During the six months ended March 31, 2020 and fiscal year ended September 30, 2019, the Company recorded impairments of approximately $723,000 and $244,000, respectively, relating to the loss of citrus trees.

During the fiscal year ended September 30, 2019, the Company purchased 203 acres of citrus blocks for approximately $1,950,000. These purchases were made from grove owners from within the Company’s existing grove locations. In April 2019, the lender, PGIM Real Estate Finance, LLC (“Prudential”), agreed to accept those purchases completed through April 2019 as substitute collateral and release $1,800,000 from restricted cash, which was completed in the fourth quarter of fiscal year 2019. In the fiscal year ended September 30, 2019, subsequent to April 2019, there were two additional purchases of Citrus blocks for approximately $100,000 that are not included as part of the substitution collateral. In the six months ended March 31, 2020, two additional purchases of Citrus blocks for approximately $70,000 were completed.

On September 27, 2019, the Company sold approximately 5,500 acres from its West Ranch for approximately $14,775,000 and realized a gain on sale of approximately $13,033,000. Upon the sale of these acres, the lease rate pertaining to the grazing and other rights was adjusted from $98,750 to $80,000 per month, as these acres were previously being leased to a third party.

Note 5. Long-Term Debt and Lines of Credit

The following table summarizes long-term debt and related deferred financing costs, net of accumulated amortization at March 31, 2020 and September 30, 2019:

	March 31, 2020				September 30, 2019
(in thousands)	Principal		Deferred Financing Costs, Net		Principal		Deferred Financing Costs, Net
Long-term debt, net of current portion:
Met Fixed-Rate Term Loans	$	86,563	$	672	$	89,688	$	724
Met Variable-Rate Term Loans	42,406		309		43,844		334
Met Citree Term Loan	4,638		38		4,750		40
Pru Loans A & B	15,677		221		16,257		224
Pru Loan E	4,345		—		4,455		9
Pru Loan F	—		—		4,455		38
	153,629		1,240		163,449		1,369
Less current portion	5,130		—		5,338		—
Long-term debt	$	148,499	$	1,240	$	158,111	$	1,369

12

The following table summarizes lines of credit and related deferred financing costs, net of accumulated amortization at March 31, 2020 and September 30, 2019:

	March 31, 2020				September 30, 2019
(in thousands)	Principal		Deferred Financing Costs, Net		Principal		Deferred Financing Costs, Net
Lines of Credit:
RLOC	$	20,000	$	149	$	—	$	8
WCLC	46,714		—		—		—
Lines of Credit	$	66,714	$	149	$	—	$	8

Future maturities of long-term debt and lines of credit as of March 31, 2020 are as follows:

(in thousands)
Due within one year	$	5,130
Due between one and two years	61,374
Due between two and three years	10,535
Due between three and four years	10,535
Due between four and five years	10,535
Due beyond five years	122,234
Total future maturities	$	220,343

Interest costs expensed and capitalized were as follows:

(in thousands)
	Three Months Ended March 31,				Six Months Ended March 31,
	2020		2019		2020		2019
Interest expense	$	1,452	$	1,963	$	2,996	$	3,880
Interest capitalized	303		229		572		445
Total	$	1,755	$	2,192	$	3,568	$	4,325

Debt

The Company's credit facilities consist of $125,000,000 in fixed interest rate term loans (“Met Fixed-Rate Term Loans”), $57,500,000 in variable interest rate term loans (“Met Variable-Rate Term Loans”), a $25,000,000 revolving line of credit (“RLOC”) with Metropolitan Life Insurance Company and New England Life Insurance Company (collectively “Met”), and a $70,000,000 working capital line of credit (“WCLC”) with Rabo Agrifinance, Inc. (“Rabo”).

The term loans and RLOC are secured by real property. The security for the term loans and RLOC consists of approximately 38,200 gross acres of citrus groves and 5,800 gross acres of ranch land. The WCLC is collateralized by the Company’s current assets and certain other personal property owned by the Company.

The term loans, collectively, are subject to quarterly principal payments of $2,281,250, and mature November 1, 2029. The Met Fixed-Rate Term Loans bear interest at 4.15% per annum, and the Met Variable-Rate Term Loans bear interest at a rate equal to 90 day LIBOR plus 165 basis points (the “LIBOR spread”). The LIBOR spread is subject to adjustment by Met beginning May 1, 2017 and is subject to further adjustment every two years thereafter until maturity. No adjustment was made at May 1, 2019. Interest on the term loans is payable quarterly. The interest rates on the Met Variable-Rate Term Loans were 3.43% per annum and 3.91% per annum as of March 31, 2020 and September 30, 2019, respectively. 

13

The Company may prepay up to $8,750,000 of the Met Fixed-Rate Term Loan principal annually without penalty, and any such prepayments may be applied to reduce subsequent mandatory principal payments. The maximum annual prepayment was made for calendar year 2015. During the first and second quarter of fiscal year 2018, the Company elected not to make its principal payment and utilized a portion of its 2015 prepayment to satisfy its principal payment requirements for such quarters. At March 31, 2020, the Company had $5,625,000 remaining available to reduce future mandatory principal payments should the Company elect to do so. The Met Variable-Rate Term Loans may be prepaid without penalty.

In March 2020, as a precautionary measure, the Company drew down an aggregate of $70,000,000 on its revolving credit facilities; $20,000,000 on its RLOC and $50,000,000 on its WCLC. This decision was made to safeguard the Company’s liquidity and to increase available cash on hand in the event of a more protracted COVID-19 outbreak.

The RLOC bears interest at a floating rate equal to 90 day LIBOR plus 165 basis points, payable quarterly. The LIBOR spread was adjusted by Met on May 1, 2017 and is subject to further adjustment every two years thereafter. No adjustment was made at May 1, 2019. In October 2019, the RLOC agreement was modified to extend the current maturity of November 1, 2019 to November 1, 2029. The RLOC is subject to an annual commitment fee of 25 basis points on the unused portion of the line of credit. The RLOC is available for funding general corporate needs. The variable interest rate was 3.43% and 3.91% per annum as of March 31, 2020 and September 30, 2019, respectively. There was $20,000,000 and $0 outstanding on the RLOC at March 31, 2020 and September 30, 2019, respectively. Availability under the RLOC was $5,000,000 and $25,000,000 as of March 31, 2020 and September 30, 2019, respectively.

The WCLC is a revolving credit facility and is available for funding working capital and general corporate requirements. The interest rate on the WCLC is based on the one month LIBOR, plus a spread, which is adjusted quarterly, based on the Company's debt service coverage ratio for the preceding quarter and can vary from 175 to 250 basis points. The rate is currently at LIBOR plus 175 basis points. The variable interest rate was 3.33% and 3.85% per annum as of March 31, 2020 and September 30, 2019, respectively. The WCLC agreement was amended on September 20, 2018, and the primary terms of the amendment were an extension of the maturity to November 1, 2021. There were no changes to the commitment amount or interest rate. The WCLC agreement provides for Rabo to issue up to $2,000,000, reduced from $20,000,000 during fiscal year 2019, in letters of credit on the Company’s behalf. As of March 31, 2020, there was approximately $399,000 in outstanding letters of credit, which correspondingly reduced the Company's availability under the line of credit.

The WCLC is subject to a quarterly commitment fee on the daily unused availability under the line computed as the commitment amount less the aggregate of the outstanding loans and outstanding letters of credit. The commitment fee is adjusted quarterly based on Alico's debt service coverage ratio for the preceding quarter and can vary from a minimum of 20 basis points to a maximum of 30 basis points. Commitment fees to date have been charged at 20 basis points.

There was $46,714,000 and $0 outstanding on the WCLC at March 31, 2020 and September 30, 2019, respectively. Availability under the WCLC was approximately $22,887,000 and $69,540,000 as of March 31, 2020 and September 30, 2019, respectively.

In 2014, the Company capitalized approximately $2,834,000 of debt financing costs related to the refinancing and approximately $339,000 of costs related to the retired debt. Additionally, financing costs of approximately $23,000 and $133,000 were incurred in the six months ended March 31, 2020 and for the fiscal year ended September 30, 2019, respectively, in connection with the extension of the RLOC. All costs are included in deferred financing and being amortized to interest expense over the applicable terms of the obligations. The unamortized balance of deferred financing costs related to the financing above was approximately $1,130,000 and approximately $1,066,000 at March 31, 2020 and September 30, 2019, respectively.

These credit facilities noted above are subject to various covenants including the following financial covenants: (i) minimum debt service coverage ratio of 1.10 to 1.00, (ii) tangible net worth of at least $160,000,000 increased annually by 10% of consolidated net income for the preceding years, or approximately $167,364,000 for the year ended September 30, 2019, (iii) minimum current ratio of 1.50 to 1.00, (iv) debt to total assets ratio not greater than .625 to 1.00, and, (v) solely in the case of the WCLC, a limit on capital expenditures of $30,000,000 per fiscal year. As of March 31, 2020, the Company was in compliance with all of the financial covenants.

Credit facilities also include a Met Life term loan collateralized by 1,200 gross acres of citrus grove owned by Citree ("Met Citree Loan"). This is a $5,000,000 credit facility that bears interest at a fixed rate of 5.28% per annum. Principal and interest payments are made on a quarterly basis. At March 31, 2020 and September 30, 2019 there was an outstanding balance of $4,638,000 and $4,750,000, respectively. The loan matures in February 2029. The unamortized balance of deferred financing costs related to this loan was approximately $38,000 and $40,000 at March 31, 2020 and September 30, 2019, respectively.

14

Transition from LIBOR

The Company is currently evaluating the impact of the transition from LIBOR as an interest rate benchmark to other potential alternative reference rates. Currently, the Company has debt instruments in place that reference LIBOR-based rates. The transition from LIBOR is estimated to take place in 2021 and management will continue to actively assess the related opportunities and risks involved in this transition.

Silver Nip Citrus Debt

There are two fixed-rate term loans, with an original combined balance of $27,550,000, bearing interest at 5.35% per annum (“Pru Loans A & B”). Principal of $290,000 is payable quarterly, together with accrued interest. On February 15, 2015, 734 Citrus Holdings, LLC d/b/a Silver Nip Citrus (“Silver Nip Citrus”) made a prepayment of $750,000. In addition, the Company made prepayments of approximately $4,453,000 in the second fiscal quarter of 2018 with proceeds from the sale of certain properties, which were collateralized under these loans. The Company may prepay up to $5,000,000 of principal without penalty. As such, the Company exceeded the allowed $5,000,000 prepayment by approximately $203,000 and was required to make a premium payment of approximately $22,000. The loans are collateralized by approximately 5,700 acres of citrus groves in Collier, Hardee, Highlands and Polk Counties, Florida and mature on June 1, 2029 and June 1, 2033, respectively.

Silver Nip Citrus entered into two additional fixed-rate term loans with Prudential to finance the acquisition of a 1,500 acre citrus grove on September 4, 2014. Each loan was in the original amount of $5,500,000. Principal of $55,000 per loan is payable quarterly, together with accrued interest. One loan bears interest at 3.85% per annum (“Pru Loan E”), while the other bears interest at 3.45% per annum (“Pru Loan F”). The interest rate on Pru Loan E is subject to adjustment on September 1, 2019 and every year thereafter until maturity. No adjustment was made at September 1, 2019. Both loans are collateralized by approximately 1,500 gross acres of citrus groves in Charlotte County, Florida.

In November 2019, the Company prepaid Pru Note F in full in the amount of $4,455,000. As a result of this prepayment, the Company’s required annual principal payments were reduced by $220,000 per annum. Pru Note E matures September 1, 2021.

The Silver Nip Citrus credit agreements are subject to a financial covenant whereby the consolidated current ratio requirement is 1.00 to 1.00. Silver Nip Citrus was in compliance with the current ratio covenant as of March 31, 2020.

The unamortized balance of deferred financing costs related to the Silver Nip Citrus debt was approximately $221,000 and $271,000 at March 31, 2020 and September 30, 2019, respectively.

Note 6. Accrued Liabilities

Accrued liabilities consist of the following at March 31, 2020 and September 30, 2019:

(in thousands)	March 31,		September 30,
	2020		2019
Ad valorem taxes	$	692	$	2,117
Accrued interest	1,063		1,110
Accrued employee wages and benefits	1,372		2,525
Accrued dividends	673		448
Accrued contractual obligation associated with sale of real estate	—		402
Accrued harvest and haul	431		—
Consulting and separation charges	346		400
Accrued insurance	—		544
Other accrued liabilities	366		223
Total accrued liabilities	$	4,943	$	7,769

15

Note 7. Derivative Asset and Derivative Liabilities/Deferred Gain on Sale

On November 21, 2014, the Company completed the sale of approximately 36,000 acres of land used for sugarcane production and land leasing in Hendry County, Florida to Global Ag Properties, LLC (“Global”) for approximately $97,900,000 in cash.

The sales price was subject to post-closing adjustments over a ten year period. The Company realized a gain of approximately $42,753,000 on the sale. Initially, $29,140,000 of the gain was deferred due to the Company’s continuing involvement in the property pursuant to a post-closing agreement and the potential price adjustments. The deferral represented the Company’s estimate of the maximum exposure to loss as a result of the continuing involvement. A net gain of approximately $13,613,000 was recognized at the time of the sale.

On October 1, 2018, the Company adopted ASC 610-20 and reevaluated the original post closing agreement under the guidance of ASC 610-20. As such, the Company recorded a derivative asset and derivative liabilities, which resulted in an increase to retained earnings of $10,897,000, net of taxes. This adjustment consisted of recording a derivative asset in the amount of $3,553,000 relating to potential payments due Alico from Global Ag Properties USA, LLC (“Global Ag”) and a derivative liability of $13,864,000 relating to potential payments due Global Ag from Alico. In the first quarter ended December 31, 2018, the Company recorded a loss of $956,000, which reflects the change in fair value of the derivative asset and derivative liabilities. In the three months ended March 31, 2019, the Company recorded an additional loss of $33,000.

On December 7, 2018, the Company and Global Ag entered into a Termination of Post Closing Agreement (the “2018 Post Closing Agreement”), pursuant to which the parties thereto agreed to certain terms and conditions under which a Post Closing Agreement, dated as of November 21, 2014 (the “2014 Post Closing Agreement”), may be terminated prior to the expiration of its stated term and with the payment of certain termination payments. The 2014 Post Closing Agreement was entered into in connection with the November 21, 2014 closing (the “Land Disposition”) of the sale by Alico to Global Ag of certain land used for sugarcane production and land leasing in Hendry County, Florida (the “Land”).

The 2014 Post Closing Agreement contained obligations, including possible payments by Alico and by Global Ag to each other over a ten year period following the closing of the Land Disposition, with the payments each year being based on the difference, if any, between certain computed amounts. Since the time of the closing of the Land Disposition and up through March 11, 2019, the computations have resulted in payments being made each year by Alico to Global Ag., which have aggregated approximately $6,518,000.

The 2018 Post Closing Agreement provided for (i) the termination of the 2014 Post Closing Agreement following the satisfaction of certain terms and conditions set forth in the termination agreement and (ii) the deposit by wire transfer into escrow of an aggregate of $11,300,000 following notification by Global Ag to Alico of the closing date of a sale of the Land by Global Ag to a third party. The conditions to the termination of the 2014 Post Closing Agreement and the payment of funds to Global Ag included (a) Global Ag’s assignment to the third party buyer, and such third party buyer’s assumption, of certain specified water management obligations, irrigation and drainage easement obligations, access easements obligations and obligations under a certain option to purchase certain railroad property owned by Alico, (b) delivery to the escrow agent of all instruments and consideration required to consummate the closing by Global Ag of the sale of the Land to the third party buyer, and (c) delivery to the escrow agent of copies of a water management project cooperation agreement running in favor of Alico and signed by Global Ag and the third party buyer.

On March 11, 2019, the 2018 Post Closing Agreement was completed. As such, all the conditions of the termination of the 2014 Post Closing Agreement, mentioned above, were met with the sale of the sugarcane land to a third party. As a result, the Company does not have any future liabilities or commitments to Global Ag in connection with the 2014 Post Closing Agreement.

16

Note 8. Income Taxes

In October 2019, the Internal Revenue Service concluded its audit of the September 30, 2015 tax year with no changes. The Federal and state filings remain subject to examination by tax authorities for tax periods ending after September 30, 2015.

The impact of adopting ASC 610-20 was modified in the quarter ended March 31, 2019 to reflect the deferred tax impact of this adoption. The deferred tax asset related to the deferred gain on sale has been decreased by $3,704,000 with a corresponding decrease to retained earnings in the quarter ended March 31, 2019, offsetting the October 1, 2018 increase to retained earnings for the ASC 610-20 implementation (see Note 7. “Derivative Asset and Derivative Liabilities/Deferred Gain on Sale”).

On March 27, 2020, President Trump signed into law the Coronavirus Aid, Relief, and Economic Security Act (H.R. 748) (the “CARES Act”). Among the changes to the U.S. federal income tax rules, the CARES Act restored net operating loss carryback rules that were eliminated by the 2017 Tax Cuts and Jobs Act, modified the limit on the deduction for net interest expense, and accelerated the timeframe for refunds of AMT credit carryovers. The Company does not expect the CARES Act will have any material impact on the Company’s cash tax liability or financial condition.

Note 9. Earnings Per Common Share

Basic earnings per share for Alico's common stock is calculated by dividing net income attributable to Alico, Inc. common stockholders by the weighted average number of shares of common stock outstanding for the period. Diluted earnings per common share is similarly calculated, except that the calculation includes the dilutive effect of the assumed issuance of common shares issuable under equity-based compensation plans in accordance with the treasury stock method, except where the inclusion of such common shares would have an anti-dilutive impact.

For the three and six months ended March 31, 2020 and 2019, basic and diluted earnings per common share were as follows:

(in thousands except per share amounts)
	Three Months Ended March 31,				Six Months Ended March 31,
	2020		2019		2020		2019
Net income attributable to Alico, Inc. common stockholders	$	3,571	$	7,547	$	4,362	$	5,080
Weighted average number of common shares outstanding - basic	7,480		7,463		7,478		7,471
Dilutive effect of equity-based awards	16		6		16		35
Weighted average number of common shares outstanding - diluted	7,496		7,469		7,494		7,506
Net income per common shares attributable to Alico, Inc. common stockholders:
Basic	$	0.48	$	1.01	$	0.58	$	0.68
Diluted	$	0.48	$	1.01	$	0.58	$	0.68

For the three and six months ended March 31, 2020 there were anti-dilutive equity awards excluded from the calculation of diluted earnings per common share.

For the three and six months ended March 31, 2019, equity awards are comprised of 227,500 stock options granted to Executive Officers, after taking into effect the forfeitures of 832,500 stock options (see Note 11. "Stockholders Equity").

17

Note 10. Segment Information

Segments

Operating segments are defined in the criteria established under the FASB ASC Topic 280 as components of public entities that engage in business activities from which they may earn revenues and incur expenses for which separate financial information is available and which is evaluated regularly by the Company’s chief operating decision maker (“CODM”) in deciding how to assess performance and allocate resources. The Company’s CODM assesses performance and allocates resources based on two operating segments: Alico Citrus and Water Resources and Other Operations.

Total revenues represent sales to unaffiliated customers, as reported in the Condensed Consolidated Statements of Operations. Goods and services produced by these segments are sold to wholesalers and processors in the United States who prepare the products for consumption. The Company evaluates the segments’ performance based on direct margins (gross profit) from operations before general and administrative expenses, interest expense, other income (expense) and income taxes, not including nonrecurring gains and losses.

Information by operating segment is as follows:

(in thousands)	Three Months Ended March 31,				Six Months Ended March 31,
	2020		2019		2020		2019
Revenues:
Alico Citrus	$	49,801	$	47,823	$	59,976	$	61,720
Water Resources and Other Operations	714		698		1,544		1,580
Total revenues	50,515		48,521		61,520		63,300
Operating expenses:
Alico Citrus	43,518		31,582		48,358		42,456
Water Resources and Other Operations	380		625		931		1,348
Total operating expenses	43,898		32,207		49,289		43,804
Gross profit:
Alico Citrus	6,283		16,241		11,618		19,264
Water Resources and Other Operations	334		73		613		232
Total gross profit	6,617		16,314		12,231		19,496
Depreciation, depletion and amortization:
Alico Citrus	3,416		3,334		6,853		6,621
Water Resources and Other Operations	46		37		92		87
Other Depreciation, Depletion and Amortization	128		122		254		243
Total depreciation, depletion and amortization	$	3,590	$	3,493	$	7,199	$	6,951

(in thousands)	March 31,		September 30,
	2020		2019
Assets:
Alico Citrus	$	452,581	$	401,212
Water Resources and Other Operations	18,325		15,332
Other Corporate Assets	1,378		844
Total Assets	$	472,284	$	417,388

18

Note 11. Stockholders' Equity

Effective January 27, 2015, the Company’s Board of Directors adopted the 2015 Stock Incentive Plan (the “2015 Plan”) which provides for up to 1,250,000 common shares available for issuance to provide a long-term incentive plan for officers, employees, directors and/or consultants to directly link incentives to stockholder value. The 2015 Plan was approved by the Company’s stockholders in February 2015. The Company’s 2015 Plan provides for grants to executives in various forms including restricted shares of the Company’s common stock and stock options. Awards are discretionary and are determined by the Compensation Committee of the Board of Directors. Awards vest based upon service conditions. Non-vested restricted shares generally vest over requisite service periods of one to six years from the date of grant.

The Company recognizes stock-based compensation expense for (i) Board of Directors fees (paid in treasury stock), and (ii) other awards under the 2015 Plan (paid in restricted stock and stock options). Stock-based compensation expense is recognized in general and administrative expenses in the Condensed Consolidated Statements of Operations.

Stock Compensation - Board of Directors

The Board of Directors can either elect to receive stock compensation or cash for their fees for services provided. Stock-based compensation expense relating to the Board of Director fees was approximately $162,000 and $355,000 for the three and six months ended March 31, 2020, and approximately $238,000 and $476,000 for the three and six months ended March 31, 2019, respectively.

Restricted Stock

Stock compensation expense related to the Restricted Stock totaled approximately $26,000 and $52,000 for the three and six months ended March 31, 2020, and approximately $26,000 and $52,000 for the three and six months ended March 31, 2019, respectively. There was approximately $17,000 and $69,000 of total unrecognized stock compensation costs related to unvested stock compensation for the Restricted Stock grants at March 31, 2020 and September 30, 2019, respectively. The total unrecognized compensation cost is expected to be recognized over a weighted-average period of 0.20 years.

Stock Option Grant

Stock option grants of 118,000 options to certain Officers and Managers of the Company (collectively the “2020 Option Grants,”) were granted on October 11, 2019. The option exercise price was set at $33.96, the closing price on October 11, 2019. The 2020 Option Grants will vest as follows: (i) 25% of the options will vest if the price of the Company’s common stock during a consecutive 20-trading day period exceeds $35.00; (ii) 25% of the options will vest if the price of the Company’s common stock during a consecutive 20-trading day period exceeds $40.00; (iii) 25% of the options will vest if the price of the Company’s common stock during a consecutive 20-trading day period exceeds $45.00; and (iv) 25% of the options will vest if the price of the Company’s common stock during a consecutive 20-trading day period exceeds $50.00. If the applicable stock price hurdles have not been achieved by (A) the date that is 18 months following the termination of employment, if the employment is terminated due to death or disability, (B) the date that is 12 months following the termination of employment, if the employment is terminated by the Company without cause, by the employee with good reason, or due to the employee’s retirement, or (C) the date of the termination of employment for any other reason, then any unvested options will be forfeited. In addition, if the applicable stock price hurdles have not been achieved by December 31, 2022 then any unvested options will be forfeited. The 2020 Option Grants will also become vested to the extent that the applicable stock price hurdles are satisfied in connection with a change in control of the Company. As of March 31, 2020, the Company’s stock closed at $31.04 per share. During the six months ended March 31, 2020 the stock did trade above $35.00 per share for twenty consecutive days; accordingly, 25% of the 2020 Option Grants are vested at March 31, 2020 and the corresponding stock option expense was recognized during the three months ended March 31, 2020.

Stock option grants of 10,000 options to Mr. John Kiernan (the “2019 Option Grants”) were granted on October 25, 2018. The option exercise price for these options was set at $33.34, the closing price on October 25, 2018. The 2019 Option Grants will vest as follows: (i) 3,333 of the options will vest if the price of the Company’s common stock during a consecutive 20-trading day period exceeds $40.00; (ii) 3,333 of the options will vest if the price of the Company’s common stock during a consecutive 20-trading day period exceeds $45.00; (iii) 3,334 of the options will vest if the price of the Company’s common stock during a consecutive 20-trading day period exceeds $50.00. If the applicable stock price hurdles have not been achieved by (A) the date that is 18 months following the Executive’s termination of employment, if the Executive’s employment is terminated due to death or disability, (B) the date that is 12 months following the Executive’s termination of employment, if the Executive’s employment is terminated by the Company without cause, by the Executive with good reason, or due to the Executive’s retirement, or (C) the date of the termination of the Executive’s employment for any other reason, then any unvested options will be forfeited. In addition, if the applicable stock price hurdles have not been achieved by December 31, 2021 then any unvested options will be forfeited.

19

The 2019 Option Grants will also become vested to the extent that the applicable stock price hurdles are satisfied in connection with a change in control of the Company. As of March 31, 2020, the Company’s stock was trading at $31.04 per share, and since the date of grant the stock did not trade above $40.00 per share; accordingly, none of the 2019 Option Grants are vested at March 31, 2020 and the corresponding stock option expense was recognized during the three months ended March 31, 2020.

Stock option grants of 210,000 options to Mr. Remy Trafelet and 90,000 options to Mr. John Kiernan (collectively, the “2018 Option Grants”) were granted on September 7, 2018. The option exercise price for these options was set at $33.60, the closing price on September 7, 2018. The 2018 Option Grants will vest as follows: (i) 25% of the options will vest if the price of the Company’s common stock during a consecutive 20-trading day period exceeds $35.00; (ii) 25% of the options will vest if the price of the Company’s common stock during a consecutive 20-trading day period exceeds $40.00; (iii) 25% of the options will vest if the price of the Company’s common stock during a consecutive 20-trading day period exceeds $45.00; and (iv) 25% of the options will vest if the price of the Company’s common stock during a consecutive 20-trading day period exceeds $50.00. If the applicable stock price hurdles have not been achieved by (A) the date that is 18 months following the Executive’s termination of employment, if the Executive’s employment is terminated due to death or disability, (B) the date that is 12 months following the Executive’s termination of employment, if the Executive’s employment is terminated by the Company without cause, by the Executive with good reason, or due to the Executive’s retirement, or (C) the date of the termination of the Executive’s employment for any other reason, then any unvested options will be forfeited. In addition, if the applicable stock price hurdles have not been achieved by December 31, 2021 then any unvested options will be forfeited. The 2018 Option Grants will also become vested to the extent that the applicable stock price hurdles are satisfied in connection with a change in control of the Company. As of March 31, 2020, the Company’s stock was trading at $31.04 per share. During the six months ended March 31, 2020, the stock did trade above $35.00 per share for a consecutive twenty days; accordingly, 25% of Mr. Kiernan's 2018 Option Grants are vested at March 31, 2020 and the corresponding stock option expense was recognized during the three months ended March 31, 2020. As set forth below, more than a majority of the 2018 Option Grants issued to Mr. Trafelet were forfeited and the vesting conditions of the remainder were modified, all pursuant to the Alico Settlement Agreement, as defined below.

A stock option grant of 300,000 options in the case of Mr. Trafelet and 225,000 options in the case of each of Mr. Henry Slack and Mr. George Brokaw (collectively, the “2016 Option Grants”) were granted on December 31, 2016. The option price was set at $27.15, the closing price on December 31, 2016. The 2016 Option Grants will vest as follows: (i) 25% of the options will vest if the price of the Company’s common stock during a consecutive 20-trading day period exceeds $60.00; (ii) 25% of the options will vest if such price exceeds $75.00; (iii) 25% of the options will vest if such price exceeds $90.00; and (iv) 25% of the options will vest if such price exceeds $105.00. If the applicable stock price hurdles have not been achieved by (A) the second anniversary of the Executive’s termination of employment, if the Executive’s employment is terminated due to death or disability, (B) the date that is 18 months following the Executive’s termination of employment, if the Executive’s employment is terminated by the Company without cause, by the Executive with good reason, or due to the Executive’s retirement, or (C) the date of the termination of the Executive’s employment for any other reason, then any unvested options will be forfeited. In addition, if the applicable stock price hurdles have not been achieved by the fifth anniversary of the grant date (or the fourth anniversary of the grant date, in the case of the tranche described in clause (i) above), then any unvested options will be forfeited. The 2016 Option Grants will also become vested to the extent that the applicable stock price hurdles are satisfied in connection with a change in control of the Company. As of March 31, 2020, the Company’s stock was trading at $31.04 per share, and since the date of grant the stock did not trade above $60.00 per share; accordingly, none of the 2016 Option Grants are vested at March 31, 2020. As set forth below, all of the 2016 Option Grants issued to Mr. Trafelet were forfeited pursuant to the Alico Settlement Agreement, as defined below.

Additionally, 187,500 shares of the 2016 Option Grants made to each of Messrs. Slack and Brokaw were forfeited on September 5, 2018 and no replacement options were granted.

Pursuant to an Alico Settlement Agreement dated February 11, 2019 (described in Note 13. “Related Party Transactions”), which was unanimously approved by the Board of Directors, Mr. Trafelet agreed to voluntarily resign from his roles as President and Chief Executive Officer and a director of the Company. Under the Settlement Agreement, Mr. Trafelet forfeited (i) all of the 2016 Option Grants granted to him and (ii) all of the 2018 Option Grants granted to him in September 2018, other than 26,250 stock options that will vest if the minimum price of Alico's common stock over 20 consecutive trading days exceeds $35.00 per share and 26,250 stock options that will vest if the minimum price of Alico's common stock over 20 consecutive trading days exceeds $40.00 per share (“2019 Modified Option Grant”), in each case, by the first anniversary of the date of the Alico Settlement Agreement (collectively, the "Retained Options"). Any Retained Options that vest in accordance with their terms will expire on the date that is six months following the date on which the Retained Option vests, and any Retained Options that do not vest by the first anniversary of the Alico Settlement Agreement will be forfeited as of such first anniversary. As of March 31, 2020, the Company’s stock was trading at $31.04 per share. During the six months ended March 31, 2020, the stock did trade above $35.00 per share for a consecutive twenty days; accordingly, 26,250 stock options from the 2019 Modified Option Grants are vested at March 31, 2020. However, since the stock did not trade above $40.00 per share for a consecutive twenty days by the first anniversary of the date of the Alico Settlement Agreement, 26,250 stock options from the 2019 Modified Option Grants were forfeited. As a

20

result of the forfeited stock options relating to the 2016 Option Grants and 2018 Option Grants, the Company reversed $823,000 of previously recorded stock compensation expense during the year ended September 30, 2019, which is recorded as a reduction of General and Administrative expense.

Forfeitures of all stock options were recognized as incurred.

Stock compensation expense related to the options totaled approximately $301,000 and $383,000 for the three and six months ended March 31, 2020, respectively, and $229,000 and $518,000 for the three and six months ended March 31, 2019, respectively. At March 31, 2020 and September 30, 2019, there was approximately $496,000 and $502,000, respectively, of total unrecognized stock compensation costs related to unvested share-based compensation for the option grants. The total unrecognized compensation cost is expected to be recognized over a weighted-average period of 1.72 years.

The fair value of the 2020 and 2019 Option Grants was estimated on the date of grant using a Monte Carlo valuation model that uses the assumptions noted in the following table. The expected term of options granted is derived from the output of the option valuation model and represents the period of time that options granted are expected to be outstanding; the range given below results from different timeframes for the various market conditions being met.

2020 Option Grant

Expected Volatility	26.0	%
Expected Term (in years)	3.61
Risk Free Rate	1.60	%

The weighted-average grant-date fair value of the 2020 Option Grants was $3.20. There were no additional stock options granted or exercised for the six months ended March 31, 2020.

2019 Modified Option Grant

Expected Volatility	25.0	%
Expected Term (in years)	1.50
Risk Free Rate	2.52	%

The weighted-average grant-date fair value of the 2019 Modified Option Grant was $1.40.

2019 Option Grants

Expected Volatility	30.0	%
Expected Term (in years)	4.09
Risk Free Rate	2.95	%

The weighted-average grant-date fair value of the 2019 Option Grants was $7.10.

Stock Repurchase Authorizations

On October 3, 2018, the Company completed a tender offer of 752,234 shares at a price of $34.00 per share aggregating $25,575,956. 734 Investors, who was Alico's largest stockholder from 2013 until November 12, 2019, participated in the tender offer and sold a small percentage of its holdings.

On October 10, 2019, the Board of Directors authorized the repurchase of up to 7,000 shares of the Company’s common stock from 734 Investors in a privately negotiated repurchase of shares. On October 15, 2019, the Company entered into a repurchase agreement to repurchase a total of 7,000 shares of the Company’s common stock from 734 Investors, effective October 15, 2019.

The following table illustrates the Company’s treasury stock activity for the six months ended March 31, 2020:

21

(in thousands, except share amounts)
	Shares		Cost
Balance as of September 30, 2019	939,632		$	31,943
Purchased	7,000		238
Issued to employees and directors	(10,158	)	(397		)
Balance as of March 31, 2020	936,474		$	31,784

Note 12. Commitments and Contingencies

Letters of Credit

The Company had outstanding standby letters of credit in the total amount of approximately $399,000 and $460,000 at March 31, 2020 and September 30, 2019, respectively, to secure its various contractual obligations.

Legal Proceedings

From time to time, Alico may be involved in litigation relating to claims arising out of its operations in the normal course of business. There are no other current legal proceedings to which the Company is a party or of which any of its property is subject that it believes will have a material adverse effect on its financial position, results of operations or cash flows.

Purchase Commitments

The Company enters into contracts for the purchase of citrus trees during the normal course of its business. As of March 31, 2020, the Company had approximately $2,288,000 relating to outstanding commitments for these purchases that will be paid upon delivery of the remaining citrus trees.

Note 13. Related Party Transactions

Henry R. Slack and George R. Brokaw

On December 31, 2016, the Company entered into new employment agreements (collectively, the “Employment Agreements”) with Henry R. Slack, and George R. Brokaw. Mr. Slack previously served as the Executive Chairman of the Company, and Mr. Brokaw previously served as the Executive Vice Chairman of the Company. The Employment Agreements provided for an annual base salary of $250,000 in the case of Mr. Slack and an annual base salary of $250,000 in the case of Mr. Brokaw.

Effective July 1, 2019, Mr. Slack resigned his employment with the Company as Executive Chairman. Effective December 31, 2019, Mr. Brokaw resigned his employment with the Company as Executive Vice Chairman. Mr. Slack and Mr. Brokaw continue to serve on the Board of the Company.

Remy W. Trafelet

On February 11, 2019, as contemplated by a settlement agreement between the Company, certain members of the Board of Directors, Mr. Trafelet, and certain third parties affiliated with Mr. Trafelet (the “Alico Settlement Agreement”) Mr. Trafelet submitted to the Board his resignation as President and Chief Executive Officer of the Company and a member of the Board, effective upon the execution of the Alico Settlement Agreement. Also, on February 11, 2019, as contemplated by the Alico Settlement Agreement, the Company entered into a consulting agreement (the "Consulting Agreement") with Mr. Trafelet and 3584 Inc., an entity controlled by Mr. Trafelet (the "Consultant"). Pursuant to the Consulting Agreement, Mr. Trafelet will make himself available to provide consulting services to the Company through the Consultant for up to 24 months. In exchange for the consulting services, the Consultant will receive an annual consulting fee of $400,000. As of March 31, 2020, the Company has paid approximately $453,000 towards these consulting fees. If the Company terminates the consulting period (other than in certain specified circumstances), the Company will continue to pay the consulting fees described above through the balance of the 24-month term.

22

Shared Services Agreement

The Company had a shared services agreement with Trafelet Brokaw Capital Management, L.P. (“TBCM”), whereby the Company reimbursed TBCM for use of office space and various administrative and support services. The agreement expired December 31, 2018 and was not extended or renewed. The annual cost of the office and services was approximately $618,000. The Company expensed $0 for the three and six months ended March 31, 2020, and expensed $0 and approximately $147,000 for the three and six months ended March 31, 2019, respectively.

Distribution of Shares by Alico’s Largest Shareholder

On November 12, 2019, 734 Investors, the Company’s largest shareholder from 2013 until November 12, 2019, distributed the 3,173,405 shares of Company common stock held by it, on a pro rata basis, to its members. The Company understands this share distribution was made in anticipation of the dissolution of 734 Investors. Transfers of these shares were not made pursuant to any current Alico registration statement.

Note 14. Subsequent Events

On May 4, 2020, the Company purchased 334 acres of citrus grove property for approximately $2,850,000. This purchase was identified as a like-kind asset, which was coordinated with the sale of certain sections of the East Ranch to allow the Company to defer the taxes relating to the gain on the sale of these certain sections (see Note 1. Description of Business and Basis of Presentation - Restricted Cash).

23

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis should be read in conjunction with the accompanying Consolidated Financial Statements and related Notes thereto.

Cautionary Statement Regarding Forward-Looking Information

We provide forward-looking information in this Quarterly Report on Form 10-Q, particularly in this Management’s Discussion and Analysis and Results of Operations, pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Any statements in this Quarterly Report on Form 10-Q that are not historical facts are forward-looking statements. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. These statements are based on our current expectations, estimates and projections about our business based, in part, on assumptions made by our management and can be identified by terms such as “plans,” “expect,” “may,” "anticipate,” “intend,” “should be,” “will be” “is likely to,” “believes,” and similar expressions referring to future periods. Alico believes the expectations reflected in the forward-looking statements are reasonable but cannot guarantee future results, level of activity, performance or achievements. Actual results may differ materially from those expressed or implied in the forward-looking statements. Therefore, Alico cautions you against relying on any of these forward-looking statements. Factors which may cause future outcomes to differ materially from those foreseen in forward-looking statements include, but are not limited to: changes in laws, regulation and rules; weather conditions that affect production, transportation, storage, demand, import and export of fresh product and their by-products; increased pressure from diseases including citrus greening and citrus canker, as well as insects and other pests; disruption of water supplies or changes in water allocations; market pricing of citrus; pricing and supply of raw materials and products; market responses to industry volume pressures; pricing and supply of energy; changes in interest rates; availability of financing for land development activities and other growth and corporate opportunities; onetime events; acquisitions and divestitures; seasonality; labor disruptions; inability to pay debt obligations; inability to engage in certain transactions due to restrictive covenants in debt instruments; government restrictions on land use; changes in agricultural land values; the Company's receipt of future funding from the state of Florida in connection with water retention projects; impact of the coronavirus pandemic on our agriculture operations, including without limitation demand for product, supply chain, health and availability of our labor force and the labor force of our competitors and access to governmental loans and incentives; any reduction in the public float resulting from repurchases of common stock by the Company; changes in equity awards to employees; any increase in public float resulting from the distribution by 734 Investors of its shares to its members; whether the Company's dividend policy, including its recent increased dividend amounts, is continued; expressed desire of certain of our stockholders to liquidate their shareholdings by virtue of past market sales of common stock by sales of common stock or by way of future transactions; political changes and economic crises; competitive actions by other companies; risks related to the duration and severity of the COVID-19 outbreak and its impact on the Company’s business; the impact of the COVID-19 outbreak on the U.S. and global economies and financial market; increased competition from international companies; changes in environmental regulations and their impact on farming practices; the ability to secure permits for the Water Storage Contract and Project from the South Florida Water Management District; the land ownership policies of governments; changes in government farm programs and policies and international reaction to such programs; changes in pricing calculations with our customers; fluctuations in the value of the U. S. dollar, interest rates, inflation and deflation rates; length of terms of contracts with customers; impact on concentration of sales to one customer; and changes in and effects of crop insurance programs, global trade agreements, trade restrictions and tariffs; and soil conditions, harvest yields, prices for commodities, and crop production expenses. These forward looking statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in the forward-looking statements due to numerous factors, including those Risks Factors described in our Annual Report on Form 10-K for the fiscal year ended September 30, 2019, and our Quarterly Reports on Form 10-Q.

24

Business Overview

Business Description

Alico, Inc., together with its subsidiaries (collectively, “Alico”, the “Company”, “we”, “us” or “our”) generates operating revenues primarily from the sale of its citrus products and grazing and hunting leasing. The Company operates as two business segments and all of its operating revenues are generated in the United States. For the three and six months ended March 31, 2020, the Company generated operating revenues of approximately $50,515,000 and $61,520,000, respectively, income from operations of approximately $3,664,000 and $6,518,000, respectively, and net income attributable to common stockholders of approximately $3,571,000 and $4,362,000, respectively. Cash provided by operating activities was approximately $11,688,000 for the six months ended March 31, 2020.

Business Segments

Operating segments are defined in the criteria established under the Financial Accounting Standards Board - Accounting Standards Codification (“FASB ASC”) Topic 280 as components of public entities that engage in business activities from which they may earn revenues and incur expenses for which separate financial information is available and which is evaluated regularly by the Company’s chief operating decision maker (“CODM”) in deciding how to assess performance and allocate resources. The Company’s CODM assesses performance and allocates resources based on its operating segments.

The Company has two segments as follows:

• Alico Citrus includes activities related to planting, owning, cultivating and/or managing citrus groves in order to produce fruit for sale to fresh and processed citrus markets, including activities related to the purchase and resale of fruit and value-added services, which include contracting for the harvesting, marketing and hauling of citrus; and

• Water Resources and Other Operations includes activities related to sod, native plant sales, grazing and hunting leasing, management and/or conservation of unimproved native pastureland and activities related to rock mining royalties and other insignificant lines of business. Also included are activities related to owning and/or leasing improved farmland. Improved farmland is acreage that has been converted, or is permitted to be converted, from native pasture and which may have various improvements including irrigation, drainage and roads.

Critical Accounting Policies and Estimates

The discussion and analysis of the Company's financial condition and results of operations is based upon its unaudited condensed consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of these financial statements requires it to make certain estimates and judgments that affect the reported amounts of assets and liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities. Alico bases these estimates on historical experience, available current market information and on various other assumptions that management believes are reasonable under the circumstances. Additionally, the Company evaluates the results of these estimates on an on-going basis. Management’s estimates form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

There have been no significant changes during this reporting period to the policies and disclosures, except for the adoption of ASC 2016-02 “Leases” as noted in Note 1 “Description of Business and Basis of Presentation” to the condensed consolidated financial statements in Item 1 of Part I of this Quarterly Report on Form 10-Q, and set forth in Part II, Item 7 in Alico's Annual Report on Form 10-K for the fiscal year ended September 30, 2019.

See Note 1. “Description of Business and Basis of Presentation” to the condensed consolidated financial statements in Item 1 of Part I of this Form 10-Q for a detailed description of recent accounting pronouncements.

25

Recent Developments

The COVID-19 Pandemic

On March 11, 2020, the World Health Organization declared the current novel coronavirus outbreak (“COVID-19”) to be a global pandemic. In response to this declaration and the rapid spread of COVID-19 within the United States, federal, state and local governments throughout the country have imposed varying degrees of restrictions on social and commercial activity to promote social distancing in an effort to slow the spread of the illness. These measures have begun to have a significant adverse impact upon many sectors of the economy, including certain agriculture businesses.

During March 2020, as a precautionary measure to ensure financial flexibility and maintain maximum liquidity in response to the COVID-19 pandemic, the Company has implemented several measures that we believe will ensure sufficient liquidity for the next several months, including drawing down an aggregate of $70,000,000 on its revolving credit facilities. Additionally, for the protection of our employees per the Centers For Disease Control and Prevention (CDC) guidelines, the Company has arranged to have the majority of office personnel work remotely, has taken steps to allow our field workers greater separation and has worked with its harvest, haulers and suppliers to minimize interactions. The Company continues to assess the situation on a daily basis.

To date, the Company has experienced no adverse impacts from this pandemic.

Federal Relief Program

The Company is eligible for Hurricane Irma federal relief programs for block grants that are being administered through the State of Florida. During the fiscal year ended September 30, 2019, the Company received approximately $15,597,000 under the Florida Citrus Recovery Block Grant (“CRBG”) program. This represented Part 1 and a portion of Part 2 reimbursement under a three-part program. In the six months ended March 31, 2020, the Company received additional proceeds of approximately $4,629,000 under the Florida CRBG program. This represented the remaining portion of Part 2 reimbursement under a three-part program. The timing and amount to be received under the remaining portion of Part 3 of the program, if any, has not been finalized.

Distribution of Shares by 734 Investors

On November 14, 2019, 734 Investors filed a Form 4 and an amendment to Schedule 13D with the SEC disclosing that on November 12, 2019, it distributed all of its shares of Company common stock previously held by it, consisting of 3,173,405 shares, on a pro rata basis, to its members. Prior to such distribution, 734 Investors was the Company’s largest shareholder.

Employee and Board of Directors Matters

In December 2019, Mr. George R. Brokaw, the then Executive Vice Chairman, informed the Board of Directors that he would voluntarily step down as Executive Vice Chairman effective December 31, 2019 and that change has taken effect. Mr. Brokaw’s decision to step down as Executive Vice Chairman was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. After the effectiveness of this change, Mr. Brokaw has remained a member of the Board of Directors.

By way of action that has been taken by and at the direction of the Board of Directors, Benjamin D. Fishman, the non-employee Executive Chairman, became the Chairman of the Board, effective as of February 27, 2020, immediately after the Annual Meeting of Shareholders. Mr. Fishman remains a non-employee.

26

Condensed Consolidated Results of Operations

The following discussion provides an analysis of Alico's results of operations and should be read in conjunction with the accompanying Condensed Consolidated Statements of Operations for the three and six months ended March 31, 2020 and 2019:

(in thousands)
	Three Months Ended March 31,					Change					Six Months Ended March 31,						Change
	2020		2019			$			%		2020			2019			$			%
Operating revenues:
Alico Citrus	$	49,801	$	47,823		$	1,978		4.1	%	$	59,976		$	61,720		$	(1,744	)	(2.8	)%
Water Resources and Other Operations	714		698			16			2.3	%	1,544			1,580			(36		)	(2.3	)%
Total operating revenues	50,515		48,521			1,994			4.1	%	61,520			63,300			(1,780		)	(2.8	)%
Gross profit:
Alico Citrus	6,283		16,241			(9,958		)	(61.3	)%	11,618			19,264			(7,646		)	(39.7	)%
Water Resources and Other Operations	334		73			261			NM		613			232			381			164.2	%
Total gross profit	6,617		16,314			(9,697		)	(59.4	)%	12,231			19,496			(7,265		)	(37.3	)%
General and administrative expenses	2,953		4,654			(1,701		)	(36.5	)%	5,713			8,104			(2,391		)	(29.5	)%
Income from operations	3,664		11,660			(7,996		)	(68.6	)%	6,518			11,392			(4,874		)	(42.8	)%
Total other income (expense), net	1,398		(1,972		)	3,370			NM		(197		)	(4,836		)	4,639			(95.9	)%
Income before income taxes	5,062		9,688			(4,626		)	(47.7	)%	6,321			6,556			(235		)	(3.6	)%
Income tax provision	1,496		2,228			(732		)	(32.9	)%	1,857			1,599			258			16.1	%
Net income	3,566		7,460			(3,894		)	(52.2	)%	4,464			4,957			(493		)	(9.9	)%
Net loss (income) attributable to noncontrolling interests	5		87			(82		)	(94.3	)%	(102		)	123			(225		)	NM
Net income attributable to Alico, Inc. common stockholders	$	3,571	$	7,547		$	(3,976	)	(52.7	)%	$	4,362		$	5,080		$	(718	)	(14.1	)%

NM - Not meaningful

27

The following discussion provides an analysis of the Company's operating segments:

Alico Citrus

The table below presents key operating measures for the three and six months ended March 31, 2020 and 2019:

(in thousands, except per box and per pound solids data)
	Three Months Ended									Six Months Ended
	March 31,				Change					March 31,					Change
	2020		2019		Unit			%		2020			2019		Unit			%
Operating Revenues:
Early and Mid-Season	$	22,237	$	27,929	$	(5,692	)	(20.4	)%	$	31,303		$	39,574	$	(8,271	)	(20.9	)%
Valencias	25,810		18,746		7,064			37.7	%	25,810			18,746		7,064			37.7	%
Fresh Fruit	802		671		131			19.5	%	1,537			2,577		(1,040		)	(40.4	)%
Purchase and Resale of Fruit	556		221		335			151.6	%	603			246		357			145.1	%
Other	396		256		140			54.7	%	723			577		146			25.3	%
Total	$	49,801	$	47,823	$	1,978		4.1	%	$	59,976		$	61,720	$	(1,744	)	(2.8	)%
Boxes Harvested:
Early and Mid-Season	2,266		2,120		146			6.9	%	3,146			3,114		32			1.0	%
Valencias	2,260		1,298		962			74.1	%	2,260			1,298		962			74.1	%
Total Processed	4,526		3,418		1,108			32.4	%	5,406			4,412		994			22.5	%
Fresh Fruit	108		33		75			NM		203			136		67			49.3	%
Total	4,634		3,451		1,183			34.3	%	5,609			4,548		1,061			23.3	%
Pound Solids Produced:
Early and Mid-Season	13,091		11,735		1,356			11.6	%	17,947			16,873		1,074			6.4	%
Valencias	13,661		7,831		5,830			74.4	%	13,661			7,831		5,830			74.4	%
Total	26,752		19,566		7,186			36.7	%	31,608			24,704		6,904			27.9	%
Pound Solids per Box:
Early and Mid-Season	5.78		5.54		0.24			4.3	%	5.70			5.42		0.28			5.2	%
Valencias	6.04		6.04		—			—	%	6.04			6.04		—			—	%
Price per Pound Solids:
Early and Mid-Season	$	1.70	$	2.38	$	(0.68	)	(28.6	)%	$	1.74		$	2.35	$	(0.61	)	(26.0	)%
Valencias	$	1.89	$	2.39	$	(0.50	)	(20.9	)%	$	1.89		$	2.39	$	(0.50	)	(20.9	)%
Price per Box:
Fresh Fruit	$	7.43	$	20.17	$	(12.74	)	(63.2	)%	$	7.57		$	18.95	$	(11.38	)	(60.1	)%
Operating Expenses:
Cost of Sales	$	30,747	$	21,886	$	8,861		40.5	%	$	37,374		$	29,794	$	7,580		25.4	%
Harvesting and Hauling	12,290		9,404		2,886			30.7	%	14,755			12,148		2,607			21.5	%
Purchase and Resale of Fruit	392		147		245			166.7	%	424			168		256			152.4	%
Other	89		145		(56		)	(38.6	)%	(4,195		)	346		(4,541		)	NM
Total	$	43,518	$	31,582	$	11,936		37.8	%	$	48,358		$	42,456	$	5,902		13.9	%

NM - Not meaningful

The Company sells its Early and Mid-Season and Valencia oranges to processors that convert the majority of the citrus crop into orange juice. They generally buy the citrus on a pound solids basis, which is the measure of the soluble solids (sugars and acids) contained in one box of fruit. Fresh fruit is generally sold to packing houses that purchase the citrus on a per box basis. Other revenues consist of third-party grove caretaking, and the purchase and reselling of fruit.

28

Alico's operating expenses consist primarily of cost of sales and harvesting and hauling costs. Cost of sales represents the cost of maintaining the citrus groves for the preceding calendar year and does not vary in relation to production. Harvesting and hauling costs represent the costs of bringing citrus product to processors and varies based upon the number of boxes produced. Other expenses include the period costs of third-party grove caretaking and the purchase and reselling of fruit.

The increase in revenue for the three months ended March 31, 2020, compared to the three months ended March 31, 2019 was primarily due to an increase in the revenue generated from Valencia fruit. The harvesting of the Company’s Valencia fruit in fiscal year 2020 commenced earlier than in the previous fiscal year. The harvesting of the Valencia fruit commenced in the middle of February, as compared to the harvesting commencing in early March in the previous harvest season. Accordingly, the Company has harvested a greater number of boxes in the three month period ended March 31, 2020 as compared to the same period in fiscal year 2019.

Offsetting the increase in revenues for the three months ended March 31, 2020, compared to the three months ended March 31, 2019, was a decrease in the price per pound solids in the market place for both the Early and Mid-season and Valencia season oranges as a result of excess supply from domestic and international growers.

The decrease in revenue for the six months ended March 31, 2020, compared to the six months ended March 31, 2019 was due to a decrease in the price per pound solids. Similar to the three months ended March 31, 2020, the decrease in the price per pound solids in the market place for both the Early and Mid-season and Valencia season oranges is a result of excess supply from domestic and international growers.

Partially offsetting the decrease for the six months ended March 31, 2020, compared to the six months ended March 31, 2019 was an increase in the revenue generated from Valencia fruit. Consistent with the increase for the three month period ended March 31, 2020, the harvesting of the Company’s Valencia fruit in fiscal year 2020 commenced earlier than in the previous fiscal year. Accordingly, the Company has harvested a greater number of boxes in the six month period ended March 31, 2020 as compared to the same period in fiscal year 2019. The Company will complete the harvesting of its Valencia fruit earlier in the current fiscal year as compared to the prior fiscal year and anticipates an overall decrease in the number of boxes harvested and revenues generated from Valencia fruit for the 2020 harvest season, as compared to the prior fiscal year. The decrease is anticipated as a result of increased fruit drop and smaller fruit size, as compared to the prior year.

As the Company is winding down its current year harvest season, which is anticipated to be completed in the middle of May 2020, the Company’s harvest has thus far not been impacted by the COVID-19 pandemic and it is not expected to have an impact throughout the remainder of the harvest season.

The USDA, in its April 10, 2020 Citrus Crop Forecast for the 2019-20 harvest season, indicated its expectation that the Florida orange crop will decrease from approximately 71,800,000 boxes for the 2018-19 crop year to approximately 70,000,000 boxes for the 2019-20 crop year, a decrease of approximately 2.5%. While the Florida production is estimated to be only slightly lower than in the prior year, the Company anticipates that the reduction in the market prices will continue throughout the remainder of the 2019-20 harvest season as a result of the excess supply from domestic and international growers. However, due to an increase in the consumption of Not from Concentrate Orange Juice ("NFC") over the last several weeks, it is anticipated that the inventory levels will decrease and, as a result, it is anticipated that market pricing will improve in the 2020-21 harvest season.

The increase in operating expenses for the three and six months ended March 31, 2020, as compared to the three and six months ended March 31, 2019, primarily relates to the timing of the harvesting of the Valencia fruit. As a result of commencing the harvesting of Valencia fruit earlier in the season and harvesting a greater percentage of boxes, in relation to estimated total boxes to be harvested for the full season, in the three and six months ended March 31, 2020, as compared to the same periods in the prior year, a greater percentage of costs were allocated to Cost of Sales in the period. Additionally, as a result of commencing harvesting earlier, the Company processed more boxes resulting in an increase in its harvesting and hauling expense. Partially offsetting this increase in the six months ended March 31, 2020, the Company received proceeds of approximately $4,629,000 through the CRBG relating to Hurricane Irma.

29

Water Resources and Other Operations

The table below presents key operating measures for the three and six months ended March 31, 2020 and 2019:

(in thousands)
	Three Months Ended March 31,				Change					Six Months Ended March 31,				Change
	2020		2019		$			%		2020		2019		$			%
Revenue From:
Land and other leasing	$	679	$	658	$	21		3.2	%	$	1,342	$	1,392	$	(50	)	(3.6	)%
Other	35		40		(5		)	(12.5	)%	202		188		14			7.4	%
Total	$	714	$	698	$	16		2.3	%	$	1,544	$	1,580	$	(36	)	(2.3	)%
Operating Expenses:
Land and other leasing	$	248	$	238	$	10		4.2	%	$	449	$	552	$	(103	)	(18.7	)%
Water conservation	130		379		(249		)	(65.7	)%	477		783		(306		)	(39.1	)%
Other	2		8		(6		)	(75.0	)%	5		13		(8		)	(61.5	)%
Total	$	380	$	625	$	(245	)	(39.2	)%	$	931	$	1,348	$	(417	)	(30.9	)%

Land and other leasing includes lease income from grazing right leases, hunting leases, a lease to a third party of an aggregate mine, leases of oil extraction rights to third parties, and farm lease revenue.

The slight decrease in revenues from Water Resources and Other Operations for the six months ended March 31, 2020 is primarily due to a reduction in the leased acreage relating to the cattle grazing lease. The reduction in the leased acreage was due to certain acres, which were included under this lease arrangement, being sold in September 2019, and a subsequent revision in December 2019 to the lease, whereby fewer acres are now being leased under this cattle grazing lease. Offsetting this decrease, and resulting in an increase in revenues for the three months ended March 31, 2020, was the Company entered into a new grazing rights agreement with a third-party for certain available acreage.

The decrease in operating expenses from Water Resources and Other Operations for the three and six months ended March 31, 2020, compared to the three and six months ended March 31, 2019 is primarily due to a reduction in incurred costs associated with the water project.

Water storage and conservation

In December 2012, the South Florida Water Management District ("SFWMD") issued a solicitation request for projects to be considered for the Northern Everglades Payment for Environmental Services Program. In March 2013, the Company submitted its response proposing a dispersed water management project on a portion of its ranch land to reduce harmful discharges to the Caloosahatchee Estuary.

On December 11, 2014, the SFWMD approved a contract with the Company. The contract term is eleven years and allows up to one year for implementation (design, permitting, construction and construction completion certification) and ten years of operation, whereby the Company will provide water retention services. Payment includes an amount not to exceed $4,000,000 of reimbursement for implementation. In addition, it provides for an annual fixed payment of $12,000,000 for operations and maintenance costs, as long as the project is in compliance with the contract and subject to annual District Board approval of funding. The contract specifies that the District Board has to approve the payments annually and there can be no assurance that it will approve the annual fixed payments. On September 19, 2018, the SFWMD issued a press release announcing the issuance of an Environmental Resource Permit for Alico. The SFWMD release also stated that (i) the issuance of the permit cleared the path for Alico to deliver a regional dispersed water storage project in the Caloosahatchee Watershed that has the opportunity to significantly reduce excessive Lake Okeechobee releases and storm water runoff to the Caloosahatchee Estuary, (ii) Alico has all necessary state approvals to proceed, and (iii) the project is expected to be operational within one year from the start of construction, which is contingent on Alico securing additional local and federal approvals. These approvals include a compatible use agreement from the Natural Resources Conservation Service, as well as approvals from the local water control districts. The project has made substantial progress toward receiving federal authorization from the US Army Corps of Engineers, which includes consultation with US Fish & Wildlife Service and the Tribes of Florida. The approved Florida budget for the state’s 2019/2020 fiscal year included funding for the Program. Operating expenses were approximately $130,000 and $379,000 for the three months ended March 31, 2020 and 2019, respectively, and were approximately $477,000 and $783,000 for the six months ended March 31, 2020 and 2019, respectively.

30

General and Administrative Expense

General and administrative expenses for the three months ended March 31, 2020 totaled approximately $2,953,000, compared to approximately $4,654,000 for the three months ended March 31, 2019. The decrease was attributable in large part to (i) a reduction in professional fees of approximately $1,800,000 relating to corporate matters incurred in the three months ended March 31, 2019, (ii) a reduction in consulting and separation fees of $800,000 incurred in the three months ended March 31, 2019 relating to a settlement agreement with a former senior executive and (iii) a reduction in rent expense of approximately $150,000 as a result of the Company not renewing its lease for office space in New York City. These decreases were partially offset by an adjustment to stock compensation expense whereby the Company recorded a reduction in stock compensation expense of $823,000 for the three

months ended March 31, 2019, as a result of a former senior executive forfeiting his stock options as part of a settled litigation. Additionally, to a smaller extent, the Company experienced increases in Directors and Officers insurance premiums and increases in it’s accrual for paid time off, aggregating $130,000.

General and administrative expenses for the six months ended March 31, 2020 totaled approximately $5,713,000, compared to approximately $8,104,000 for the six months ended March 31, 2019. The decrease was attributable in large part to (i) a reduction in professional fees of approximately $2,300,000 relating to corporate matters incurred in the six months ended March 31, 2019, (ii) a reduction in consulting and separation fees of $800,000 incurred in the six months ended March 31, 2019 relating to a settlement agreement with a former senior executive and (iii) a reduction in rent expense of approximately $150,000 as a result of the Company not renewing its lease for office space in New York City. These decreases were partially offset by an adjustment to stock compensation expense whereby the Company recorded a reduction in stock compensation expense of $823,000 for the six months ended March 31, 2019, as a result of a former senior executive forfeiting his stock options as part of a settled litigation.

Other Income (Expenses), net

Other income (expense), net, for the three months ended March 31, 2020 and 2019 was approximately $1,398,000 and approximately $(1,972,000), respectively. The shift in other income (expense), net is primarily due to the Company recognizing a gain on sale of real estate, property and equipment and assets held for sale of approximately $2,800,000 for the three months ended March 31, 2020. No significant gain on the sale of assets was recorded for the three months ended March 31, 2019. Additionally, the Company recognized a reduction of approximately $511,000 in lower interest expense as a result of borrowing on average fewer funds under its line of credit in the three months ended March 31, 2020, as compared to the three months ended March 31, 2019, along with the reduction of its long-term debt attributable to making its mandatory principal payments.

Other income (expense), net, for the six months ended March 31, 2020 and 2019 was approximately $(197,000) and approximately $(4,836,000), respectively. The decrease in the other income (expense), net is primarily due to (i) the Company recognizing a gain on sale of real estate, property and equipment and assets held for sale of approximately $2,800,000 during the six months ended March 31, 2020 compared to the same period in the prior year where no significant gain on sale of assets was recorded, (ii) the Company recognizing a reduction of approximately $884,000 in lower interest expense as a result of borrowing on average fewer funds under its line of credit in the six months ended March 31, 2020, as compared to the six months ended March 31, 2019, along with the reduction of its long-term debt attributable to making its mandatory principal payments and (iii) during the six months ended March 31, 2019, the Company recorded an expense of $989,000 relating to the change in fair value of the derivative asset and derivative liabilities (see “Note 7. Derivative Gain on Sale”).

With the Company drawing down substantially on its lines of credit in response to the COVID-19 pandemic, the Company anticipates it will incur increased in interest expense until such borrowings are paid.

Income Taxes

The income tax provision was approximately $1,496,000 and $2,228,000 for the three months ended March 31, 2020 and 2019, respectively, and a provision of approximately $1,857,000 and $1,599,000 for the six months ended March 31, 2020 and 2019, respectively. The reduction in the tax provision for the three months ended March 31, 2020, as compared to the three months ended March 31, 2019, primarily resulted from the Company generating lower net income, compared to the three months ended March 31, 2019. The increase in the tax provision for the six months ended March 31, 2020, as compared to the six months ended March 31, 2019, primarily resulted from an increase in permanent book and tax differences whereby the Company is not afforded tax deductions.

Seasonality

The Company is primarily engaged in the production of fruit for sale to citrus markets, which is of a seasonal nature, and subject to the influence of natural phenomena and wide price fluctuations. Historically, the second and third quarters of Alico's fiscal year produce the majority of the Company's annual revenue. Working capital requirements are typically greater in the first and fourth

31

quarters of the fiscal year, coinciding with harvesting cycles. Because of the seasonality of the business, results for any quarter are not necessarily indicative of the results that may be achieved for the full fiscal year.

32

Liquidity and Capital Resources

A comparative balance sheet summary is presented in the following table:

(in thousands)	March 31,		September 30,
	2020		2019		Change
Cash and cash equivalents and restricted cash	$	84,078	$	23,838	$	60,240
Total current assets	$	116,182	$	61,977	$	54,205
Total current liabilities	$	23,667	$	28,951	$	(5,284	)
Working capital	$	92,515	$	33,026	$	59,489
Total assets	$	472,284	$	417,388	$	54,896
Principal amount of term loans and lines of credit	$	220,343	$	163,449	$	56,894
Current ratio	4.91 to 1		2.14 to 1

Management believes that a combination of cash-on-hand (much of which has been generated from a recent draw on lines of credit), cash generated from operations, asset sales and additional availability under the Company's lines of credit will provide sufficient liquidity to service the principal and interest payments on its indebtedness, and will satisfy working capital requirements and capital expenditures for at least the next twelve months and over the long term. Alico maintains a $70,000,000 working capital line of credit and a $25,000,000 revolving line of credit, which are available for general use (see Note 5. “Long-Term Debt and Lines of Credit” to the accompanying Condensed Consolidated Financial Statements). In March 2020, as a precautionary measure, the Company drew down an aggregate of $70,000,000 on its revolving credit facilities; $50,000,000 on its WCLC and $20,000,000 on its RLOC. This decision was made to safeguard the Company’s liquidity and to increase available cash on hand in the event of a more protracted COVID-19 outbreak.

The level of debt could have important consequences on Alico's business, including, but not limited to, increasing its vulnerability to general adverse economic and industry conditions, limiting the availability of cash flow to fund future investments, capital expenditures, working capital, business activities and other general corporate requirements, and limiting flexibility in planning for, or reacting to, changes in its business and industry.

Net Cash Provided By Operating Activities

The following table details the items contributing to Net Cash Provided By Operating Activities for the six months ended March 31, 2020 and 2019:

(in thousands)	Six Months Ended March 31,
	2020			2019			Change
Net income	$	4,464		$	4,957		$	(493	)
Depreciation, depletion and amortization	7,199			6,951			248
Deferred income tax (benefit) expense	(827		)	73			(900		)
Gain on sale of real estate, property and equipment and assets held for sale	(2,863		)	(23		)	(2,840		)
Change in fair value of derivatives	—			989			(989		)
Impairment of long-lived assets	723			—			723
Impairment of right-of-use asset	87			—			87
Stock-based compensation expense	790			223			567
Other	(36		)	(51		)	15
Change in working capital	2,151			(7,051		)	9,202
Net cash provided by operating activities	$	11,688		$	6,068		$	5,620

The increase in net cash provided by operating activities for the six months ended March 31, 2020, as compared to the same period in 2019, was primarily due to an increase in working capital, which is primarily due to a decrease in inventory as a result of more costs being allocated to cost of goods sold as a result of a greater percentage of boxes being harvested through March 31, 2020, compared to the six months ended March 31, 2019. Partially offsetting this increase was the Company’s recording of a gain on sale in the six months ended March 31, 2020 relating to the sale of certain sections of the East Ranch.

33

Net Cash Used In Investing Activities

The following table details the items contributing to Net Cash Used In Investing Activities for the six months ended March 31, 2020 and 2019:

(in thousands)	Six Months Ended March 31,
	2020			2019			Change
Capital expenditures:
Citrus trees	$	(7,685	)	$	(7,407	)	$	(278	)
Land	(34		)	(512		)	478
Equipment and other	(2,241		)	(1,605		)	(636		)
Total	(9,960		)	(9,524		)	(436		)
Net proceeds from sale of property and equipment and assets held for sale	2,994			202			2,792
Change in deposits on purchase of citrus trees	(57		)	(515		)	458
Deposit on purchase of citrus grove	(25		)	—			(25		)
Advances on notes receivables, net	87			50			37
Net cash used in investing activities	$	(6,961	)	$	(9,787	)	$	2,826

The decrease in the amount of net cash used in investing activities for the six months ended March 31, 2020, as compared to the six months ended March 31, 2019, was primarily due to proceeds received from the sale of certain sections of the East Ranch during the six month period ended March 31, 2020.

Net Cash Provided By (Used In) Financing Activities

The following table details the items contributing to Net Cash Provided By (Used In) Financing Activities for the six months ended March 31, 2020 and 2019:

(in thousands)	Six Months Ended March 31,
	2020			2019			Change
Repayments on revolving lines of credit	$	(18,805	)	$	(41,360	)	$	22,555
Borrowings on revolving lines of credit	85,519			63,637			21,882
Principal payments on term loans	(9,820		)	(5,437		)	(4,383		)
Treasury stock purchases	(238		)	(25,576		)	25,338
Payment on termination of sugarcane agreement	—			(11,300		)	11,300
Dividends paid	(1,120		)	(895		)	(225		)
Deferred financing costs	(23		)	—			(23		)
Net cash provided by (used in) financing activities	$	55,513		$	(20,931	)	$	76,444

The shift from cash used in financing activities to cash provided by financing activities is primarily due to the Company recently

drawing down on its lines of credit. During March 2020, the Company drew down $70,000,000 as a precautionary measure to safeguard the Company’s liquidity and to increase available cash on hand in the event of a more protracted COVID-19 outbreak. Additionally, the Company purchased its common shares through a tender offer in October 2018 for an aggregate approximate amount of $25,576,000 and terminated its 2014 Post-Closing Agreement in March 2019 pursuant to which the Company paid $11,300,000. Partially offsetting this shift was a prepayment of one of its long-term debt obligations in November 2019 in the amount of $4,455,000.

Alico had $66,714,000 outstanding on its revolving lines of credit as of March 31, 2020.

The WCLC line of credit agreement provides for Rabo Agrifinance, Inc. to issue up to $2,000,000 in letters of credit on the Company’s behalf. As of March 31, 2020, there was approximately $399,000 in outstanding letters of credit, which correspondingly slightly reduced Alico's availability under the line of credit.

34

Purchase Commitments

The Company enters into contracts for the purchase of citrus trees during the normal course of its business. As of March 31, 2020, the Company had approximately $2,288,000 relating to outstanding commitments for these purchases, which will be paid upon delivery.

Contractual Obligations and Off Balance Sheet Arrangements

There have been no material changes during this reporting period to the disclosures set forth in Part II, Item 7 in Alico's Annual Report on Form 10-K for the fiscal year ended September 30, 2019.

35

Item 3. Quantitative and Qualitative Disclosures about Market Risk

There have been no material changes during this reporting period in the disclosures set forth in Part II, Item 7A in our Annual Report on Form 10-K for the fiscal year ended September 30, 2019, as filed with the SEC on December 5, 2019.

Item 4. Controls and Procedures

(a) Evaluation of Disclosure Controls and Procedures.

Our Principal Executive Officer and Chief Financial Officer have evaluated the effectiveness of the our disclosure controls and procedures as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, (the “Exchange Act”) as of the end of the period covered by this report. Based on this evaluation, our Principal Executive Officer and Chief Financial Officer have concluded that, as of the end of the period covered by this report, our disclosure controls and procedures were effective.

(b) Changes in Internal Control over Financial Reporting.

During the fiscal quarter ended March 31, 2020, there were no changes in our internal controls over financial reporting that have materially affected or are reasonably likely to materially affect, our internal control over financial reporting.

36

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

From time to time, Alico may be involved in litigation relating to claims arising out of its operations in the normal course of business. There are no other current legal proceedings to which the Company is a party or of which any of its property is subject that it believes will have a material adverse effect on its financial position, results of operations or cash flows.

Item 1A. Risk Factors

With the exception of the following, there have been no material changes in the risk factors set forth in Part 1, Item 1A, “Risk Factors” in Alico's Annual Report on Form 10-K for the fiscal year ended September 30, 2019, as filed with the SEC on December 5, 2019.

Our business, results of operations and our financial condition may be impacted by the outbreak of COVID-19 and such impact could be materially adverse.

On March 11, 2020, the World Health Organization declared the current novel coronavirus outbreak (“COVID-19”) to be a global pandemic. In response to this declaration and the rapid spread of COVID-19 within the United States, federal, state and local governments throughout the country have imposed varying degrees of restriction on social and commercial activity to promote social distancing in an effort to slow the spread of the illness.

The spread of the COVID-19 has created significant volatility, uncertainty and economic disruption. The extent to which the COVID-19 pandemic impacts our business, operations, and financial results is uncertain and will depend on certain factors that we may not be able to accurately predict, including:

• the duration and scope of the pandemic;

• governmental, business and individual actions taken in response to the pandemic and the impact of those actions on economic activity;

• the actions of our customers, particularly Tropicana, and their respective abilities to continue their facility operations;

• our ability to secure the necessary products/chemicals from our vendors to allow us to continue to provide proper care to our citrus trees;

• our ability to continue to obtain third-party resources, including laborers and truck drivers, to provide the harvesting and hauling of our citrus fruit including the extent to which the laborers and/or truck drivers are unable and/or refuse to work as a result of experiencing and/or caring for those experiencing the COVID-19 disease;

• our ability to avoid business disruptions as a result of our employees working remotely.

Any of these factors could cause or contribute to the risks and uncertainties identified in our fiscal 2019 Form 10-K and could materially adversely affect our business, financial condition, results of operations and cashflows.

37

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

There were no sales of unregistered equity securities during the period covered by this Quarterly Report on Form 10-Q.

Issuer Purchases of Equity Securities

Period	(a) Total number of shares (or units) purchased	(b) Average price paid per share (or unit)		(c) Total number of shares (or units) purchased as part of publicly announced plans or programs	(d) Maximum number (or approximate dollar value) of shares (or units) that may yet be purchased under the plans or programs
1/1/2020 - 1/31/2020	—	—		—	—
2/1/2020 - 2/29/2020	—	—		—	—
3/1/2020 - 3/31/2020	—	—		—	—
Total	—	$	—	—	—

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosure

Not Applicable.

38

Item 5. Other Information

None.

Item 6. Exhibits

Exhibit Number		Exhibit Index
3.1		Restated Certificate of Incorporation, dated February 17, 1972 (incorporated by reference to Exhibit 3.1 of Alico's filing on Form 10-K dated December 11, 2017)
3.2		Certificate of Amendment to Certificate of Incorporation, dated January 14, 1974 (incorporated by reference to Alico’s Registration Statement on Form S-8, dated December 21, 2005, Registration No. 333-130575)
3.3		Amendment to Articles of Incorporation, dated January 14, 1987 (incorporated by reference to Alico’s Registration Statement on Form S-8, dated December 21, 2005, Registration No. 333-130575)
3.4		Amendment to Articles of Incorporation, dated December 27, 1988 (incorporated by reference to Alico’s Registration Statement on Form S-8, dated December 21, 2005, Registration No. 333-130575)
3.5		By-Laws of Alico, Inc., amended and restated
31.1		Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 Rule 13a-14(a) certification
31.2		Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 Rule 13a-14(a) certification
32.1		Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350
32.2		Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350
101
101.INS	**	XBRL Instance Document
101.SCH	**	XBRL Taxonomy Extension Schema Document
101.CAL	**	XBRL Taxonomy Calculation Linkbase Document
101.DEF	**	XBRL Taxonomy Definition Linkbase Document
101.LAB		XBRL Taxonomy Label Linkbase Document
101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document
*	Denotes a management contract or compensatory plan, contract or arrangement.
**	In accordance with Rule 406T of Regulation S-T, these XBRL (eXtensible Business Reporting Language) documents are furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933 or Section 18 of the Securities Exchange Act of 1934 and otherwise are not subject to liability under these sections.

39

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	ALICO, INC. (Registrant)
May 11, 2020	By:	/s/ John E. Kiernan
		John E. Kiernan
		President and Chief Executive Officer
		(Principal Executive Officer)
May 11, 2020	By:	/s/ Richard Rallo
		Richard Rallo
		Senior Vice President and Chief Financial Officer
		(Principal Financial and Accounting Officer)

40

EX-31.1

Exhibit 31.1

CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, John E. Kiernan, certify that;

1. I have reviewed this Quarterly Report on Form 10-Q of Alico, Inc. (Alico),

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of Alico as of, and for, the periods presented in this report;

4. Alico’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for Alico and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to Alico, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of Alico’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in Alico’s internal control over financial reporting that occurred during Alico’s most recent fiscal quarter ended March 31, 2020, that has materially affected, or is reasonably likely to materially affect, Alico’s internal control over financial reporting; and

5. Alico’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to Alico’s auditors and audit committee of Alico’s Board of Directors:

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 11, 2020	By:	/s/ John E. Kiernan
		John E. Kiernan
		President and Chief Executive Officer
		(Principal Executive Officer)

EX-31.2

Exhibit 31.2

CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Richard Rallo, certify that;

1. I have reviewed this Quarterly Report on Form 10-Q of Alico, Inc. (Alico),

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of Alico as of, and for, the periods presented in this report;

4. Alico’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for Alico and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to Alico, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of Alico’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in Alico’s internal control over financial reporting that occurred during Alico’s most recent fiscal quarter ended March 31, 2020, that has materially affected, or is reasonably likely to materially affect, Alico’s internal control over financial reporting; and

5. Alico’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to Alico’s auditors and audit committee of Alico’s Board of Directors:

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 11, 2020	By:	/s/ Richard Rallo
		Richard Rallo
		Senior Vice President and Chief Financial Officer (Principal Financial and Accounting Officer)

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Alico, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2020 as filed with the Securities and Exchange Commission on May 11, 2020, (the “Form 10-Q”), I, John E. Kiernan, President and Chief Executive Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Form 10-Q fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

(2) The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 11, 2020	By:	/s/ John E. Kiernan
		John E. Kiernan
		President and Chief Executive Officer
		(Principal Executive Officer)

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Alico, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2020, as filed with the Securities and Exchange Commission on May 11, 2020, (the “Form 10-Q”), I, Richard Rallo, Senior Vice President and Chief Financial Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Form 10-Q fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

(2) The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 11, 2020	By:	/s/ Richard Rallo
		Richard Rallo
		Senior Vice President and Chief Financial Officer (Principal Financial and Accounting Officer)

XML

Derivative Asset and Derivative Liabilities/Deferred Gain on Sale - Narrative (Details) a in Thousands, $ in Thousands					3 Months Ended			6 Months Ended		52 Months Ended
	Mar. 27, 2020 USD ($)	Dec. 07, 2018 USD ($)	Oct. 30, 2018 USD ($)	Nov. 21, 2014 USD ($) a	Mar. 31, 2020 USD ($)	Mar. 31, 2019 USD ($)	Dec. 31, 2018 USD ($)	Mar. 31, 2020 USD ($)	Mar. 31, 2019 USD ($)	Mar. 11, 2019 USD ($)	Sep. 30, 2019 USD ($)	Oct. 01, 2018 USD ($)
Business Acquisition [Line Items]
Gain on sale of investment in real estate					$ 2,838	$ 1		$ 2,863	$ 23
Retained earnings					201,065			201,065
Loss on derivatives					$ 0	33		$ 0	989
Hendry County Florida
Business Acquisition [Line Items]
Post-closing adjustment period				10 years
Aggregate amount of payments made due to post closing agreement										$ 6,518
Amount to be deposited into escrow		$ 11,300
Discontinued Operations, Disposed of by Sale
Business Acquisition [Line Items]
Consideration for discontinued operation	$ 2,952		$ 206,000								$ 47
Aggregate amount of payments made due to post closing agreement	$ (2,838)		$ (12,000)
Discontinued Operations, Disposed of by Sale | Hendry County Florida
Business Acquisition [Line Items]
Acres of land | a				36
Consideration for discontinued operation				$ 97,900
Post-closing adjustment period				10 years
Realized gain on disposal				$ 42,753
Deferred gain on sale				29,140
Gain on sale of investment in real estate				$ 13,613
ASC 610-20
Business Acquisition [Line Items]
Retained earnings						$ (3,704)			(3,704)
ASC 610-20 | Discontinued Operations, Disposed of by Sale
Business Acquisition [Line Items]
Retained earnings												$ 10,897
Derivative asset												3,553
Other current liabilities												$ 13,864
Loss on derivatives							$ 956		$ 33

XML

Segment Information - Information by Operating Segment (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019	Sep. 30, 2019
Revenues:
Total revenues	$ 50,515	$ 48,521	$ 61,520	$ 63,300
Operating expenses:
Total operating expenses	43,898	32,207	49,289	43,804
Gross profit:
Gross profit	6,617	16,314	12,231	19,496
Depreciation, depletion and amortization:
Total depreciation, depletion and amortization	3,590	3,493	7,199	6,951
Assets:
Total assets	472,284		472,284		$ 417,388
Alico Citrus
Revenues:
Total revenues	49,801	47,823	59,976	61,720
Operating expenses:
Total operating expenses	43,518	31,582	48,358	42,456
Gross profit:
Gross profit	6,283	16,241	11,618	19,264
Water Resources and Other Operations
Revenues:
Total revenues	714	698	1,544	1,580
Operating expenses:
Total operating expenses	380	625	931	1,348
Gross profit:
Gross profit	334	73	613	232
Operating Segments | Alico Citrus
Depreciation, depletion and amortization:
Total depreciation, depletion and amortization	3,416	3,334	6,853	6,621
Assets:
Total assets	452,581		452,581		401,212
Operating Segments | Water Resources and Other Operations
Depreciation, depletion and amortization:
Total depreciation, depletion and amortization	46	37	92	87
Assets:
Total assets	18,325		18,325		15,332
Other Corporate Assets
Assets:
Total assets	1,378		1,378		$ 844
Other Depreciation, Depletion and Amortization
Depreciation, depletion and amortization:
Total depreciation, depletion and amortization	$ 128	$ 122	$ 254	$ 243

XML

Commitments and Contingencies - Letters of Credit (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Sep. 30, 2019
Financial Standby Letter of Credit
Loss Contingencies [Line Items]
Outstanding standby letters of credit	$ 399	$ 460

XML

Accrued Liabilities

6 Months Ended

Mar. 31, 2020

Payables and Accruals [Abstract]

Accrued Liabilities

Accrued Liabilities

Accrued liabilities consist of the following at March 31, 2020 and September 30, 2019:

(in thousands)	March 31,		September 30,
	2020		2019
Ad valorem taxes	$	692	$	2,117
Accrued interest	1,063		1,110
Accrued employee wages and benefits	1,372		2,525
Accrued dividends	673		448
Accrued contractual obligation associated with sale of real estate	—		402
Accrued harvest and haul	431		—
Consulting and separation charges	346		400
Accrued insurance	—		544
Other accrued liabilities	366		223
Total accrued liabilities	$	4,943	$	7,769

XML

Segment Information

6 Months Ended

Mar. 31, 2020

Segment Reporting [Abstract]

Segment Information

Segment Information

Segments

Operating segments are defined in the criteria established under the FASB ASC Topic 280 as components of public entities that engage in business activities from which they may earn revenues and incur expenses for which separate financial information is available and which is evaluated regularly by the Company’s chief operating decision maker (“CODM”) in deciding how to assess performance and allocate resources. The Company’s CODM assesses performance and allocates resources based on two operating segments: Alico Citrus and Water Resources and Other Operations.

Total revenues represent sales to unaffiliated customers, as reported in the Condensed Consolidated Statements of Operations. Goods and services produced by these segments are sold to wholesalers and processors in the United States who prepare the products for consumption. The Company evaluates the segments’ performance based on direct margins (gross profit) from operations before general and administrative expenses, interest expense, other income (expense) and income taxes, not including nonrecurring gains and losses.

Information by operating segment is as follows:

(in thousands)	Three Months Ended March 31,				Six Months Ended March 31,
	2020		2019		2020		2019
Revenues:
Alico Citrus	$	49,801	$	47,823	$	59,976	$	61,720
Water Resources and Other Operations	714		698		1,544		1,580
Total revenues	50,515		48,521		61,520		63,300
Operating expenses:
Alico Citrus	43,518		31,582		48,358		42,456
Water Resources and Other Operations	380		625		931		1,348
Total operating expenses	43,898		32,207		49,289		43,804
Gross profit:
Alico Citrus	6,283		16,241		11,618		19,264
Water Resources and Other Operations	334		73		613		232
Total gross profit	6,617		16,314		12,231		19,496
Depreciation, depletion and amortization:
Alico Citrus	3,416		3,334		6,853		6,621
Water Resources and Other Operations	46		37		92		87
Other Depreciation, Depletion and Amortization	128		122		254		243
Total depreciation, depletion and amortization	$	3,590	$	3,493	$	7,199	$	6,951

(in thousands)	March 31,		September 30,
	2020		2019
Assets:
Alico Citrus	$	452,581	$	401,212
Water Resources and Other Operations	18,325		15,332
Other Corporate Assets	1,378		844
Total Assets	$	472,284	$	417,388

XML

Description of Business and Basis of Presentation - Supplemental Cash Flow (Details) $ in Thousands	6 Months Ended
	Mar. 31, 2020 USD ($)
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$ 101
Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$ 511

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Mar. 31, 2020	Sep. 30, 2019
Statement of Financial Position [Abstract]
Preferred stock, shares authorized (in shares)	1,000,000	1,000,000
Preferred stock, shares issued (in shares)	0	0
Common stock, par value per share (in dollars per share)	$ 1	$ 1.00
Common stock, shares authorized (in shares)	15,000,000	15,000,000
Common stock, shares issued (in shares)	8,416,145	8,416,145
Common stock, shares outstanding (in shares)	7,479,671	7,476,513
Treasury stock at cost, shares (in shares)	936,474	939,632

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended		6 Months Ended		12 Months Ended
	Mar. 31, 2020	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019	Sep. 30, 2019
Net cash provided by operating activities:
Net income		$ 3,566	$ 7,460	$ 4,464	$ 4,957
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, depletion and amortization		3,590	3,493	7,199	6,951
Deferred income tax (benefit) expense				(827)	73
Gain on sale of real estate, property and equipment and assets held for sale				(2,863)	(23)
Change in fair value of derivatives		0	33	0	989
Impairment of long-lived assets				723	0
Impairment of right-of-use asset		0		87
Stock-based compensation expense				790	223
Other				(36)	(51)
Changes in operating assets and liabilities:
Accounts receivable				(3,672)	(11,453)
Inventories				11,640	4,922
Prepaid expenses				(234)	92
Other assets				(387)	0
Accounts payable and accrued liabilities				(2,061)	370
Income tax payable				(2,876)	(852)
Other liabilities				(259)	(130)
Net cash provided by operating activities				11,688	6,068
Cash flows from investing activities:
Purchases of property and equipment				(9,960)	(9,524)
Net proceeds from sale of property and equipment and assets held for sale	$ 2,952			2,994	202
Change in deposits on purchase of citrus trees				(57)	(515)
Deposit on purchase of citrus grove				(25)	0
Advances on notes receivables, net				87	50
Net cash used in investing activities				(6,961)	(9,787)
Cash flows from financing activities:
Repayments on revolving lines of credit				(18,805)	(41,360)
Borrowings on revolving lines of credit	70,000			85,519	63,637
Principal payments on term loans				(9,820)	(5,437)
Treasury stock purchases				(238)	(25,576)
Payment on termination of sugarcane agreement				0	(11,300)
Dividends paid				(1,120)	(895)
Deferred financing costs				(23)	0
Net cash provided by (used in) financing activities				55,513	(20,931)
Net increase (decrease) in cash and cash equivalents and restricted cash				60,240	(24,650)
Cash and cash equivalents and restricted cash at beginning of the period				23,838	32,260	$ 32,260
Cash and cash equivalents and restricted cash at end of the period	$ 84,078	$ 84,078	$ 7,610	$ 84,078	$ 7,610	$ 23,838

XML

Description of Business and Basis of Presentation - Operating Leases (Details) $ in Thousands	Mar. 31, 2020 USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Right-of-use assets	$ 329
Current lease liabilities	167
Non-current lease liabilities	$ 252

XML

Segment Information (Tables)

6 Months Ended

Mar. 31, 2020

Segment Reporting [Abstract]

Schedule of information by business segment

Information by operating segment is as follows:

(in thousands)	Three Months Ended March 31,				Six Months Ended March 31,
	2020		2019		2020		2019
Revenues:
Alico Citrus	$	49,801	$	47,823	$	59,976	$	61,720
Water Resources and Other Operations	714		698		1,544		1,580
Total revenues	50,515		48,521		61,520		63,300
Operating expenses:
Alico Citrus	43,518		31,582		48,358		42,456
Water Resources and Other Operations	380		625		931		1,348
Total operating expenses	43,898		32,207		49,289		43,804
Gross profit:
Alico Citrus	6,283		16,241		11,618		19,264
Water Resources and Other Operations	334		73		613		232
Total gross profit	6,617		16,314		12,231		19,496
Depreciation, depletion and amortization:
Alico Citrus	3,416		3,334		6,853		6,621
Water Resources and Other Operations	46		37		92		87
Other Depreciation, Depletion and Amortization	128		122		254		243
Total depreciation, depletion and amortization	$	3,590	$	3,493	$	7,199	$	6,951

(in thousands)	March 31,		September 30,
	2020		2019
Assets:
Alico Citrus	$	452,581	$	401,212
Water Resources and Other Operations	18,325		15,332
Other Corporate Assets	1,378		844
Total Assets	$	472,284	$	417,388

XML

Subsequent Event

6 Months Ended

Mar. 31, 2020

Subsequent Events [Abstract]

Subsequent Events

Subsequent EventsOn May 4, 2020, the Company purchased 334 acres of citrus grove property for approximately $2,850,000. This purchase was identified as a like-kind asset, which was coordinated with the sale of certain sections of the East Ranch to allow the Company to defer the taxes relating to the gain on the sale of these certain sections (see Note 1. Description of Business and Basis of Presentation - Restricted Cash).

XML

Assets Held for Sale (Tables)

6 Months Ended

Mar. 31, 2020

Discontinued Operations and Disposal Groups [Abstract]

Schedule of assets held for sale

In accordance with its strategy to dispose of non-core and under-performing assets, the following assets have been classified as assets held for sale at March 31, 2020 and September 30, 2019:

(in thousands)	Carrying Value
	March 31,		September 30,
	2020		2019
East Ranch	$	1,366	$	1,442
Total Assets Held for Sale	$	1,366	$	1,442

XML

Earnings Per Common Share (Tables)

6 Months Ended

Mar. 31, 2020

Earnings Per Share [Abstract]

Schedule of basic and diluted earnings per common share

For the three and six months ended March 31, 2020 and 2019, basic and diluted earnings per common share were as follows:

(in thousands except per share amounts)
	Three Months Ended March 31,				Six Months Ended March 31,
	2020		2019		2020		2019
Net income attributable to Alico, Inc. common stockholders	$	3,571	$	7,547	$	4,362	$	5,080
Weighted average number of common shares outstanding - basic	7,480		7,463		7,478		7,471
Dilutive effect of equity-based awards	16		6		16		35
Weighted average number of common shares outstanding - diluted	7,496		7,469		7,494		7,506
Net income per common shares attributable to Alico, Inc. common stockholders:
Basic	$	0.48	$	1.01	$	0.58	$	0.68
Diluted	$	0.48	$	1.01	$	0.58	$	0.68

XML

Long-Term Debt and Lines of Credit - Schedule of Interest Costs Expensed and Capitalized (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019
Debt Disclosure [Abstract]
Interest expense	$ 1,452	$ 1,963	$ 2,996	$ 3,880
Interest capitalized	303	229	572	445
Total	$ 1,755	$ 2,192	$ 3,568	$ 4,325

XML

Property and Equipment, Net - Narrative (Details)					3 Months Ended		5 Months Ended	6 Months Ended		12 Months Ended
	Mar. 27, 2020 USD ($)	Sep. 27, 2019 USD ($) a	Sep. 26, 2019 USD ($)	Oct. 30, 2018 USD ($)	Mar. 31, 2020 USD ($) property	Mar. 31, 2019 USD ($)	Sep. 30, 2019 USD ($) a	Mar. 31, 2020 USD ($) property	Mar. 31, 2019 USD ($)	Sep. 30, 2019 USD ($) a
Property, Plant and Equipment [Line Items]
Gain on sale of investment in real estate					$ 2,838,000	$ 1,000		$ 2,863,000	$ 23,000
Discontinued Operations, Disposed of by Sale
Property, Plant and Equipment [Line Items]
Consideration for discontinued operation	$ 2,952,000			$ 206,000,000			$ 47,000			$ 47,000
Gain (loss) on disposal of discontinued operation	$ 2,838,000			$ 12,000,000
Citrus Blocks
Property, Plant and Equipment [Line Items]
Acres of land purchased | a							203			203
Gain on sale of investment in real estate							$ 100,000	$ 70,000		$ 1,950,000
Amount of collateral and release substituted							$ 1,800,000			1,800,000
Number of additional purchases | property					2			2
West Ranch | Discontinued Operations, Disposed of by Sale
Property, Plant and Equipment [Line Items]
Acres of land sold | a		5,500
Consideration for discontinued operation		$ 14,775,000
Gain (loss) on disposal of discontinued operation		13,033,000
Lease rate		$ 80,000	$ 98,750
Citrus trees
Property, Plant and Equipment [Line Items]
Asset impairment charges								$ 723,000		$ 244,000

XML

Inventories - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended	12 Months Ended
	Sep. 30, 2019	Mar. 31, 2020	Sep. 30, 2019	Sep. 30, 2018
Inventory [Line Items]
Proceeds received from insurance relating to property and casualty damage claims			$ 486
Proceeds from federal relief grants	$ 15,597	$ 4,629
Property and Casualty Claims
Inventory [Line Items]
Insurance proceeds received				$ 477
Crop Claims
Inventory [Line Items]
Insurance proceeds received				$ 8,952

XML

Related Party Transactions - Shared Services Agreement (Details) - TBCO - USD ($)	3 Months Ended		6 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019
Related Party Transaction [Line Items]
Payments for services and covenants			$ 618,000
Expense under shared services agreement	$ 0	$ 0	$ 0	$ 147,000

XML

Accrued Liabilities (Tables)

6 Months Ended

Mar. 31, 2020

Payables and Accruals [Abstract]

Schedule of accrued liabilities

Accrued liabilities consist of the following at March 31, 2020 and September 30, 2019:

(in thousands)	March 31,		September 30,
	2020		2019
Ad valorem taxes	$	692	$	2,117
Accrued interest	1,063		1,110
Accrued employee wages and benefits	1,372		2,525
Accrued dividends	673		448
Accrued contractual obligation associated with sale of real estate	—		402
Accrued harvest and haul	431		—
Consulting and separation charges	346		400
Accrued insurance	—		544
Other accrued liabilities	366		223
Total accrued liabilities	$	4,943	$	7,769

XML

Related Party Transactions

6 Months Ended

Mar. 31, 2020

Related Party Transactions [Abstract]

Related Party Transactions

Related Party Transactions

Henry R. Slack and George R. Brokaw

On December 31, 2016, the Company entered into new employment agreements (collectively, the “Employment Agreements”) with Henry R. Slack, and George R. Brokaw. Mr. Slack previously served as the Executive Chairman of the Company, and Mr. Brokaw previously served as the Executive Vice Chairman of the Company. The Employment Agreements provided for an annual base salary of $250,000 in the case of Mr. Slack and an annual base salary of $250,000 in the case of Mr. Brokaw.

Effective July 1, 2019, Mr. Slack resigned his employment with the Company as Executive Chairman. Effective December 31, 2019, Mr. Brokaw resigned his employment with the Company as Executive Vice Chairman. Mr. Slack and Mr. Brokaw continue to serve on the Board of the Company.

Remy W. Trafelet

On February 11, 2019, as contemplated by a settlement agreement between the Company, certain members of the Board of Directors, Mr. Trafelet, and certain third parties affiliated with Mr. Trafelet (the “Alico Settlement Agreement”) Mr. Trafelet submitted to the Board his resignation as President and Chief Executive Officer of the Company and a member of the Board, effective upon the execution of the Alico Settlement Agreement. Also, on February 11, 2019, as contemplated by the Alico Settlement Agreement, the Company entered into a consulting agreement (the "Consulting Agreement") with Mr. Trafelet and 3584 Inc., an entity controlled by Mr. Trafelet (the "Consultant"). Pursuant to the Consulting Agreement, Mr. Trafelet will make himself available to provide consulting services to the Company through the Consultant for up to 24 months. In exchange for the consulting services, the Consultant will receive an annual consulting fee of $400,000. As of March 31, 2020, the Company has paid approximately $453,000 towards these consulting fees. If the Company terminates the consulting period (other than in certain specified circumstances), the Company will continue to pay the consulting fees described above through the balance of the 24-month term.

Shared Services Agreement

The Company had a shared services agreement with Trafelet Brokaw Capital Management, L.P. (“TBCM”), whereby the Company reimbursed TBCM for use of office space and various administrative and support services. The agreement expired December 31, 2018 and was not extended or renewed. The annual cost of the office and services was approximately $618,000. The Company expensed $0 for the three and six months ended March 31, 2020, and expensed $0 and approximately $147,000 for the three and six months ended March 31, 2019, respectively.

Distribution of Shares by Alico’s Largest Shareholder

On November 12, 2019, 734 Investors, the Company’s largest shareholder from 2013 until November 12, 2019, distributed the 3,173,405 shares of Company common stock held by it, on a pro rata basis, to its members. The Company understands this share distribution was made in anticipation of the dissolution of 734 Investors. Transfers of these shares were not made pursuant to any current Alico registration statement.

XML

Inventories (Tables)

6 Months Ended

Mar. 31, 2020

Inventory Disclosure [Abstract]

Schedule of inventories

Inventories consist of the following at March 31, 2020 and September 30, 2019:

(in thousands)	March 31,		September 30,
	2020		2019
Unharvested fruit crop on the trees	$	27,054	$	39,276
Other	1,449		867
Total inventories	$	28,503	$	40,143

XML

Long-Term Debt and Lines of Credit - Schedule of Long-term Debt, Net of Current Portion (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Nov. 30, 2019	Sep. 30, 2019
Debt Instrument [Line Items]
Principal	$ 220,343
Deferred Financing Costs, Net	1,240		$ 1,369
Less current portion	5,130		5,338
Met Fixed-Rate Term Loans
Debt Instrument [Line Items]
Principal	86,563	$ 4,455	89,688
Deferred Financing Costs, Net	672		724
Met Variable-Rate Term Loans
Debt Instrument [Line Items]
Principal	42,406		43,844
Deferred Financing Costs, Net	309		334
Met Citree Term Loan
Debt Instrument [Line Items]
Principal	4,638		4,750
Deferred Financing Costs, Net	38		40
Pru Loans A & B
Debt Instrument [Line Items]
Principal	15,677		16,257
Deferred Financing Costs, Net	221		224
Pru Loan E
Debt Instrument [Line Items]
Principal	4,345		4,455
Deferred Financing Costs, Net	0		9
Pru Loan F
Debt Instrument [Line Items]
Principal	0		4,455
Deferred Financing Costs, Net	0		38
Term Loans and PRU Loans
Debt Instrument [Line Items]
Principal	153,629		163,449
Deferred Financing Costs, Net	1,240		1,369
Less current portion	5,130		5,338
Long-term debt	$ 148,499		$ 158,111

XML

Assets Held for Sale - Components (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Sep. 30, 2019
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Assets held for sale	$ 1,366	$ 1,442
Discontinued Operations, Held-for-sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Assets held for sale	1,366	1,442
Discontinued Operations, Held-for-sale | East Ranch
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Assets held for sale	$ 1,366	$ 1,442

XML

Long-Term Debt and Lines of Credit - Narrative (Details)		1 Months Ended		6 Months Ended
	Sep. 04, 2014 USD ($) a loan	Mar. 31, 2020 USD ($) a loan	Nov. 30, 2019 USD ($)	Mar. 31, 2020 USD ($) a loan	Mar. 31, 2019 USD ($)	Sep. 30, 2019 USD ($)	Mar. 31, 2018 USD ($)	Feb. 15, 2015 USD ($)	Sep. 30, 2014 USD ($)
Debt Instrument [Line Items]
Borrowings on revolving lines of credit		$ 70,000,000		$ 85,519,000	$ 63,637,000
Debt issuance cost, net		$ 1,240,000		$ 1,240,000		$ 1,369,000
Minimum debt service coverage ratio		1.10		1.10
Tangible net worth		$ 160,000,000		$ 160,000,000
Percentage of consolidated net income				10.00%
Annual increase of tangible net worth				$ 167,364,000
Minimum current ratio		1.50		1.50
Debt to total assets ratio		0.625		0.625
Limit on capital expenditures		$ 30,000,000		$ 30,000,000
Interest rate term loans		$ 220,343,000		$ 220,343,000
Silver Nip Citrus
Debt Instrument [Line Items]
Area of property that served as collateral (in acres) | a	1,500
Number of fixed rate term loans | loan	2
Covenant ratio		1.00		1.00
Silver Nip Citrus | Citrus Grove
Debt Instrument [Line Items]
Area of land owned (in acres) | a	1,500
Met Fixed-Rate Term Loans
Debt Instrument [Line Items]
Quarterly principal payments			$ 220,000	$ 2,281,250
Fixed interest rate		4.15%		4.15%
Prepayment amount of the fixed term loan (up to)		$ 8,750,000		$ 8,750,000
Availability under line of credit		5,625,000		5,625,000
Debt issuance cost, net		672,000		672,000		724,000
Interest rate term loans		$ 86,563,000	$ 4,455,000	86,563,000		$ 89,688,000
Met Fixed-Rate Term Loans | Silver Nip Citrus
Debt Instrument [Line Items]
Quarterly principal payments				$ 290,000
Fixed interest rate		5.35%		5.35%
Prepayment amount of the fixed term loan (up to)		$ 5,000,000		$ 5,000,000
Area of property that served as collateral (in acres) | a		5,700		5,700
Number of fixed rate term loans | loan		2		2
Interest rate term loans		$ 27,550,000		$ 27,550,000
Amount of prepayment							$ 4,453,000	$ 750,000
Amount of prepayment in excess of total without penalty				203,000
Premium payment of penalty				$ 22,000
Met Fixed-Rate Term Loans | Silver Nip Citrus | Prudential
Debt Instrument [Line Items]
Quarterly principal payments	$ 55,000
Interest rate term loans	$ 5,500,000
Met Variable-Rate Term Loans
Debt Instrument [Line Items]
LIBOR spread subject to adjustment period				2 years
Variable interest rate		3.43%		3.43%		3.91%
Debt issuance cost, net		$ 309,000		$ 309,000		$ 334,000
Interest rate term loans		42,406,000		$ 42,406,000		43,844,000
Met Variable-Rate Term Loans | LIBOR
Debt Instrument [Line Items]
LIBOR spread (as a percent)				1.65%
Fixed Rate Term Loan1 | Silver Nip Citrus
Debt Instrument [Line Items]
Fixed interest rate	3.85%
Fixed Rate Term Loan 2 | Silver Nip Citrus
Debt Instrument [Line Items]
Fixed interest rate	3.45%
Silver Nip Citrus Debt | Silver Nip Citrus
Debt Instrument [Line Items]
Debt issuance cost, net		$ 221,000		$ 221,000		271,000
Citrus Groves
Debt Instrument [Line Items]
Area of land (in acres) | a		38,200		38,200
Farm and Ranch Land
Debt Instrument [Line Items]
Area of land (in acres) | a		5,800		5,800
Line of Credit
Debt Instrument [Line Items]
Outstanding balance		$ 66,714,000		$ 66,714,000		0
Debt issuance cost, net		149,000		149,000		8,000
Revolving Credit Facility
Debt Instrument [Line Items]
Debt issuance cost, gross									$ 2,834,000
Debt issuance cost, net		1,130,000		1,130,000		1,066,000			$ 339,000
Revolving Credit Facility | Met Fixed-Rate Term Loans
Debt Instrument [Line Items]
Revolving line of credit		125,000,000		125,000,000
Revolving Credit Facility | Met Variable-Rate Term Loans
Debt Instrument [Line Items]
Revolving line of credit		57,500,000		57,500,000
Revolving Credit Facility | Line of Credit
Debt Instrument [Line Items]
Outstanding balance		20,000,000		20,000,000		0
Debt issuance cost, net		149,000		149,000		8,000
RLOC
Debt Instrument [Line Items]
Revolving line of credit		25,000,000		25,000,000
Availability under line of credit		5,000,000		$ 5,000,000		$ 25,000,000
Borrowings on revolving lines of credit		$ 20,000,000
Annual commitment fee (as a percent)				0.25%
RLOC | LIBOR
Debt Instrument [Line Items]
LIBOR spread (as a percent)				1.65%
RLOC | Met Variable-Rate Term Loans
Debt Instrument [Line Items]
LIBOR spread subject to adjustment period				2 years
Variable interest rate		3.43%		3.43%		3.91%
RLOC | Line of Credit
Debt Instrument [Line Items]
Outstanding balance		$ 20,000,000		$ 20,000,000		$ 0
WCLC
Debt Instrument [Line Items]
Revolving line of credit		$ 70,000,000		$ 70,000,000
Variable interest rate		3.33%		3.33%		3.85%
Availability under line of credit		$ 22,887,000		$ 22,887,000		$ 69,540,000
Borrowings on revolving lines of credit		50,000,000
Annual commitment fee (as a percent)				0.20%
WCLC | Letter of Credit
Debt Instrument [Line Items]
Revolving line of credit		2,000,000		$ 2,000,000		20,000,000
Outstanding balance		46,714,000		46,714,000		0
Outstanding letters of credit		399,000		$ 399,000
WCLC | Minimum
Debt Instrument [Line Items]
Annual commitment fee (as a percent)				0.20%
WCLC | Maximum
Debt Instrument [Line Items]
Annual commitment fee (as a percent)				0.30%
WCLC | LIBOR
Debt Instrument [Line Items]
LIBOR spread (as a percent)				1.75%
WCLC | LIBOR | Minimum
Debt Instrument [Line Items]
LIBOR spread (as a percent)				1.75%
WCLC | LIBOR | Maximum
Debt Instrument [Line Items]
LIBOR spread (as a percent)				2.50%
WCLC | Line of Credit
Debt Instrument [Line Items]
Outstanding balance		46,714,000		$ 46,714,000		0
Debt issuance cost, net		0		0		0
Letter of Credit
Debt Instrument [Line Items]
Debt issuance cost, gross		23,000		23,000		133,000
Metlife Term Loan | Citree
Debt Instrument [Line Items]
Revolving line of credit		$ 5,000,000		$ 5,000,000
Fixed interest rate		5.28%		5.28%
Outstanding balance		$ 4,638,000		$ 4,638,000		4,750,000
Debt issuance cost, net		$ 38,000		$ 38,000		$ 40,000
Area of property that served as collateral (in acres) | a		1,200		1,200

XML

Related Party Transactions - Remy Trafelet (Details) - Remy W. Trafelet - USD ($)		6 Months Ended
	Feb. 11, 2019	Mar. 31, 2020
Related Party Transaction [Line Items]
Period of consulting services provided (up to)	24 months
Payments for services and covenants	$ 400,000	$ 453,000

XML

Stockholders' Equity - Schedule of Treasury Stock Purchases and Issuance (Details) - USD ($) $ in Thousands	6 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Shares
Beginning Balance (in shares)	939,632
Purchased (in shares)	7,000
Issued to employees and directors (in shares)	(10,158)
Ending Balance (in shares)	936,474
Cost
Beginning Balance	$ 31,943
Purchased	238	$ 25,576
Issued to employees and directors	(397)
Ending Balance	$ 31,784

XML

Accrued Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Sep. 30, 2019
Payables and Accruals [Abstract]
Ad valorem taxes	$ 692	$ 2,117
Accrued interest	1,063	1,110
Accrued employee wages and benefits	1,372	2,525
Accrued dividends	673	448
Accrued contractual obligation associated with sale of real estate	0	402
Accrued harvest and haul	431	0
Consulting and separation charges	346	400
Accrued insurance	0	544
Other accrued liabilities	366	223
Total accrued liabilities	$ 4,943	$ 7,769

XML

Segment Information - Narrative (Details)	6 Months Ended
	Mar. 31, 2020 segment
Segment Reporting [Abstract]
Number of operating segments	2

XML

Long-Term Debt and Lines of Credit

6 Months Ended

Mar. 31, 2020

Debt Disclosure [Abstract]

Long-Term Debt and Lines of Credit

Long-Term Debt and Lines of Credit

The following table summarizes long-term debt and related deferred financing costs, net of accumulated amortization at March 31, 2020 and September 30, 2019:

	March 31, 2020				September 30, 2019
(in thousands)	Principal		Deferred Financing Costs, Net		Principal		Deferred Financing Costs, Net
Long-term debt, net of current portion:
Met Fixed-Rate Term Loans	$	86,563	$	672	$	89,688	$	724
Met Variable-Rate Term Loans	42,406		309		43,844		334
Met Citree Term Loan	4,638		38		4,750		40
Pru Loans A & B	15,677		221		16,257		224
Pru Loan E	4,345		—		4,455		9
Pru Loan F	—		—		4,455		38
	153,629		1,240		163,449		1,369
Less current portion	5,130		—		5,338		—
Long-term debt	$	148,499	$	1,240	$	158,111	$	1,369

The following table summarizes lines of credit and related deferred financing costs, net of accumulated amortization at March 31, 2020 and September 30, 2019:

	March 31, 2020				September 30, 2019
(in thousands)	Principal		Deferred Financing Costs, Net		Principal		Deferred Financing Costs, Net
Lines of Credit:
RLOC	$	20,000	$	149	$	—	$	8
WCLC	46,714		—		—		—
Lines of Credit	$	66,714	$	149	$	—	$	8

Future maturities of long-term debt and lines of credit as of March 31, 2020 are as follows:

(in thousands)
Due within one year	$	5,130
Due between one and two years	61,374
Due between two and three years	10,535
Due between three and four years	10,535
Due between four and five years	10,535
Due beyond five years	122,234
Total future maturities	$	220,343

Interest costs expensed and capitalized were as follows:

(in thousands)
	Three Months Ended March 31,				Six Months Ended March 31,
	2020		2019		2020		2019
Interest expense	$	1,452	$	1,963	$	2,996	$	3,880
Interest capitalized	303		229		572		445
Total	$	1,755	$	2,192	$	3,568	$	4,325

Debt

The Company's credit facilities consist of $125,000,000 in fixed interest rate term loans (“Met Fixed-Rate Term Loans”), $57,500,000 in variable interest rate term loans (“Met Variable-Rate Term Loans”), a $25,000,000 revolving line of credit (“RLOC”) with Metropolitan Life Insurance Company and New England Life Insurance Company (collectively “Met”), and a $70,000,000 working capital line of credit (“WCLC”) with Rabo Agrifinance, Inc. (“Rabo”).

The term loans and RLOC are secured by real property. The security for the term loans and RLOC consists of approximately 38,200 gross acres of citrus groves and 5,800 gross acres of ranch land. The WCLC is collateralized by the Company’s current assets and certain other personal property owned by the Company.

The term loans, collectively, are subject to quarterly principal payments of $2,281,250, and mature November 1, 2029. The Met Fixed-Rate Term Loans bear interest at 4.15% per annum, and the Met Variable-Rate Term Loans bear interest at a rate equal to 90 day LIBOR plus 165 basis points (the “LIBOR spread”). The LIBOR spread is subject to adjustment by Met beginning May 1, 2017 and is subject to further adjustment every two years thereafter until maturity. No adjustment was made at May 1, 2019. Interest on the term loans is payable quarterly. The interest rates on the Met Variable-Rate Term Loans were 3.43% per annum and 3.91% per annum as of March 31, 2020 and September 30, 2019, respectively. 

The Company may prepay up to $8,750,000 of the Met Fixed-Rate Term Loan principal annually without penalty, and any such prepayments may be applied to reduce subsequent mandatory principal payments. The maximum annual prepayment was made for calendar year 2015. During the first and second quarter of fiscal year 2018, the Company elected not to make its principal payment and utilized a portion of its 2015 prepayment to satisfy its principal payment requirements for such quarters. At March 31, 2020, the Company had $5,625,000 remaining available to reduce future mandatory principal payments should the Company elect to do so. The Met Variable-Rate Term Loans may be prepaid without penalty.

In March 2020, as a precautionary measure, the Company drew down an aggregate of $70,000,000 on its revolving credit facilities; $20,000,000 on its RLOC and $50,000,000 on its WCLC. This decision was made to safeguard the Company’s liquidity and to increase available cash on hand in the event of a more protracted COVID-19 outbreak.

The RLOC bears interest at a floating rate equal to 90 day LIBOR plus 165 basis points, payable quarterly. The LIBOR spread was adjusted by Met on May 1, 2017 and is subject to further adjustment every two years thereafter. No adjustment was made at May 1, 2019. In October 2019, the RLOC agreement was modified to extend the current maturity of November 1, 2019 to November 1, 2029. The RLOC is subject to an annual commitment fee of 25 basis points on the unused portion of the line of credit. The RLOC is available for funding general corporate needs. The variable interest rate was 3.43% and 3.91% per annum as of March 31, 2020 and September 30, 2019, respectively. There was $20,000,000 and $0 outstanding on the RLOC at March 31, 2020 and September 30, 2019, respectively. Availability under the RLOC was $5,000,000 and $25,000,000 as of March 31, 2020 and September 30, 2019, respectively.

The WCLC is a revolving credit facility and is available for funding working capital and general corporate requirements. The interest rate on the WCLC is based on the one month LIBOR, plus a spread, which is adjusted quarterly, based on the Company's debt service coverage ratio for the preceding quarter and can vary from 175 to 250 basis points. The rate is currently at LIBOR plus 175 basis points. The variable interest rate was 3.33% and 3.85% per annum as of March 31, 2020 and September 30, 2019, respectively. The WCLC agreement was amended on September 20, 2018, and the primary terms of the amendment were an extension of the maturity to November 1, 2021. There were no changes to the commitment amount or interest rate. The WCLC agreement provides for Rabo to issue up to $2,000,000, reduced from $20,000,000 during fiscal year 2019, in letters of credit on the Company’s behalf. As of March 31, 2020, there was approximately $399,000 in outstanding letters of credit, which correspondingly reduced the Company's availability under the line of credit.

The WCLC is subject to a quarterly commitment fee on the daily unused availability under the line computed as the commitment amount less the aggregate of the outstanding loans and outstanding letters of credit. The commitment fee is adjusted quarterly based on Alico's debt service coverage ratio for the preceding quarter and can vary from a minimum of 20 basis points to a maximum of 30 basis points. Commitment fees to date have been charged at 20 basis points.

There was $46,714,000 and $0 outstanding on the WCLC at March 31, 2020 and September 30, 2019, respectively. Availability under the WCLC was approximately $22,887,000 and $69,540,000 as of March 31, 2020 and September 30, 2019, respectively.

In 2014, the Company capitalized approximately $2,834,000 of debt financing costs related to the refinancing and approximately $339,000 of costs related to the retired debt. Additionally, financing costs of approximately $23,000 and $133,000 were incurred in the six months ended March 31, 2020 and for the fiscal year ended September 30, 2019, respectively, in connection with the extension of the RLOC. All costs are included in deferred financing and being amortized to interest expense over the applicable terms of the obligations. The unamortized balance of deferred financing costs related to the financing above was approximately $1,130,000 and approximately $1,066,000 at March 31, 2020 and September 30, 2019, respectively.

These credit facilities noted above are subject to various covenants including the following financial covenants: (i) minimum debt service coverage ratio of 1.10 to 1.00, (ii) tangible net worth of at least $160,000,000 increased annually by 10% of consolidated net income for the preceding years, or approximately $167,364,000 for the year ended September 30, 2019, (iii) minimum current ratio of 1.50 to 1.00, (iv) debt to total assets ratio not greater than .625 to 1.00, and, (v) solely in the case of the WCLC, a limit on capital expenditures of $30,000,000 per fiscal year. As of March 31, 2020, the Company was in compliance with all of the financial covenants.

Credit facilities also include a Met Life term loan collateralized by 1,200 gross acres of citrus grove owned by Citree ("Met Citree Loan"). This is a $5,000,000 credit facility that bears interest at a fixed rate of 5.28% per annum. Principal and interest payments are made on a quarterly basis. At March 31, 2020 and September 30, 2019 there was an outstanding balance of $4,638,000 and $4,750,000, respectively. The loan matures in February 2029. The unamortized balance of deferred financing costs related to this loan was approximately $38,000 and $40,000 at March 31, 2020 and September 30, 2019, respectively.

Transition from LIBOR

The Company is currently evaluating the impact of the transition from LIBOR as an interest rate benchmark to other potential alternative reference rates. Currently, the Company has debt instruments in place that reference LIBOR-based rates. The transition from LIBOR is estimated to take place in 2021 and management will continue to actively assess the related opportunities and risks involved in this transition.

Silver Nip Citrus Debt

There are two fixed-rate term loans, with an original combined balance of $27,550,000, bearing interest at 5.35% per annum (“Pru Loans A & B”). Principal of $290,000 is payable quarterly, together with accrued interest. On February 15, 2015, 734 Citrus Holdings, LLC d/b/a Silver Nip Citrus (“Silver Nip Citrus”) made a prepayment of $750,000. In addition, the Company made prepayments of approximately $4,453,000 in the second fiscal quarter of 2018 with proceeds from the sale of certain properties, which were collateralized under these loans. The Company may prepay up to $5,000,000 of principal without penalty. As such, the Company exceeded the allowed $5,000,000 prepayment by approximately $203,000 and was required to make a premium payment of approximately $22,000. The loans are collateralized by approximately 5,700 acres of citrus groves in Collier, Hardee, Highlands and Polk Counties, Florida and mature on June 1, 2029 and June 1, 2033, respectively.

Silver Nip Citrus entered into two additional fixed-rate term loans with Prudential to finance the acquisition of a 1,500 acre citrus grove on September 4, 2014. Each loan was in the original amount of $5,500,000. Principal of $55,000 per loan is payable quarterly, together with accrued interest. One loan bears interest at 3.85% per annum (“Pru Loan E”), while the other bears interest at 3.45% per annum (“Pru Loan F”). The interest rate on Pru Loan E is subject to adjustment on September 1, 2019 and every year thereafter until maturity. No adjustment was made at September 1, 2019. Both loans are collateralized by approximately 1,500 gross acres of citrus groves in Charlotte County, Florida.

In November 2019, the Company prepaid Pru Note F in full in the amount of $4,455,000. As a result of this prepayment, the Company’s required annual principal payments were reduced by $220,000 per annum. Pru Note E matures September 1, 2021.

The Silver Nip Citrus credit agreements are subject to a financial covenant whereby the consolidated current ratio requirement is 1.00 to 1.00. Silver Nip Citrus was in compliance with the current ratio covenant as of March 31, 2020.

The unamortized balance of deferred financing costs related to the Silver Nip Citrus debt was approximately $221,000 and $271,000 at March 31, 2020 and September 30, 2019, respectively.

XML

Earnings Per Common Share

6 Months Ended

Mar. 31, 2020

Earnings Per Share [Abstract]

Earnings Per Common Share

Earnings Per Common Share

Basic earnings per share for Alico's common stock is calculated by dividing net income attributable to Alico, Inc. common stockholders by the weighted average number of shares of common stock outstanding for the period. Diluted earnings per common share is similarly calculated, except that the calculation includes the dilutive effect of the assumed issuance of common shares issuable under equity-based compensation plans in accordance with the treasury stock method, except where the inclusion of such common shares would have an anti-dilutive impact.

For the three and six months ended March 31, 2020 and 2019, basic and diluted earnings per common share were as follows:

(in thousands except per share amounts)
	Three Months Ended March 31,				Six Months Ended March 31,
	2020		2019		2020		2019
Net income attributable to Alico, Inc. common stockholders	$	3,571	$	7,547	$	4,362	$	5,080
Weighted average number of common shares outstanding - basic	7,480		7,463		7,478		7,471
Dilutive effect of equity-based awards	16		6		16		35
Weighted average number of common shares outstanding - diluted	7,496		7,469		7,494		7,506
Net income per common shares attributable to Alico, Inc. common stockholders:
Basic	$	0.48	$	1.01	$	0.58	$	0.68
Diluted	$	0.48	$	1.01	$	0.58	$	0.68

For the three and six months ended March 31, 2020 there were anti-dilutive equity awards excluded from the calculation of diluted earnings per common share.

For the three and six months ended March 31, 2019, equity awards are comprised of 227,500 stock options granted to Executive Officers, after taking into effect the forfeitures of 832,500 stock options (see Note 11. "Stockholders Equity").

XML

Label	Element	Value
Cumulative Effect of New Accounting Principle in Period of Adoption	us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	$ 10,897,000
Retained Earnings [Member]
Cumulative Effect of New Accounting Principle in Period of Adoption	us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	10,897,000
Parent [Member]
Cumulative Effect of New Accounting Principle in Period of Adoption	us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	$ 10,897,000

XML

Description of Business and Basis of Presentation - Components of Lease Cost (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Mar. 31, 2020	Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Operating lease costs	$ 52	$ 104
Operating lease right-of-use asset impairment	$ 0	$ 87

XML

Stockholders' Equity (Tables)

6 Months Ended

Mar. 31, 2020

Equity [Abstract]

Schedule of stock options using valuation assumptions

The expected term of options granted is derived from the output of the option valuation model and represents the period of time that options granted are expected to be outstanding; the range given below results from different timeframes for the various market conditions being met.

2020 Option Grant

Expected Volatility	26.0	%
Expected Term (in years)	3.61
Risk Free Rate	1.60	%

2019 Option Grants

Expected Volatility	30.0	%
Expected Term (in years)	4.09
Risk Free Rate	2.95	%

2019 Modified Option Grant

Expected Volatility	25.0	%
Expected Term (in years)	1.50
Risk Free Rate	2.52	%

Schedule of treasury stock purchases and issuances

The following table illustrates the Company’s treasury stock activity for the six months ended March 31, 2020:

(in thousands, except share amounts)
	Shares		Cost
Balance as of September 30, 2019	939,632		$	31,943
Purchased	7,000		238
Issued to employees and directors	(10,158	)	(397		)
Balance as of March 31, 2020	936,474		$	31,784

XML

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2020	Sep. 30, 2019
Current assets:
Cash and cash equivalents	$ 80,407	$ 18,630
Accounts receivable, net	4,385	713
Inventories	28,503	40,143
Assets held for sale	1,366	1,442
Prepaid expenses and other current assets	1,521	1,049
Total current assets	116,182	61,977
Restricted cash	3,671	5,208
Property and equipment, net	347,816	345,648
Goodwill	2,246	2,246
Other non-current assets	2,369	2,309
Total assets	472,284	417,388
Current liabilities:
Accounts payable	5,154	4,163
Accrued liabilities	4,943	7,769
Long-term debt, current portion	5,130	5,338
Deferred retirement obligations	5,226	5,226
Income taxes payable	2,660	5,536
Other current liabilities	554	919
Total current liabilities	23,667	28,951
Long-term debt:
Principal amount, net of current portion	148,499	158,111
Less: deferred financing costs, net	(1,240)	(1,369)
Long-term debt less current portion and deferred financing costs, net	147,259	156,742
Lines of credit	66,714	0
Deferred income tax liabilities, net	31,298	32,125
Other liabilities	278	172
Total liabilities	269,216	217,990
Commitments and Contingencies (Note 12)
Stockholders' equity:
Preferred stock, no par value, 1,000,000 shares authorized; none issued	0	0
Common stock, $1.00 par value, 15,000,000 shares authorized; 8,416,145 shares issued and 7,479,671 and 7,476,513 shares outstanding at March 31, 2020 and September 30, 2019, respectively	8,416	8,416
Additional paid in capital	20,174	19,781
Treasury stock, at cost, 936,474 and 939,632 shares held at March 31, 2020 and September 30, 2019, respectively	(31,784)	(31,943)
Retained earnings	201,065
Total Alico stockholders' equity	197,871	194,303
Noncontrolling interest	5,197
Total stockholders' equity	203,068	199,398
Total liabilities and stockholders' equity	$ 472,284	$ 417,388

XML

Inventories - Components (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Sep. 30, 2019
Inventory Disclosure [Abstract]
Unharvested fruit crop on the trees	$ 27,054	$ 39,276
Other	1,449	867
Total inventories	$ 28,503	$ 40,143

XML

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED) (PARENTHETICAL) - $ / shares	3 Months Ended		6 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019
Statement of Stockholders' Equity [Abstract]
Cash dividends declared per common share (in dollars per share)	$ 0.09	$ 0.06	$ 0.18	$ 0.12

XML

Description of Business and Basis of Presentation (Policies)

6 Months Ended

Mar. 31, 2020

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Presentation

Basis of Presentation

The Company has prepared the accompanying financial statements on a condensed consolidated basis. These accompanying unaudited condensed consolidated interim financial statements, which are referred to herein as the “Financial Statements", have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to Article 10-01 of Regulation S-X of the U.S. Securities and Exchange Commission ("SEC") for interim financial information. These Financial Statements do not include all of the disclosures required for complete annual financial statements and, accordingly, certain information, footnotes and disclosures normally included in annual financial statements, prepared in accordance with U.S. GAAP, have been condensed or omitted in accordance with SEC rules and regulations. Accordingly, the Financial Statements should be read in conjunction with the Company's audited Consolidated Financial Statements and Notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended September 30, 2019, as filed with the SEC on December 5, 2019.

The Financial Statements presented in this Quarterly Report on Form 10-Q are unaudited. However, in the opinion of management, such Financial Statements include all adjustments, consisting solely of normal recurring adjustments, necessary to present fairly the financial position, results of operations and cash flows for the periods presented in conformity with U.S. GAAP applicable to interim periods.

Operating results for the interim periods presented are not necessarily indicative of the results that may be expected for the current fiscal year ending September 30, 2020. All intercompany transactions and account balances between the consolidated businesses have been eliminated.

Segments

Segments

Operating segments are defined in the criteria established under the Financial Accounting Standards Board - Accounting Standards Codification (“FASB ASC”) Topic 280 as components of public entities that engage in business activities from which they may earn revenues and incur expenses for which separate financial information is available and which is evaluated regularly by the Company’s chief operating decision maker (“CODM”) in deciding how to assess performance and allocate resources. The Company’s CODM assesses performance and allocates resources based on two operating segments: (i) Alico Citrus and (ii) Water Resources and Other Operations.

Principles of Consolidation

Principles of Consolidation

The Financial Statements include the accounts of Alico and the accounts of all the subsidiaries in which a controlling interest is held by the Company. Under U.S. GAAP, consolidation is generally required for investments of more than 50% of the outstanding voting stock of an investee, except when control is not held by the majority owner. The Company’s subsidiaries include: Alico Land Development, Inc., Alico-Agri, Ltd., Alico Plant World, LLC, Alico Fruit Company, LLC, Alico Citrus Nursery, LLC, Alico Chemical Sales, LLC, 734 Citrus Holdings, LLC and subsidiaries, Alico Skink Mitigation, LLC and Citree Holdings 1, LLC (“Citree”). The Company considers the criteria established under FASB ASC Topic 810, “Consolidations” in its consolidation process. All significant intercompany balances and transactions have been eliminated in consolidation.

Use of Estimates

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities as of the date of the accompanying Financial Statements, the disclosure of contingent assets and liabilities in the Financial Statements and the accompanying Notes, and the reported amounts

of revenues and expenses and cash flows during the periods presented. Actual results could differ from those estimates. The Company evaluates estimates on an ongoing basis. The estimates are based on current and expected economic conditions, historical experience, the experience and judgment of the Company’s management and various other specific assumptions that the Company believes to be reasonable.

Recent Accounting Pronouncements and Recently Adopted Accounting Pronouncements

Recent Accounting Pronouncements

In January 2017, the FASB issued Accounting Standards Update (“ASU”) 2017-04, “Intangibles-Goodwill and Other” (Topic 350), which simplifies the accounting for goodwill impairment. The updated guidance eliminates Step 2 of the impairment test, which requires entities to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, entities will record an impairment charge based on the excess of a reporting unit’s carrying amount over its fair value, determined in Step 1. This guidance will become effective for us in the fiscal years beginning after December 15, 2019, including interim periods within those reporting periods. We will adopt this guidance using a prospective approach. The Company does not expect the adoption of ASU 2017-04 will have a material impact on its consolidated financial statements and will adopt the standard effective October 1, 2020.

In August 2018, the FASB issued ASU 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurements” (“ASU 2018-13”), which aims to improve the overall usefulness of disclosures to financial statement users and reduce unnecessary costs to companies when preparing fair value measurement disclosures. ASU 2018-13 is effective for annual and interim periods in the fiscal years beginning after December 15, 2019. Retrospective adoption is required, except for certain disclosures, which will be required to be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. The Company does not expect the adoption of ASU 2018-13 will have a material impact on its consolidated financial statements and will adopt the standard effective October 1, 2020.

In November 2018, the FASB issued ASU 2018-19, “Codification Improvements to Topic 326, Financial Instruments-Credit Losses.” ASU 2018-19 clarifies that receivables arising from operating leases are not within the scope of Subtopic 326-20. Instead,

impairment of receivables arising from operating leases should be accounted for in accordance with Leases (Topic 842). The standard is effective for us on October 1, 2020, with early adoption permitted. The Company does not expect the adoption of ASU 2018-19 to have a material impact on its consolidated financial statements of the Company.

The Company has reviewed other recently issued accounting standards which have not yet been adopted in order to determine their potential effect, if any, on the results of operations or financial condition. Based on the review of these other recently issued standards, the Company does not currently believe that any of those accounting pronouncements will have a significant effect on its current or future financial position, results of operations, cash flows or disclosures.

Recently Adopted Accounting Pronouncements

In February 2016, the FASB issued ASU 2016-02, “Leases (Topic 842).” This guidance requires entities that sign leases as a lessee to recognize right-of-use assets and lease liabilities for those leases classified as operating leases under previous U.S. GAAP. The accounting applied by a lessor is largely unchanged from that applied under previous U.S. GAAP. The Company adopted ASU 2016-02 on October 1, 2019.

The Company determines whether an arrangement is a lease at inception. The Company’s leases consist of operating lease arrangements for certain office space and IT facilities. When these lease arrangements include lease and non-lease components, the Company accounts for lease components and non-lease components (e.g. common area maintenance) separately based on their relative standalone prices.

Any lease arrangements with an initial term of 12 months or less are not recorded on the Company’s Condensed Consolidated Balance Sheet, and it recognizes lease cost for these lease arrangements on a straight-line basis over the lease term. Many lease arrangements provide the options to exercise one or more renewal terms or to terminate the lease arrangement. The Company includes these options when it will be reasonably certain to exercise them in the lease term used to establish the right of use assets and lease liabilities. Generally, lease agreements do not include an option to purchase the leased asset, residual value guarantees or material restrictive covenants.

As most of our lease arrangements do not provide an implicit interest rate, the Company applies an incremental borrowing rate based on the information available at the commencement date of the lease arrangement to determine the present value of lease payments.

No lease costs associated with finance leases and sale-leaseback transactions occurred and our lease income associated with lessor and sublease arrangements are not material to our Condensed Consolidated Financial Statements.

Seasonality

Seasonality

The Company is primarily engaged in the production of fruit for sale to citrus markets, which is of a seasonal nature, and subject to the influence of natural phenomena and wide price fluctuations. Historically, the second and third quarters of Alico's fiscal year produce the majority of the Company's annual revenue. Working capital requirements are typically greater in the first and fourth quarters of the fiscal year, coinciding with harvesting cycles. Because of the seasonality of the business, results for any quarter are not necessarily indicative of the results that may be achieved for the full fiscal year.

XML

Property and Equipment, Net (Tables)

6 Months Ended

Mar. 31, 2020

Property, Plant and Equipment [Abstract]

Schedule of property and equipment, net

Property and equipment, net consists of the following at March 31, 2020 and September 30, 2019:

(in thousands)	March 31,			September 30,
	2020			2019
Citrus trees	$	287,238		$	281,149
Equipment and other facilities	56,216			54,622
Buildings and improvements	8,189			8,224
Total depreciable properties	351,643			343,995
Less: accumulated depreciation and depletion	(109,662		)	(104,169		)
Net depreciable properties	241,981			239,826
Land and land improvements	105,835			105,822
Property and equipment, net	$	347,816		$	345,648

XML

Commitments and Contingencies - Purchase Commitments (Details) $ in Thousands	Mar. 31, 2020 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Outstanding purchase commitments	$ 2,288

XML

Related Party Transactions - Distribution of Shares by Alicos Largest Shareholder (Details)	Nov. 12, 2019 shares
Majority Shareholder | 734 Investors
Related Party Transaction [Line Items]
Distribution of common stock (in shares)	3,173,405

XML

Long-Term Debt and Lines of Credit - Schedule of Future Maturities of Debt and Lines of Credit (Details) $ in Thousands	Mar. 31, 2020 USD ($)
Debt Disclosure [Abstract]
Due within one year	$ 5,130
Due between one and two years	61,374
Due between two and three years	10,535
Due between three and four years	10,535
Due between four and five years	10,535
Due beyond five years	122,234
Principal	$ 220,343

XML

Property and Equipment, Net - Components (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Sep. 30, 2019
Property, Plant and Equipment [Line Items]
Property and equipment, net	$ 347,816	$ 345,648
Depreciable properties
Property, Plant and Equipment [Line Items]
Property and equipment, gross	351,643	343,995
Less: accumulated depreciation and depletion	(109,662)	(104,169)
Property and equipment, net	241,981	239,826
Citrus trees
Property, Plant and Equipment [Line Items]
Property and equipment, gross	287,238	281,149
Equipment and other facilities
Property, Plant and Equipment [Line Items]
Property and equipment, gross	56,216	54,622
Buildings and improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	8,189	8,224
Land and land improvements
Property, Plant and Equipment [Line Items]
Property and equipment, net	$ 105,835	$ 105,822

XML

Income Taxes - Narrative (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Mar. 31, 2019
Income Tax Contingency [Line Items]
Retained earnings	$ (201,065)
ASC 610-20
Income Tax Contingency [Line Items]
Deferred gain on sale		$ 3,704
Retained earnings		$ 3,704

XML

Stockholders' Equity - Narrative (Details) - USD ($)							3 Months Ended		6 Months Ended
	Oct. 11, 2019	Oct. 25, 2018	Oct. 03, 2018	Sep. 07, 2018	Sep. 05, 2018	Dec. 31, 2016	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019	Oct. 10, 2019	Sep. 30, 2019	Feb. 27, 2015
Class of Stock [Line Items]
Number of shares authorized to be repurchased (up to)											7,000
Stock compensation expense							$ 162,000	$ 355,000	$ 238,000	$ 476,000
Shares issued (in dollars per share)			$ 34.00
Shares issued (in shares)			752,234
Cost of shares			$ 25,575,956
Restricted Stock
Class of Stock [Line Items]
Stock compensation expense							26,000	52,000	26,000	52,000
Unrecognized expense							17,000		$ 17,000			$ 69,000
Unrecognized compensation cost, expected recognition period									2 months 12 days
Options
Class of Stock [Line Items]
Stock compensation expense							301,000	$ 383,000	$ 229,000	$ 518,000
Unrecognized expense							$ 496,000		$ 496,000			$ 502,000
Unrecognized compensation cost, expected recognition period									1 year 8 months 19 days
2015 Option Grants
Class of Stock [Line Items]
Number of shares authorized to be repurchased (up to)													1,250,000
2015 Option Grants | Minimum
Class of Stock [Line Items]
Award vesting period									1 year
2015 Option Grants | Maximum
Class of Stock [Line Items]
Award vesting period									6 years
2020 Option Grants
Class of Stock [Line Items]
Granted (in shares)	118,000
Shares issued (in dollars per share)	$ 33.96
Period following an executive's termination of employment for a number of reasons	18 months
Period following an executive's termination of employment without cause	12 months
Share price (in dollars per share)							$ 31.04		$ 31.04
Percentage of options									25.00%
2020 Option Grants | Tranche One
Class of Stock [Line Items]
Period of consecutive trading days	20 days
Amount per share (in dollars per share)	$ 35.00
Percentage of options	25.00%
2020 Option Grants | Tranche Two
Class of Stock [Line Items]
Period of consecutive trading days	20 days
Amount per share (in dollars per share)	$ 40.00
Percentage of options	25.00%
2020 Option Grants | Tranche Three
Class of Stock [Line Items]
Period of consecutive trading days	20 days
Amount per share (in dollars per share)	$ 45.00
Percentage of options	25.00%
2020 Option Grants | Tranche Four
Class of Stock [Line Items]
Period of consecutive trading days	20 days
Amount per share (in dollars per share)	$ 50.00
Percentage of options	25.00%
2020 Option Grants | Options
Class of Stock [Line Items]
Grants in period, weighted average (in dollars per share)									$ 3.20
2020 Option Grants | Maximum
Class of Stock [Line Items]
Share price (in dollars per share)							35.00		35.00
2019 Option Grants
Class of Stock [Line Items]
Shares issued (in dollars per share)		$ 33.34
Period following an executive's termination of employment for a number of reasons		18 months
Period following an executive's termination of employment without cause		12 months
Share price (in dollars per share)							31.04		$ 31.04
Number of awards vesting (in shares)									0
2019 Option Grants | Tranche One
Class of Stock [Line Items]
Period of consecutive trading days		20 days
Amount per share (in dollars per share)		$ 40.00
Number of awards vesting (in shares)		3,333
2019 Option Grants | Tranche Two
Class of Stock [Line Items]
Period of consecutive trading days		20 days
Amount per share (in dollars per share)		$ 45.00
Number of awards vesting (in shares)		3,333
2019 Option Grants | Tranche Three
Class of Stock [Line Items]
Period of consecutive trading days		20 days
Amount per share (in dollars per share)		$ 50.00
Number of awards vesting (in shares)		3,334
2019 Option Grants | Options
Class of Stock [Line Items]
Grants in period, weighted average (in dollars per share)									$ 7.10
2019 Option Grants | Maximum
Class of Stock [Line Items]
Share price (in dollars per share)							40.00		$ 40.00
2018 Option Grants
Class of Stock [Line Items]
Stock compensation expense									$ (823,000)
Shares issued (in dollars per share)				$ 33.60
Period following an executive's termination of employment for a number of reasons				18 months
Period following an executive's termination of employment without cause				12 months
Share price (in dollars per share)							31.04		$ 31.04
Percentage of options									25.00%
2018 Option Grants | Tranche One
Class of Stock [Line Items]
Period of consecutive trading days				20 years
Amount per share (in dollars per share)				$ 35.00
Percentage of options				25.00%
2018 Option Grants | Tranche Two
Class of Stock [Line Items]
Period of consecutive trading days				20 years
Amount per share (in dollars per share)				$ 40.00
Percentage of options				25.00%
2018 Option Grants | Tranche Three
Class of Stock [Line Items]
Period of consecutive trading days				20 years
Amount per share (in dollars per share)				$ 45.00
Percentage of options				25.00%
2018 Option Grants | Tranche Four
Class of Stock [Line Items]
Period of consecutive trading days				20 years
Amount per share (in dollars per share)				$ 50.00
Percentage of options				25.00%
2018 Option Grants | Maximum
Class of Stock [Line Items]
Share price (in dollars per share)							35.00		$ 35.00
2016 Option Grants
Class of Stock [Line Items]
Shares issued (in dollars per share)						$ 27.15
Period of consecutive trading days						20 days
Period following an executive's termination of employment for a number of reasons						18 months
Share price (in dollars per share)							31.04		$ 31.04
Number of awards vesting (in shares)									0
2016 Option Grants | Tranche One
Class of Stock [Line Items]
Amount per share (in dollars per share)						$ 60.00
Percentage of options						25.00%
2016 Option Grants | Tranche Two
Class of Stock [Line Items]
Amount per share (in dollars per share)						$ 75.00
Percentage of options						25.00%
2016 Option Grants | Tranche Three
Class of Stock [Line Items]
Amount per share (in dollars per share)						$ 90.00
Percentage of options						25.00%
2016 Option Grants | Tranche Four
Class of Stock [Line Items]
Amount per share (in dollars per share)						$ 105.00
Percentage of options						25.00%
2016 Option Grants | Maximum
Class of Stock [Line Items]
Share price (in dollars per share)							60.00		$ 60.00
2019 Modified Option Grants | Options
Class of Stock [Line Items]
Grants in period, weighted average (in dollars per share)									1.40
2019 Modified Option Grants | Maximum
Class of Stock [Line Items]
Share price (in dollars per share)							$ 40.00		$ 40.00
Chief Executive Officer | 2018 Option Grants
Class of Stock [Line Items]
Granted (in shares)				210,000
Chief Executive Officer | 2018 Option Grants | Tranche One
Class of Stock [Line Items]
Period of consecutive trading days									20 days
Amount per share (in dollars per share)									$ 35.00
Number of shares expected to vest (in shares)									26,250
Chief Executive Officer | 2018 Option Grants | Tranche Two
Class of Stock [Line Items]
Period of consecutive trading days									20 days
Amount per share (in dollars per share)									$ 40.00
Number of shares expected to vest (in shares)									26,250
Chief Executive Officer | 2016 Option Grants
Class of Stock [Line Items]
Granted (in shares)						300,000
Chief Executive Officer | 2019 Modified Option Grants
Class of Stock [Line Items]
Award expiration period									6 months
Chief Executive Officer | 2019 Modified Option Grants | Tranche One
Class of Stock [Line Items]
Number of shares expected to vest (in shares)									26,250
Board of Directors Chairman | 2016 Option Grants
Class of Stock [Line Items]
Granted (in shares)						225,000
Shares forfeited (in shares)					187,500
Chief Financial Officer | 2019 Option Grants
Class of Stock [Line Items]
Granted (in shares)		10,000
Chief Financial Officer | 2018 Option Grants
Class of Stock [Line Items]
Granted (in shares)				90,000

XML

Description of Business and Basis of Presentation - Lease Terms (Details)	Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Weighted-average remaining lease term	2 years 6 months 29 days
Weighted-average discount rate	3.89%

XML

Description of Business and Basis of Presentation

6 Months Ended

Mar. 31, 2020

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Description of Business and Basis of Presentation

Description of Business and Basis of Presentation

Description of Business

Alico, Inc., together with its subsidiaries (collectively, “Alico”, the “Company", "we", "us" or "our”), is a Florida agribusiness and land management company owning approximately 110,000 acres of land throughout Florida, including approximately 90,000 acres of mineral rights. The Company manages its land based upon its primary usage, and reviews its performance based upon two primary classifications: (i) Alico Citrus and (ii) Water Resources and Other Operations. Financial results are presented based upon these two business segments. 

Basis of Presentation

The Company has prepared the accompanying financial statements on a condensed consolidated basis. These accompanying unaudited condensed consolidated interim financial statements, which are referred to herein as the “Financial Statements", have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to Article 10-01 of Regulation S-X of the U.S. Securities and Exchange Commission ("SEC") for interim financial information. These Financial Statements do not include all of the disclosures required for complete annual financial statements and, accordingly, certain information, footnotes and disclosures normally included in annual financial statements, prepared in accordance with U.S. GAAP, have been condensed or omitted in accordance with SEC rules and regulations. Accordingly, the Financial Statements should be read in conjunction with the Company's audited Consolidated Financial Statements and Notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended September 30, 2019, as filed with the SEC on December 5, 2019.

The Financial Statements presented in this Quarterly Report on Form 10-Q are unaudited. However, in the opinion of management, such Financial Statements include all adjustments, consisting solely of normal recurring adjustments, necessary to present fairly the financial position, results of operations and cash flows for the periods presented in conformity with U.S. GAAP applicable to interim periods.

Operating results for the interim periods presented are not necessarily indicative of the results that may be expected for the current fiscal year ending September 30, 2020. All intercompany transactions and account balances between the consolidated businesses have been eliminated.

Segments

Operating segments are defined in the criteria established under the Financial Accounting Standards Board - Accounting Standards Codification (“FASB ASC”) Topic 280 as components of public entities that engage in business activities from which they may earn revenues and incur expenses for which separate financial information is available and which is evaluated regularly by the Company’s chief operating decision maker (“CODM”) in deciding how to assess performance and allocate resources. The Company’s CODM assesses performance and allocates resources based on two operating segments: (i) Alico Citrus and (ii) Water Resources and Other Operations.

Principles of Consolidation

The Financial Statements include the accounts of Alico and the accounts of all the subsidiaries in which a controlling interest is held by the Company. Under U.S. GAAP, consolidation is generally required for investments of more than 50% of the outstanding voting stock of an investee, except when control is not held by the majority owner. The Company’s subsidiaries include: Alico Land Development, Inc., Alico-Agri, Ltd., Alico Plant World, LLC, Alico Fruit Company, LLC, Alico Citrus Nursery, LLC, Alico Chemical Sales, LLC, 734 Citrus Holdings, LLC and subsidiaries, Alico Skink Mitigation, LLC and Citree Holdings 1, LLC (“Citree”). The Company considers the criteria established under FASB ASC Topic 810, “Consolidations” in its consolidation process. All significant intercompany balances and transactions have been eliminated in consolidation.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities as of the date of the accompanying Financial Statements, the disclosure of contingent assets and liabilities in the Financial Statements and the accompanying Notes, and the reported amounts

of revenues and expenses and cash flows during the periods presented. Actual results could differ from those estimates. The Company evaluates estimates on an ongoing basis. The estimates are based on current and expected economic conditions, historical experience, the experience and judgment of the Company’s management and various other specific assumptions that the Company believes to be reasonable.

Restricted Cash

Restricted cash is comprised of cash received from the sale of certain assets in which the use of funds is restricted and certain cash receipts from the sale of property which was being held specifically for the purpose of deferring a tax impact on the gain on sale of the property.

For certain sales transactions, the Company sells property which serves as collateral for specific debt obligations. As a result, the sale proceeds are only permitted to be used to purchase like-kind citrus groves acceptable to the debt holder or to pay down existing debt obligations and thus are included in restricted cash. During the fiscal year ended September 30, 2019, the Company utilized restricted cash of $1,800,000 towards the purchase of citrus groves. Such purchases are included as part of the collateral under certain debt obligations. Additionally, in November 2019, the Company utilized restricted cash to pay down existing debt, including outstanding interest on such debt, $4,489,000. If the remaining restricted cash is not otherwise used as of September 30, 2020, it will need to be used to pay down principal on Company debt.

In March 2020, the Company sold certain sections of the East     Ranch, from which the Company received net cash proceeds (through its qualified intermediary) of approximately $2,952,000. The Company used substantially all of the net cash proceeds to purchase a like-kind asset in May 2020 (See Note 14.” Subsequent Events”), which will allow the Company to defer substantially all of the tax impact of the gain on sale of the ranch land.

Revenue Recognition

Revenues are derived from the sale of processed fruit, fresh fruit, other citrus revenue, leasing revenue and other water and resource revenues. The majority of the revenue is generated from the sale of citrus fruit to processing facilities and fresh fruit sales. The Company recognizes revenue at the amount it expects to be entitled to be paid, determined when control of the products or services is transferred to its customers, which occurs upon delivery of and acceptance of the fruit by the customer and when the Company has a right to payment.

The Company has identified one performance obligation as the delivery of fruit to the processing facility of the customer (or harvesting of the citrus in the case of fresh fruit) for each separate variety of fruit identified in the contract. The Company initially recognizes revenue in an amount which is estimated based on contractual and market prices, including if such market price falls within the range (known as “floor” and “ceiling” prices) identified in the specific contracts. Additionally, the Company also has a contractual agreement whereby revenue is determined based on applying a cost-plus structure methodology. As such, since these contracts contain elements of variable consideration, the Company recognizes this variable consideration by using the expected value method. On a quarterly basis, management reviews the reasonableness of the revenues accrued based on buyers’ and processors’ advances to growers, cash and futures markets and experience in the industry. Adjustments are made throughout the year to these estimates as more current relevant industry information becomes available. Differences between the estimates and the final realization of revenues at the close of the harvesting season can result in either an increase or decrease to reported revenues. During the periods presented, no material adjustments were made to the reported citrus revenues.

Receivables under contracts, whereby pricing is based on contractual and market prices, are primarily paid at the floor amount and are collected within seven days after the harvest week. Any adjustments to pricing as a result of changes in market prices are collected or paid thirty to sixty days after final market pricing is published. Receivables under contracts, whereby pricing is based off a cost-plus structure methodology, are paid at the final prior year rate. Any adjustments to pricing as a result of the cost-plus calculation are collected or paid upon finalization of the calculation and agreement by both parties. As of March 31, 2020, and September 30, 2019, the Company had total receivables relating to sales of citrus of approximately $4,183,000 and $160,000, respectively, recorded in Accounts Receivable, net, in the Condensed Consolidated Balance Sheets.

Disaggregated Revenue

Revenues disaggregated by significant products and services for the three and six months ended March 31, 2020 and 2019 are as follows:

(in thousands)
	Three Months Ended March 31,				Six Months Ended March 31,
	2020		2019		2020		2019
Alico Citrus
Early and Mid-Season	$	22,237	$	27,929	$	31,303	$	39,574
Valencias	25,810		18,746		25,810		18,746
Fresh Fruit	802		671		1,537		2,577
Other	952		477		1,326		823
Total	$	49,801	$	47,823	$	59,976	$	61,720
Water Resources and Other Operations
Land and other leasing	$	679	$	658	$	1,342	$	1,392
Other	35		40		202		188
Total	$	714	$	698	$	1,544	$	1,580
Total Revenues	$	50,515	$	48,521	$	61,520	$	63,300

Noncontrolling Interest in Consolidated Subsidiary

The Financial Statements include all assets and liabilities of the less-than-100%-owned subsidiary the Company controls, Citree. Accordingly, the Company has recorded a noncontrolling interest in the equity of such entity. Citree had a net loss of approximately $11,000 and $177,000 for the three months ended March 31, 2020 and 2019, respectively, and had a net income of approximately $208,000 and a net loss of $251,000 for the six months ended March 31, 2020 and 2019, respectively, of which 51% is attributable to the Company. The shift to net income for the six months ended March 31, 2020 was the result of reimbursements received under the federal relief program relating to Hurricane Irma aggregating approximately $493,000.

Recent Accounting Pronouncements

In January 2017, the FASB issued Accounting Standards Update (“ASU”) 2017-04, “Intangibles-Goodwill and Other” (Topic 350), which simplifies the accounting for goodwill impairment. The updated guidance eliminates Step 2 of the impairment test, which requires entities to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, entities will record an impairment charge based on the excess of a reporting unit’s carrying amount over its fair value, determined in Step 1. This guidance will become effective for us in the fiscal years beginning after December 15, 2019, including interim periods within those reporting periods. We will adopt this guidance using a prospective approach. The Company does not expect the adoption of ASU 2017-04 will have a material impact on its consolidated financial statements and will adopt the standard effective October 1, 2020.

In August 2018, the FASB issued ASU 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurements” (“ASU 2018-13”), which aims to improve the overall usefulness of disclosures to financial statement users and reduce unnecessary costs to companies when preparing fair value measurement disclosures. ASU 2018-13 is effective for annual and interim periods in the fiscal years beginning after December 15, 2019. Retrospective adoption is required, except for certain disclosures, which will be required to be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. The Company does not expect the adoption of ASU 2018-13 will have a material impact on its consolidated financial statements and will adopt the standard effective October 1, 2020.

In November 2018, the FASB issued ASU 2018-19, “Codification Improvements to Topic 326, Financial Instruments-Credit Losses.” ASU 2018-19 clarifies that receivables arising from operating leases are not within the scope of Subtopic 326-20. Instead,

impairment of receivables arising from operating leases should be accounted for in accordance with Leases (Topic 842). The standard is effective for us on October 1, 2020, with early adoption permitted. The Company does not expect the adoption of ASU 2018-19 to have a material impact on its consolidated financial statements of the Company.

The Company has reviewed other recently issued accounting standards which have not yet been adopted in order to determine their potential effect, if any, on the results of operations or financial condition. Based on the review of these other recently issued standards, the Company does not currently believe that any of those accounting pronouncements will have a significant effect on its current or future financial position, results of operations, cash flows or disclosures.

Recently Adopted Accounting Pronouncements

In February 2016, the FASB issued ASU 2016-02, “Leases (Topic 842).” This guidance requires entities that sign leases as a lessee to recognize right-of-use assets and lease liabilities for those leases classified as operating leases under previous U.S. GAAP. The accounting applied by a lessor is largely unchanged from that applied under previous U.S. GAAP. The Company adopted ASU 2016-02 on October 1, 2019.

The Company determines whether an arrangement is a lease at inception. The Company’s leases consist of operating lease arrangements for certain office space and IT facilities. When these lease arrangements include lease and non-lease components, the Company accounts for lease components and non-lease components (e.g. common area maintenance) separately based on their relative standalone prices.

Any lease arrangements with an initial term of 12 months or less are not recorded on the Company’s Condensed Consolidated Balance Sheet, and it recognizes lease cost for these lease arrangements on a straight-line basis over the lease term. Many lease arrangements provide the options to exercise one or more renewal terms or to terminate the lease arrangement. The Company includes these options when it will be reasonably certain to exercise them in the lease term used to establish the right of use assets and lease liabilities. Generally, lease agreements do not include an option to purchase the leased asset, residual value guarantees or material restrictive covenants.

As most of our lease arrangements do not provide an implicit interest rate, the Company applies an incremental borrowing rate based on the information available at the commencement date of the lease arrangement to determine the present value of lease payments.

No lease costs associated with finance leases and sale-leaseback transactions occurred and our lease income associated with lessor and sublease arrangements are not material to our Condensed Consolidated Financial Statements.

Our operating leases are reported in our Condensed Consolidated Balance Sheet as follows:

(in thousands)
Operating lease components	Classification	March 31, 2020
Right-of-use assets	Other non-current assets	$	329
Current lease liabilities	Other current liabilities	$	167
Non-current lease liabilities	Other liabilities	$	252

Our operating leases cost components are reported in our Condensed Consolidated Statement of Operations as follows:

(in thousands)
		Three Months Ended		Six Months Ended
Operating lease components	Classification	March 31, 2020		March 31, 2020
Operating lease costs	General and administrative expenses	$	52	$	104
Operating lease right-of-use asset impairment	Other expense	$	—	$	87

Future maturities of our operating lease obligations as of March 31, 2020 by fiscal year are as follows:

(in thousands)
2020	$	82
2021	169
2022	175
2023	15
Total noncancelable future lease obligations	$	441
Less: Interest	(22		)
Present value of lease obligations	$	419

The weighted-average remaining lease term and weighted-average discount rate for our operating leases are as follows:

	March 31, 2020
Weighted-average remaining lease term	2.58	years
Weighted-average discount rate	3.89	%

Cash flow information related to leases consists of the following:
(in thousands)	Six Months Ended
	March 31, 2020
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	101
Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$	511

The COVID-19 Pandemic

On March 11, 2020, the World Health Organization declared the current novel coronavirus outbreak (“COVID-19”) to be a global pandemic. In response to this declaration and the rapid spread of COVID-19 within the United States, federal, state and local governments throughout the country have imposed varying degrees of restrictions on social and commercial activity to promote social distancing in an effort to slow the spread of the illness. These measures have begun to have a significant adverse impact upon many sectors of the economy, including certain agriculture businesses. To date, the Company has experienced no adverse impact from this pandemic.

Seasonality

The Company is primarily engaged in the production of fruit for sale to citrus markets, which is of a seasonal nature, and subject to the influence of natural phenomena and wide price fluctuations. Historically, the second and third quarters of Alico's fiscal year produce the majority of the Company's annual revenue. Working capital requirements are typically greater in the first and fourth quarters of the fiscal year, coinciding with harvesting cycles. Because of the seasonality of the business, results for any quarter are not necessarily indicative of the results that may be achieved for the full fiscal year.

XML

Description of Business and Basis of Presentation - Disaggregated Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019
Disaggregation of Revenue [Line Items]
Total Revenues	$ 50,515	$ 48,521	$ 61,520	$ 63,300
Alico Citrus
Disaggregation of Revenue [Line Items]
Total Revenues	49,801	47,823	59,976	61,720
Water Resources and Other Operations
Disaggregation of Revenue [Line Items]
Total Revenues	714	698	1,544	1,580
Early and Mid-Season | Alico Citrus
Disaggregation of Revenue [Line Items]
Total Revenues	22,237	27,929	31,303	39,574
Valencias | Alico Citrus
Disaggregation of Revenue [Line Items]
Total Revenues	25,810	18,746	25,810	18,746
Fresh Fruit | Alico Citrus
Disaggregation of Revenue [Line Items]
Total Revenues	802	671	1,537	2,577
Other | Alico Citrus
Disaggregation of Revenue [Line Items]
Total Revenues	952	477	1,326	823
Other | Water Resources and Other Operations
Disaggregation of Revenue [Line Items]
Total Revenues	35	40	202	188
Land and Other Leasing | Water Resources and Other Operations
Disaggregation of Revenue [Line Items]
Total Revenues	$ 679	$ 658	$ 1,342	$ 1,392

XML

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019
Operating revenues:
Total operating revenues	$ 50,515	$ 48,521	$ 61,520	$ 63,300
Operating expenses:
Total operating expenses	43,898	32,207	49,289	43,804
Gross profit	6,617	16,314	12,231	19,496
General and administrative expenses	2,953	4,654	5,713	8,104
Income from operations	3,664	11,660	6,518	11,392
Other income (expense), net:
Interest expense	(1,452)	(1,963)	(2,996)	(3,880)
Gain on sale of real estate, property and equipment and assets held for sale	2,838	1	2,863	23
Change in fair value of derivatives	0	(33)	0	(989)
Other income (expense)	12	23	(64)	10
Total other income (expense), net	1,398	(1,972)	(197)	(4,836)
Income before income taxes	5,062	9,688	6,321	6,556
Income tax provision	1,496	2,228	1,857	1,599
Net income	3,566	7,460	4,464	4,957
Net loss (income) attributable to noncontrolling interests	5	87	(102)	123
Net income attributable to Alico, Inc. common stockholders	$ 3,571	$ 7,547	$ 4,362	$ 5,080
Earnings per common share:
Basic (in dollars per share)	$ 0.48	$ 1.01	$ 0.58	$ 0.68
Diluted (in dollars per share)	$ 0.48	$ 1.01	$ 0.58	$ 0.68
Weighted-average number of common shares outstanding:
Basic (in shares)	7,480	7,463	7,478	7,471
Diluted (in shares)	7,496	7,469	7,494	7,506
Cash dividends declared per common share (in dollars per share)	$ 0.09	$ 0.06	$ 0.18	$ 0.12
Alico Citrus
Operating revenues:
Total operating revenues	$ 49,801	$ 47,823	$ 59,976	$ 61,720
Operating expenses:
Total operating expenses	43,518	31,582	48,358	42,456
Gross profit	6,283	16,241	11,618	19,264
Water Resources and Other Operations
Operating revenues:
Total operating revenues	714	698	1,544	1,580
Operating expenses:
Total operating expenses	380	625	931	1,348
Gross profit	$ 334	$ 73	$ 613	$ 232

XML

Assets Held for Sale

6 Months Ended

Mar. 31, 2020

Discontinued Operations and Disposal Groups [Abstract]

Assets Held for Sale

Assets Held for Sale

In accordance with its strategy to dispose of non-core and under-performing assets, the following assets have been classified as assets held for sale at March 31, 2020 and September 30, 2019:

(in thousands)	Carrying Value
	March 31,		September 30,
	2020		2019
East Ranch	$	1,366	$	1,442
Total Assets Held for Sale	$	1,366	$	1,442

On March 27, 2020, the Company sold certain sections at the East Ranch for approximately $2,952,000 and realized a gain of approximately $2,838,000.

During the fiscal year ended September 30, 2019, the Company sold certain trailers for approximately $47,000, and reclassified the remaining Assets Held for Sale to property and equipment, as management has determined not to offer for sale the remaining trailers.

On October 30, 2018, the Company sold certain parcels at Frostproof for approximately $206,000 and realized a gain of approximately $12,000.

XML

Derivative Asset and Derivative Liabilities/Deferred Gain on Sale

6 Months Ended

Mar. 31, 2020

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Asset and Derivative Liabilities/Deferred Gain on Sale

Derivative Asset and Derivative Liabilities/Deferred Gain on Sale

On November 21, 2014, the Company completed the sale of approximately 36,000 acres of land used for sugarcane production and land leasing in Hendry County, Florida to Global Ag Properties, LLC (“Global”) for approximately $97,900,000 in cash.

The sales price was subject to post-closing adjustments over a ten year period. The Company realized a gain of approximately $42,753,000 on the sale. Initially, $29,140,000 of the gain was deferred due to the Company’s continuing involvement in the property pursuant to a post-closing agreement and the potential price adjustments. The deferral represented the Company’s estimate of the maximum exposure to loss as a result of the continuing involvement. A net gain of approximately $13,613,000 was recognized at the time of the sale.

On October 1, 2018, the Company adopted ASC 610-20 and reevaluated the original post closing agreement under the guidance of ASC 610-20. As such, the Company recorded a derivative asset and derivative liabilities, which resulted in an increase to retained earnings of $10,897,000, net of taxes. This adjustment consisted of recording a derivative asset in the amount of $3,553,000 relating to potential payments due Alico from Global Ag Properties USA, LLC (“Global Ag”) and a derivative liability of $13,864,000 relating to potential payments due Global Ag from Alico. In the first quarter ended December 31, 2018, the Company recorded a loss of $956,000, which reflects the change in fair value of the derivative asset and derivative liabilities. In the three months ended March 31, 2019, the Company recorded an additional loss of $33,000.

On December 7, 2018, the Company and Global Ag entered into a Termination of Post Closing Agreement (the “2018 Post Closing Agreement”), pursuant to which the parties thereto agreed to certain terms and conditions under which a Post Closing Agreement, dated as of November 21, 2014 (the “2014 Post Closing Agreement”), may be terminated prior to the expiration of its stated term and with the payment of certain termination payments. The 2014 Post Closing Agreement was entered into in connection with the November 21, 2014 closing (the “Land Disposition”) of the sale by Alico to Global Ag of certain land used for sugarcane production and land leasing in Hendry County, Florida (the “Land”).

The 2014 Post Closing Agreement contained obligations, including possible payments by Alico and by Global Ag to each other over a ten year period following the closing of the Land Disposition, with the payments each year being based on the difference, if any, between certain computed amounts. Since the time of the closing of the Land Disposition and up through March 11, 2019, the computations have resulted in payments being made each year by Alico to Global Ag., which have aggregated approximately $6,518,000.

The 2018 Post Closing Agreement provided for (i) the termination of the 2014 Post Closing Agreement following the satisfaction of certain terms and conditions set forth in the termination agreement and (ii) the deposit by wire transfer into escrow of an aggregate of $11,300,000 following notification by Global Ag to Alico of the closing date of a sale of the Land by Global Ag to a third party. The conditions to the termination of the 2014 Post Closing Agreement and the payment of funds to Global Ag included (a) Global Ag’s assignment to the third party buyer, and such third party buyer’s assumption, of certain specified water management obligations, irrigation and drainage easement obligations, access easements obligations and obligations under a certain option to purchase certain railroad property owned by Alico, (b) delivery to the escrow agent of all instruments and consideration required to consummate the closing by Global Ag of the sale of the Land to the third party buyer, and (c) delivery to the escrow agent of copies of a water management project cooperation agreement running in favor of Alico and signed by Global Ag and the third party buyer.

On March 11, 2019, the 2018 Post Closing Agreement was completed. As such, all the conditions of the termination of the 2014 Post Closing Agreement, mentioned above, were met with the sale of the sugarcane land to a third party. As a result, the Company does not have any future liabilities or commitments to Global Ag in connection with the 2014 Post Closing Agreement.

XML

Stockholders' Equity

6 Months Ended

Mar. 31, 2020

Equity [Abstract]

Stockholders' Equity

Stockholders' Equity

Effective January 27, 2015, the Company’s Board of Directors adopted the 2015 Stock Incentive Plan (the “2015 Plan”) which provides for up to 1,250,000 common shares available for issuance to provide a long-term incentive plan for officers, employees, directors and/or consultants to directly link incentives to stockholder value. The 2015 Plan was approved by the Company’s stockholders in February 2015. The Company’s 2015 Plan provides for grants to executives in various forms including restricted shares of the Company’s common stock and stock options. Awards are discretionary and are determined by the Compensation Committee of the Board of Directors. Awards vest based upon service conditions. Non-vested restricted shares generally vest over requisite service periods of one to six years from the date of grant.

The Company recognizes stock-based compensation expense for (i) Board of Directors fees (paid in treasury stock), and (ii) other awards under the 2015 Plan (paid in restricted stock and stock options). Stock-based compensation expense is recognized in general and administrative expenses in the Condensed Consolidated Statements of Operations.

Stock Compensation - Board of Directors

The Board of Directors can either elect to receive stock compensation or cash for their fees for services provided. Stock-based compensation expense relating to the Board of Director fees was approximately $162,000 and $355,000 for the three and six months ended March 31, 2020, and approximately $238,000 and $476,000 for the three and six months ended March 31, 2019, respectively.

Restricted Stock

Stock compensation expense related to the Restricted Stock totaled approximately $26,000 and $52,000 for the three and six months ended March 31, 2020, and approximately $26,000 and $52,000 for the three and six months ended March 31, 2019, respectively. There was approximately $17,000 and $69,000 of total unrecognized stock compensation costs related to unvested stock compensation for the Restricted Stock grants at March 31, 2020 and September 30, 2019, respectively. The total unrecognized compensation cost is expected to be recognized over a weighted-average period of 0.20 years.

Stock Option Grant

Stock option grants of 118,000 options to certain Officers and Managers of the Company (collectively the “2020 Option Grants,”) were granted on October 11, 2019. The option exercise price was set at $33.96, the closing price on October 11, 2019. The 2020 Option Grants will vest as follows: (i) 25% of the options will vest if the price of the Company’s common stock during a consecutive 20-trading day period exceeds $35.00; (ii) 25% of the options will vest if the price of the Company’s common stock during a consecutive 20-trading day period exceeds $40.00; (iii) 25% of the options will vest if the price of the Company’s common stock during a consecutive 20-trading day period exceeds $45.00; and (iv) 25% of the options will vest if the price of the Company’s common stock during a consecutive 20-trading day period exceeds $50.00. If the applicable stock price hurdles have not been achieved by (A) the date that is 18 months following the termination of employment, if the employment is terminated due to death or disability, (B) the date that is 12 months following the termination of employment, if the employment is terminated by the Company without cause, by the employee with good reason, or due to the employee’s retirement, or (C) the date of the termination of employment for any other reason, then any unvested options will be forfeited. In addition, if the applicable stock price hurdles have not been achieved by December 31, 2022 then any unvested options will be forfeited. The 2020 Option Grants will also become vested to the extent that the applicable stock price hurdles are satisfied in connection with a change in control of the Company. As of March 31, 2020, the Company’s stock closed at $31.04 per share. During the six months ended March 31, 2020 the stock did trade above $35.00 per share for twenty consecutive days; accordingly, 25% of the 2020 Option Grants are vested at March 31, 2020 and the corresponding stock option expense was recognized during the three months ended March 31, 2020.

Stock option grants of 10,000 options to Mr. John Kiernan (the “2019 Option Grants”) were granted on October 25, 2018. The option exercise price for these options was set at $33.34, the closing price on October 25, 2018. The 2019 Option Grants will vest as follows: (i) 3,333 of the options will vest if the price of the Company’s common stock during a consecutive 20-trading day period exceeds $40.00; (ii) 3,333 of the options will vest if the price of the Company’s common stock during a consecutive 20-trading day period exceeds $45.00; (iii) 3,334 of the options will vest if the price of the Company’s common stock during a consecutive 20-trading day period exceeds $50.00. If the applicable stock price hurdles have not been achieved by (A) the date that is 18 months following the Executive’s termination of employment, if the Executive’s employment is terminated due to death or disability, (B) the date that is 12 months following the Executive’s termination of employment, if the Executive’s employment is terminated by the Company without cause, by the Executive with good reason, or due to the Executive’s retirement, or (C) the date of the termination of the Executive’s employment for any other reason, then any unvested options will be forfeited. In addition, if the applicable stock price hurdles have not been achieved by December 31, 2021 then any unvested options will be forfeited.

The 2019 Option Grants will also become vested to the extent that the applicable stock price hurdles are satisfied in connection with a change in control of the Company. As of March 31, 2020, the Company’s stock was trading at $31.04 per share, and since the date of grant the stock did not trade above $40.00 per share; accordingly, none of the 2019 Option Grants are vested at March 31, 2020 and the corresponding stock option expense was recognized during the three months ended March 31, 2020.

Stock option grants of 210,000 options to Mr. Remy Trafelet and 90,000 options to Mr. John Kiernan (collectively, the “2018 Option Grants”) were granted on September 7, 2018. The option exercise price for these options was set at $33.60, the closing price on September 7, 2018. The 2018 Option Grants will vest as follows: (i) 25% of the options will vest if the price of the Company’s common stock during a consecutive 20-trading day period exceeds $35.00; (ii) 25% of the options will vest if the price of the Company’s common stock during a consecutive 20-trading day period exceeds $40.00; (iii) 25% of the options will vest if the price of the Company’s common stock during a consecutive 20-trading day period exceeds $45.00; and (iv) 25% of the options will vest if the price of the Company’s common stock during a consecutive 20-trading day period exceeds $50.00. If the applicable stock price hurdles have not been achieved by (A) the date that is 18 months following the Executive’s termination of employment, if the Executive’s employment is terminated due to death or disability, (B) the date that is 12 months following the Executive’s termination of employment, if the Executive’s employment is terminated by the Company without cause, by the Executive with good reason, or due to the Executive’s retirement, or (C) the date of the termination of the Executive’s employment for any other reason, then any unvested options will be forfeited. In addition, if the applicable stock price hurdles have not been achieved by December 31, 2021 then any unvested options will be forfeited. The 2018 Option Grants will also become vested to the extent that the applicable stock price hurdles are satisfied in connection with a change in control of the Company. As of March 31, 2020, the Company’s stock was trading at $31.04 per share. During the six months ended March 31, 2020, the stock did trade above $35.00 per share for a consecutive twenty days; accordingly, 25% of Mr. Kiernan's 2018 Option Grants are vested at March 31, 2020 and the corresponding stock option expense was recognized during the three months ended March 31, 2020. As set forth below, more than a majority of the 2018 Option Grants issued to Mr. Trafelet were forfeited and the vesting conditions of the remainder were modified, all pursuant to the Alico Settlement Agreement, as defined below.

A stock option grant of 300,000 options in the case of Mr. Trafelet and 225,000 options in the case of each of Mr. Henry Slack and Mr. George Brokaw (collectively, the “2016 Option Grants”) were granted on December 31, 2016. The option price was set at $27.15, the closing price on December 31, 2016. The 2016 Option Grants will vest as follows: (i) 25% of the options will vest if the price of the Company’s common stock during a consecutive 20-trading day period exceeds $60.00; (ii) 25% of the options will vest if such price exceeds $75.00; (iii) 25% of the options will vest if such price exceeds $90.00; and (iv) 25% of the options will vest if such price exceeds $105.00. If the applicable stock price hurdles have not been achieved by (A) the second anniversary of the Executive’s termination of employment, if the Executive’s employment is terminated due to death or disability, (B) the date that is 18 months following the Executive’s termination of employment, if the Executive’s employment is terminated by the Company without cause, by the Executive with good reason, or due to the Executive’s retirement, or (C) the date of the termination of the Executive’s employment for any other reason, then any unvested options will be forfeited. In addition, if the applicable stock price hurdles have not been achieved by the fifth anniversary of the grant date (or the fourth anniversary of the grant date, in the case of the tranche described in clause (i) above), then any unvested options will be forfeited. The 2016 Option Grants will also become vested to the extent that the applicable stock price hurdles are satisfied in connection with a change in control of the Company. As of March 31, 2020, the Company’s stock was trading at $31.04 per share, and since the date of grant the stock did not trade above $60.00 per share; accordingly, none of the 2016 Option Grants are vested at March 31, 2020. As set forth below, all of the 2016 Option Grants issued to Mr. Trafelet were forfeited pursuant to the Alico Settlement Agreement, as defined below.

Additionally, 187,500 shares of the 2016 Option Grants made to each of Messrs. Slack and Brokaw were forfeited on September 5, 2018 and no replacement options were granted.

Pursuant to an Alico Settlement Agreement dated February 11, 2019 (described in Note 13. “Related Party Transactions”), which was unanimously approved by the Board of Directors, Mr. Trafelet agreed to voluntarily resign from his roles as President and Chief Executive Officer and a director of the Company. Under the Settlement Agreement, Mr. Trafelet forfeited (i) all of the 2016 Option Grants granted to him and (ii) all of the 2018 Option Grants granted to him in September 2018, other than 26,250 stock options that will vest if the minimum price of Alico's common stock over 20 consecutive trading days exceeds $35.00 per share and 26,250 stock options that will vest if the minimum price of Alico's common stock over 20 consecutive trading days exceeds $40.00 per share (“2019 Modified Option Grant”), in each case, by the first anniversary of the date of the Alico Settlement Agreement (collectively, the "Retained Options"). Any Retained Options that vest in accordance with their terms will expire on the date that is six months following the date on which the Retained Option vests, and any Retained Options that do not vest by the first anniversary of the Alico Settlement Agreement will be forfeited as of such first anniversary. As of March 31, 2020, the Company’s stock was trading at $31.04 per share. During the six months ended March 31, 2020, the stock did trade above $35.00 per share for a consecutive twenty days; accordingly, 26,250 stock options from the 2019 Modified Option Grants are vested at March 31, 2020. However, since the stock did not trade above $40.00 per share for a consecutive twenty days by the first anniversary of the date of the Alico Settlement Agreement, 26,250 stock options from the 2019 Modified Option Grants were forfeited. As a

result of the forfeited stock options relating to the 2016 Option Grants and 2018 Option Grants, the Company reversed $823,000 of previously recorded stock compensation expense during the year ended September 30, 2019, which is recorded as a reduction of General and Administrative expense.

Forfeitures of all stock options were recognized as incurred.

Stock compensation expense related to the options totaled approximately $301,000 and $383,000 for the three and six months ended March 31, 2020, respectively, and $229,000 and $518,000 for the three and six months ended March 31, 2019, respectively. At March 31, 2020 and September 30, 2019, there was approximately $496,000 and $502,000, respectively, of total unrecognized stock compensation costs related to unvested share-based compensation for the option grants. The total unrecognized compensation cost is expected to be recognized over a weighted-average period of 1.72 years.

The fair value of the 2020 and 2019 Option Grants was estimated on the date of grant using a Monte Carlo valuation model that uses the assumptions noted in the following table. The expected term of options granted is derived from the output of the option valuation model and represents the period of time that options granted are expected to be outstanding; the range given below results from different timeframes for the various market conditions being met.

2020 Option Grant

Expected Volatility	26.0	%
Expected Term (in years)	3.61
Risk Free Rate	1.60	%

The weighted-average grant-date fair value of the 2020 Option Grants was $3.20. There were no additional stock options granted or exercised for the six months ended March 31, 2020.

2019 Modified Option Grant

Expected Volatility	25.0	%
Expected Term (in years)	1.50
Risk Free Rate	2.52	%

The weighted-average grant-date fair value of the 2019 Modified Option Grant was $1.40.

2019 Option Grants

Expected Volatility	30.0	%
Expected Term (in years)	4.09
Risk Free Rate	2.95	%

The weighted-average grant-date fair value of the 2019 Option Grants was $7.10.

Stock Repurchase Authorizations

On October 3, 2018, the Company completed a tender offer of 752,234 shares at a price of $34.00 per share aggregating $25,575,956. 734 Investors, who was Alico's largest stockholder from 2013 until November 12, 2019, participated in the tender offer and sold a small percentage of its holdings.

On October 10, 2019, the Board of Directors authorized the repurchase of up to 7,000 shares of the Company’s common stock from 734 Investors in a privately negotiated repurchase of shares. On October 15, 2019, the Company entered into a repurchase agreement to repurchase a total of 7,000 shares of the Company’s common stock from 734 Investors, effective October 15, 2019.

The following table illustrates the Company’s treasury stock activity for the six months ended March 31, 2020:

(in thousands, except share amounts)
	Shares		Cost
Balance as of September 30, 2019	939,632		$	31,943
Purchased	7,000		238
Issued to employees and directors	(10,158	)	(397		)
Balance as of March 31, 2020	936,474		$	31,784

XML

Earnings Per Common Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019
Earnings Per Share [Abstract]
Net income attributable to Alico, Inc. common stockholders	$ 3,571	$ 7,547	$ 4,362	$ 5,080
Weighted average number of common shares outstanding - basic (in shares)	7,480,000	7,463,000	7,478,000	7,471,000
Dilutive effect of equity-based awards (in shares)	16,000	6,000	16,000	35,000
Weighted average number of common shares outstanding - diluted (in shares)	7,496,000	7,469,000	7,494,000	7,506,000
Net income per common shares attributable to Alico, Inc. common stockholders:
Basic (in dollars per share)	$ 0.48	$ 1.01	$ 0.58	$ 0.68
Diluted (in dollars per share)	$ 0.48	$ 1.01	$ 0.58	$ 0.68
Officer
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)		227,500		832,500

XML

Stockholders' Equity - Schedule of Stock Options Using Valuation Assumptions (Details) - Options	6 Months Ended
	Mar. 31, 2020
2020 Option Grants
Class of Stock [Line Items]
Expected Volatility (as a percent)	26.00%
Expected Term (in years)	3 years 7 months 9 days
Risk Free Rate	1.60%
2019 Modified Option Grant
Class of Stock [Line Items]
Expected Volatility (as a percent)	25.00%
Expected Term (in years)	1 year 6 months
Risk Free Rate	2.52%
2019 Option Grants
Class of Stock [Line Items]
Expected Volatility (as a percent)	30.00%
Expected Term (in years)	4 years 1 month 2 days
Risk Free Rate	2.95%

XML

Cover Page - shares	6 Months Ended
	Mar. 31, 2020	May 08, 2020
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2020
Document Transition Report	false
Entity File Number	0-261
Entity Registrant Name	ALICO, INC.
Entity Incorporation, State or Country Code	FL
Entity Tax Identification Number	59-0906081
Entity Address, Address Line One	10070 Daniels Interstate Court
Entity Address, Address Line Two	Suite 100
Entity Address, City or Town	Fort Myers
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	33913
City Area Code	(239)
Local Phone Number	226-2000
Title of 12(b) Security	Common Stock
Trading Symbol	ALCO
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Smaller Reporting Company	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		7,486,108
Amendment Flag	false
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q2
Entity Central Index Key	0000003545
Current Fiscal Year End Date	--09-30

XML

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED) - USD ($) shares in Thousands, $ in Thousands	Total	Directors	Executives	Common stock	Additional Paid-In Capital	Additional Paid-In Capital Directors	Additional Paid-In Capital Executives	Treasury Stock	Treasury Stock Directors	Treasury Stock Executives	Retained Earnings	Retained Earnings Executives	Total Alico, Inc. Equity	Total Alico, Inc. Equity Directors	Total Alico, Inc. Equity Executives	Noncontrolling Interest	Noncontrolling Interest Executives
Beginning balance (in shares) at Sep. 30, 2018				8,416
Beginning balance at Sep. 30, 2018	$ 177,595			$ 8,416	$ 20,126			$ (7,536)			$ 151,111		$ 172,117			$ 5,478
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	4,957										5,080		5,080			(123)
Dividends	(895)										(895)		(895)
Treasury stock purchases	(25,576)							(25,576)					(25,576)
Stock-based compensation		$ 476	$ 570			$ (140)	$ 570		$ 616					$ 476	$ 570
Executive forfeiture			(823)				(823)								(823)
Ending balance (in shares) at Mar. 31, 2019				8,416
Ending balance at Mar. 31, 2019	167,201			$ 8,416	19,733			(32,496)			166,193		161,846			5,355
Beginning balance (in shares) at Dec. 31, 2018				8,416
Beginning balance at Dec. 31, 2018	160,519			$ 8,416	20,384			(32,817)			159,094		155,077			5,442
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	7,460										7,547		7,547			(87)
Dividends	(448)										(448)		(448)
Stock-based compensation		238	255			(83)	255		321					238	255
Executive forfeiture			(823)				(823)			$ 0		$ 0			(823)		$ 0
Ending balance (in shares) at Mar. 31, 2019				8,416
Ending balance at Mar. 31, 2019	167,201			$ 8,416	19,733			(32,496)			166,193		161,846			5,355
Beginning balance (in shares) at Sep. 30, 2019				8,416
Beginning balance at Sep. 30, 2019	199,398			$ 8,416	19,781			(31,943)			198,049		194,303			5,095
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	4,464										4,362		4,362			102
Dividends	(1,346)										(1,346)		(1,346)
Treasury stock purchases	(238)							(238)					(238)
Stock-based compensation		355	435			(42)	435		397					355	435
Ending balance (in shares) at Mar. 31, 2020				8,416
Ending balance at Mar. 31, 2020	203,068			$ 8,416	20,174			(31,784)			201,065		197,871			5,197
Beginning balance (in shares) at Dec. 31, 2019				8,416
Beginning balance at Dec. 31, 2019	199,688			$ 8,416	19,857			(31,956)			198,169		194,486			5,202
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	3,566										3,571		3,571			(5)
Dividends	(675)										(675)		(675)
Stock-based compensation		$ 162	$ 327			$ (10)	$ 327		$ 172					$ 162	$ 327
Ending balance (in shares) at Mar. 31, 2020				8,416
Ending balance at Mar. 31, 2020	$ 203,068			$ 8,416	$ 20,174			$ (31,784)			$ 201,065		$ 197,871			$ 5,197

XML

Description of Business and Basis of Presentation - Maturities of Operating Lease Obligations (Details) $ in Thousands	Mar. 31, 2020 USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]
2020	$ 82
2021	169
2022	175
2023	15
Total noncancelable future lease obligations	441
Less: Interest	(22)
Present value of lease obligations	$ 419

XML

Description of Business and Basis of Presentation - (Details) a in Thousands, $ in Thousands	1 Months Ended		3 Months Ended		6 Months Ended		12 Months Ended
	Mar. 31, 2020 USD ($) a classification	Nov. 30, 2019 USD ($)	Mar. 31, 2020 USD ($) a classification	Mar. 31, 2019 USD ($)	Mar. 31, 2020 USD ($) a classification segment	Mar. 31, 2019 USD ($)	Sep. 30, 2019 USD ($)
Property, Plant and Equipment [Line Items]
Number of business segments | segment					2
Payments to acquire property plant and equipment					$ 9,960	$ 9,524
Repayments of debt		$ 4,489
Net proceeds from sale of ranch land	$ 2,952				$ 2,994	202
Revenue, description of timing					Receivables under contracts, whereby pricing is based on contractual and market prices, are primarily paid at the floor amount and are collected within seven days after the harvest week. Any adjustments to pricing as a result of changes in market prices are collected or paid thirty to sixty days after final market pricing is published.
Accounts receivable, net	4,385		$ 4,385		$ 4,385		$ 713
Net loss attributable to subsidiary			(5)	$ (87)	102	(123)
Proceeds from federal relief program					493
Citrus
Property, Plant and Equipment [Line Items]
Accounts receivable, net	$ 4,183		4,183		4,183		160
Citree
Property, Plant and Equipment [Line Items]
Net loss attributable to subsidiary			$ 11	$ 177	$ 208	$ 251
Land
Property, Plant and Equipment [Line Items]
Area of land owned (in acres) | a	110		110		110
Number of primary classifications | classification	2		2		2
Mineral Rights
Property, Plant and Equipment [Line Items]
Area of land owned (in acres) | a	90		90		90
Citrus Groves
Property, Plant and Equipment [Line Items]
Payments to acquire property plant and equipment							$ 1,800
Citree
Property, Plant and Equipment [Line Items]
Ownership interest (as a percent)	51.00%		51.00%		51.00%		51.00%

XML

Inventories

6 Months Ended

Mar. 31, 2020

Inventory Disclosure [Abstract]

Inventories

Inventories

Inventories consist of the following at March 31, 2020 and September 30, 2019:

(in thousands)	March 31,		September 30,
	2020		2019
Unharvested fruit crop on the trees	$	27,054	$	39,276
Other	1,449		867
Total inventories	$	28,503	$	40,143

The Company records its inventory at the lower of cost or net realizable value. For the three and six months ended March 31, 2020, the Company did not record any adjustments to reduce inventory to net realizable value.

During the fiscal year ended September 30, 2018, the Company received insurance proceeds relating to Hurricane Irma of approximately $477,000 for property and casualty damage claims and approximately $8,952,000 for crop claims. During the fiscal year ended September 30, 2019, the Company received additional insurance proceeds relating to Hurricane Irma of approximately $486,000 in property and casualty claims reimbursement. There are no further property and casualty or crop insurance claims pending relating to Hurricane Irma. These insurance proceeds are included as a reduction to operating expenses in the Condensed Consolidated Statements of Operations.

The Company is eligible for Hurricane Irma federal relief programs for block grants that are being administered through the State of Florida. During the fiscal year ended September 30, 2019, the Company received approximately $15,597,000 under the Florida Citrus Recovery Block Grant (“CRBG”) program. This represented Part 1 and a portion of Part 2 reimbursement under the three-part program. During the six months ended March 31, 2020, the Company received additional proceeds of approximately $4,629,000 under the Florida CRBG program. This represented the remaining portion of Part 2 reimbursement under the three-part program. The timing and amount to be received under Part 3 of the program, if any, has not been finalized. These federal relief proceeds are included as a reduction to operating expenses in the Condensed Consolidated Statements of Operations.

XML

Commitments and Contingencies

6 Months Ended

Mar. 31, 2020

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies

Letters of Credit

The Company had outstanding standby letters of credit in the total amount of approximately $399,000 and $460,000 at March 31, 2020 and September 30, 2019, respectively, to secure its various contractual obligations.

Legal Proceedings

From time to time, Alico may be involved in litigation relating to claims arising out of its operations in the normal course of business. There are no other current legal proceedings to which the Company is a party or of which any of its property is subject that it believes will have a material adverse effect on its financial position, results of operations or cash flows.

Purchase Commitments

The Company enters into contracts for the purchase of citrus trees during the normal course of its business. As of March 31, 2020, the Company had approximately $2,288,000 relating to outstanding commitments for these purchases that will be paid upon delivery of the remaining citrus trees.

XML

Property and Equipment, Net

6 Months Ended

Mar. 31, 2020

Property, Plant and Equipment [Abstract]

Property and Equipment, Net

Property and Equipment, Net

Property and equipment, net consists of the following at March 31, 2020 and September 30, 2019:

(in thousands)	March 31,			September 30,
	2020			2019
Citrus trees	$	287,238		$	281,149
Equipment and other facilities	56,216			54,622
Buildings and improvements	8,189			8,224
Total depreciable properties	351,643			343,995
Less: accumulated depreciation and depletion	(109,662		)	(104,169		)
Net depreciable properties	241,981			239,826
Land and land improvements	105,835			105,822
Property and equipment, net	$	347,816		$	345,648

During the six months ended March 31, 2020 and fiscal year ended September 30, 2019, the Company recorded impairments of approximately $723,000 and $244,000, respectively, relating to the loss of citrus trees.

During the fiscal year ended September 30, 2019, the Company purchased 203 acres of citrus blocks for approximately $1,950,000. These purchases were made from grove owners from within the Company’s existing grove locations. In April 2019, the lender, PGIM Real Estate Finance, LLC (“Prudential”), agreed to accept those purchases completed through April 2019 as substitute collateral and release $1,800,000 from restricted cash, which was completed in the fourth quarter of fiscal year 2019. In the fiscal year ended September 30, 2019, subsequent to April 2019, there were two additional purchases of Citrus blocks for approximately $100,000 that are not included as part of the substitution collateral. In the six months ended March 31, 2020, two additional purchases of Citrus blocks for approximately $70,000 were completed.

On September 27, 2019, the Company sold approximately 5,500 acres from its West Ranch for approximately $14,775,000 and realized a gain on sale of approximately $13,033,000. Upon the sale of these acres, the lease rate pertaining to the grazing and other rights was adjusted from $98,750 to $80,000 per month, as these acres were previously being leased to a third party.

XML

Income Taxes

6 Months Ended

Mar. 31, 2020

Income Tax Disclosure [Abstract]

Income Taxes

Income Taxes

In October 2019, the Internal Revenue Service concluded its audit of the September 30, 2015 tax year with no changes. The Federal and state filings remain subject to examination by tax authorities for tax periods ending after September 30, 2015.

The impact of adopting ASC 610-20 was modified in the quarter ended March 31, 2019 to reflect the deferred tax impact of this adoption. The deferred tax asset related to the deferred gain on sale has been decreased by $3,704,000 with a corresponding decrease to retained earnings in the quarter ended March 31, 2019, offsetting the October 1, 2018 increase to retained earnings for the ASC 610-20 implementation (see Note 7. “Derivative Asset and Derivative Liabilities/Deferred Gain on Sale”).

On March 27, 2020, President Trump signed into law the Coronavirus Aid, Relief, and Economic Security Act (H.R. 748) (the “CARES Act”). Among the changes to the U.S. federal income tax rules, the CARES Act restored net operating loss carryback rules that were eliminated by the 2017 Tax Cuts and Jobs Act, modified the limit on the deduction for net interest expense, and accelerated the timeframe for refunds of AMT credit carryovers. The Company does not expect the CARES Act will have any material impact on the Company’s cash tax liability or financial condition.

XML

Description of Business and Basis of Presentation (Tables)

6 Months Ended

Mar. 31, 2020

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of disaggregation of revenue

Revenues disaggregated by significant products and services for the three and six months ended March 31, 2020 and 2019 are as follows:

(in thousands)
	Three Months Ended March 31,				Six Months Ended March 31,
	2020		2019		2020		2019
Alico Citrus
Early and Mid-Season	$	22,237	$	27,929	$	31,303	$	39,574
Valencias	25,810		18,746		25,810		18,746
Fresh Fruit	802		671		1,537		2,577
Other	952		477		1,326		823
Total	$	49,801	$	47,823	$	59,976	$	61,720
Water Resources and Other Operations
Land and other leasing	$	679	$	658	$	1,342	$	1,392
Other	35		40		202		188
Total	$	714	$	698	$	1,544	$	1,580
Total Revenues	$	50,515	$	48,521	$	61,520	$	63,300

Condensed balance sheet

Our operating leases are reported in our Condensed Consolidated Balance Sheet as follows:

(in thousands)
Operating lease components	Classification	March 31, 2020
Right-of-use assets	Other non-current assets	$	329
Current lease liabilities	Other current liabilities	$	167
Non-current lease liabilities	Other liabilities	$	252

Components of lease cost

The weighted-average remaining lease term and weighted-average discount rate for our operating leases are as follows:

	March 31, 2020
Weighted-average remaining lease term	2.58	years
Weighted-average discount rate	3.89	%

Cash flow information related to leases consists of the following:
(in thousands)	Six Months Ended
	March 31, 2020
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	101
Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$	511

Our operating leases cost components are reported in our Condensed Consolidated Statement of Operations as follows:

(in thousands)
		Three Months Ended		Six Months Ended
Operating lease components	Classification	March 31, 2020		March 31, 2020
Operating lease costs	General and administrative expenses	$	52	$	104
Operating lease right-of-use asset impairment	Other expense	$	—	$	87

Maturities of our operating lease obligations

Future maturities of our operating lease obligations as of March 31, 2020 by fiscal year are as follows:

(in thousands)
2020	$	82
2021	169
2022	175
2023	15
Total noncancelable future lease obligations	$	441
Less: Interest	(22		)
Present value of lease obligations	$	419

XML

Long-Term Debt and Lines of Credit (Tables)

6 Months Ended

Mar. 31, 2020

Debt Disclosure [Abstract]

Schedule of long-term debt, net of current portion

The following table summarizes long-term debt and related deferred financing costs, net of accumulated amortization at March 31, 2020 and September 30, 2019:

	March 31, 2020				September 30, 2019
(in thousands)	Principal		Deferred Financing Costs, Net		Principal		Deferred Financing Costs, Net
Long-term debt, net of current portion:
Met Fixed-Rate Term Loans	$	86,563	$	672	$	89,688	$	724
Met Variable-Rate Term Loans	42,406		309		43,844		334
Met Citree Term Loan	4,638		38		4,750		40
Pru Loans A & B	15,677		221		16,257		224
Pru Loan E	4,345		—		4,455		9
Pru Loan F	—		—		4,455		38
	153,629		1,240		163,449		1,369
Less current portion	5,130		—		5,338		—
Long-term debt	$	148,499	$	1,240	$	158,111	$	1,369

Schedule of lines of credit

The following table summarizes lines of credit and related deferred financing costs, net of accumulated amortization at March 31, 2020 and September 30, 2019:

	March 31, 2020				September 30, 2019
(in thousands)	Principal		Deferred Financing Costs, Net		Principal		Deferred Financing Costs, Net
Lines of Credit:
RLOC	$	20,000	$	149	$	—	$	8
WCLC	46,714		—		—		—
Lines of Credit	$	66,714	$	149	$	—	$	8

Schedule of future maturities of debt and lines of credit

Future maturities of long-term debt and lines of credit as of March 31, 2020 are as follows:

(in thousands)
Due within one year	$	5,130
Due between one and two years	61,374
Due between two and three years	10,535
Due between three and four years	10,535
Due between four and five years	10,535
Due beyond five years	122,234
Total future maturities	$	220,343

Schedule of interest costs expensed and capitalized

Interest costs expensed and capitalized were as follows:

(in thousands)
	Three Months Ended March 31,				Six Months Ended March 31,
	2020		2019		2020		2019
Interest expense	$	1,452	$	1,963	$	2,996	$	3,880
Interest capitalized	303		229		572		445
Total	$	1,755	$	2,192	$	3,568	$	4,325

XML

Related Party Transactions - Henry R. Slack and George R. Brokaw (Details)	Dec. 31, 2016 USD ($)
Henry R. Slack
Related Party Transaction [Line Items]
Annual base salary	$ 250,000
George R. Brokaw
Related Party Transaction [Line Items]
Annual base salary	$ 250,000

XML

Subsequent Event (Details) - Subsequent Event $ in Thousands	May 04, 2020 USD ($) a
Subsequent Event [Line Items]
Acres of land purchased | a	334
Like-kind asset purchased | $	$ 2,850

XML

Long-Term Debt and Lines of Credit - Schedule of Lines of Credit (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Sep. 30, 2019	Sep. 30, 2014
Line of Credit Facility [Line Items]
Deferred Financing Costs, Net	$ 1,240	$ 1,369
RLOC
Line of Credit Facility [Line Items]
Deferred Financing Costs, Net	1,130	1,066	$ 339
Line of Credit
Line of Credit Facility [Line Items]
Principal	66,714	0
Deferred Financing Costs, Net	149	8
Line of Credit | RLOC
Line of Credit Facility [Line Items]
Principal	20,000	0
Deferred Financing Costs, Net	149	8
Line of Credit | WCLC
Line of Credit Facility [Line Items]
Principal	46,714	0
Deferred Financing Costs, Net	$ 0	$ 0

XML

Assets Held for Sale - Narrative (Details) - Discontinued Operations, Disposed of by Sale - USD ($) $ in Thousands	Mar. 27, 2020	Oct. 30, 2018	Sep. 30, 2019
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Consideration for discontinued operation	$ 2,952	$ 206,000	$ 47
Gain (loss) on disposal of discontinued operation	$ 2,838	$ 12,000